Generated Narrative: Library HIVConcepts
| Depends On | Code System HIVConcepts | WHO SMART HIV Concepts CodeSystem |
| Depends On | Value Set Referred by Choices | Referred by ValueSet |
| Depends On | Value Set Country of birth Choices | Country of birth ValueSet |
| Depends On | Value Set Gender Choices | Gender ValueSet |
| Depends On | Value Set Sex Choices | Sex ValueSet |
| Depends On | Value Set Marital Status Choices | Marital Status ValueSet |
| Depends On | Value Set Administrative Area Choices | Administrative Area ValueSet |
| Depends On | Value Set Communication preferences Choices | Communication preference(s) ValueSet |
| Depends On | Value Set Reason for visit - HIV.B.DE1 Choices | Reason for visit ValueSet |
| Depends On | Value Set Referred through partner services Choices | Referred through partner services ValueSet |
| Depends On | Value Set Type of contact or partner for partner services Choices | Type of contact or partner for partner services ValueSet |
| Depends On | Value Set Testing entry point Choices | Testing entry point ValueSet |
| Depends On | Value Set Entry point for community-level testing Choices | Entry point for community-level testing ValueSet |
| Depends On | Value Set Entry point for facility-level testing - HIV.B.DE22 Choices | Entry point for facility-level testing ValueSet |
| Depends On | Value Set Partner HIV status reported Choices | Partner HIV status (reported) ValueSet |
| Depends On | Value Set Partner is from a key population Choices | Partner is from a key population ValueSet |
| Depends On | Value Set HIV self-test result Choices | HIV self-test result ValueSet |
| Depends On | Value Set Key population member type - HIV.B.DE50 Choices | Key population member type ValueSet |
| Depends On | Value Set HIV exposure type Choices | HIV exposure type ValueSet |
| Depends On | Value Set HIV diagnosing facility Choices | HIV diagnosing facility ValueSet |
| Depends On | Value Set HIV serotype Choices | HIV serotype ValueSet |
| Depends On | Value Set Type of contact elicited Choices | Type of contact elicited ValueSet |
| Depends On | Value Set HIV test type - HIV.B.DE81 Choices | HIV test type ValueSet |
| Depends On | Value Set Assay number in testing strategy - HIV.B.DE88 Choices | Assay number in testing strategy ValueSet |
| Depends On | Value Set Test result of HIV assay 1 - HIV.B.DE94 Choices | Test result of HIV assay 1 ValueSet |
| Depends On | Value Set Test result of HIV assay 2 - HIV.B.DE98 Choices | Test result of HIV assay 2 ValueSet |
| Depends On | Value Set Test result of HIV assay 3 - HIV.B.DE102 Choices | Test result of HIV assay 3 ValueSet |
| Depends On | Value Set Test result of HIV assay 1 repeated - HIV.B.DE106 Choices | Test result of HIV assay 1 repeated ValueSet |
| Depends On | Value Set HIV test result - HIV.B.DE111 Choices | HIV test result ValueSet |
| Depends On | Value Set HIV status Choices | HIV status ValueSet |
| Depends On | Value Set Site where positive HIV test confirmed Choices | Site where positive HIV test confirmed ValueSet |
| Depends On | Value Set Probable route of transmission Choices | Probable route of transmission ValueSet |
| Depends On | Value Set Partner HIV test result Choices | Partner HIV test result ValueSet |
| Depends On | Value Set Partner HIV status confirmed Choices | Partner HIV status (confirmed) ValueSet |
| Depends On | Value Set Counselling provided Choices | Counselling provided ValueSet |
| Depends On | Value Set Prevention services offered and referrals - HIV.B.DE149 Choices | Prevention services offered and referrals ValueSet |
| Depends On | Value Set Sexual and reproductive health integrated services - HIV.B.DE158 Choices | Sexual and reproductive health integrated services ValueSet |
| Depends On | Value Set Offer other clinical services - HIV.B.DE165 Choices | Offer other clinical services ValueSet |
| Depends On | Value Set Other support services - HIV.B.DE172 Choices | Other support services ValueSet |
| Depends On | Value Set Intimate partner violence enquiry results Choices | Intimate partner violence enquiry results ValueSet |
| Depends On | Value Set Type of follow-up appointment - HIV.B.DE191 Choices | Type of follow-up appointment ValueSet |
| Depends On | Value Set Adverse event severity Choices | Adverse event severity ValueSet |
| Depends On | Value Set Timing of adverse event Choices | Timing of adverse event ValueSet |
| Depends On | Value Set Type of adverse VMMC event Choices | Type of adverse VMMC event ValueSet |
| Depends On | Value Set Syndrome/STI diagnosed - HIV.B.DE226 Choices | Syndrome/STI diagnosed ValueSet |
| Depends On | Value Set STI tested for - HIV.B.DE237 Choices | STI tested for ValueSet |
| Depends On | Value Set Syphilis test result - HIV.B.DE250 Choices | Syphilis test result ValueSet |
| Depends On | Value Set Gonorrhoea test result - HIV.B.DE256 Choices | Gonorrhoea test result ValueSet |
| Depends On | Value Set Type of specimen - HIV.B.DE261 Choices | Type of specimen ValueSet |
| Depends On | Value Set Syphilis test type - HIV.B.DE269 Choices | Syphilis test type ValueSet |
| Depends On | Value Set Neisseria gonorrhoeae test type - HIV.B.DE276 Choices | Neisseria gonorrhoeae test type ValueSet |
| Depends On | Value Set Chlamydia trachomatis test type - HIV.B.DE284 Choices | Chlamydia trachomatis test type ValueSet |
| Depends On | Value Set Trichomonas vaginalis test type - HIV.B.DE293 Choices | Trichomonas vaginalis test type ValueSet |
| Depends On | Value Set Herpes simplex virus HSV test type - HIV.B.DE301 Choices | Herpes simplex virus (HSV) test type ValueSet |
| Depends On | Value Set Mycoplasma genitalium test type - HIV.B.DE306 Choices | Mycoplasma genitalium test type ValueSet |
| Depends On | Value Set STI test result - HIV.B.DE312 Choices | STI test result ValueSet |
| Depends On | Value Set Confirmatory syphilis test type - HIV.B.DE317 Choices | Confirmatory syphilis test type ValueSet |
| Depends On | Value Set Confirmatory STI test result - HIV.B.DE325 Choices | Confirmatory STI test result ValueSet |
| Depends On | Value Set Reason for PrEP visit Choices | Reason for PrEP visit ValueSet |
| Depends On | Value Set PrEP dosing type Choices | PrEP dosing type ValueSet |
| Depends On | Value Set Current PrEP regimen Choices | Current PrEP regimen ValueSet |
| Depends On | Value Set Experience with PrEP Choices | Experience with PrEP ValueSet |
| Depends On | Value Set PEP history Choices | PEP history ValueSet |
| Depends On | Value Set Signs of substantial risk of HIV infection - HIV.C.DE36 Choices | Signs of substantial risk of HIV infection ValueSet |
| Depends On | Value Set Pregnancy intention in serodiscordant partnerships Choices | Pregnancy intention in serodiscordant partnerships ValueSet |
| Depends On | Value Set Acute HIV infection symptoms - HIV.C.DE46 Choices | Acute HIV infection symptoms ValueSet |
| Depends On | Value Set Sex partners HIV treatment status Choices | Sex partner's HIV treatment status ValueSet |
| Depends On | Value Set Screenings and diagnostics for PrEP users Choices | Screenings and diagnostics for PrEP users ValueSet |
| Depends On | Value Set Medications prescribed - HIV.C.DE75 Choices | Medications prescribed ValueSet |
| Depends On | Value Set PrEP product prescribed Choices | PrEP product prescribed ValueSet |
| Depends On | Value Set Preferred PEP backbone regimen Choices | Preferred PEP backbone regimen ValueSet |
| Depends On | Value Set Alternative PEP backbone regimen Choices | Alternative PEP backbone regimen ValueSet |
| Depends On | Value Set Preferred third PEP drug Choices | Preferred third PEP drug ValueSet |
| Depends On | Value Set Alternative third PEP drug Choices | Alternative third PEP drug ValueSet |
| Depends On | Value Set Sex factor for estimating creatinine clearance Choices | Sex factor for estimating creatinine clearance ValueSet |
| Depends On | Value Set Contraindications to PrEP usage Choices | Contraindications to PrEP usage ValueSet |
| Depends On | Value Set PrEP regimen prescribed Choices | PrEP regimen prescribed ValueSet |
| Depends On | Value Set Type of follow-up appointment - HIV.C.DE125 Choices | Type of follow-up appointment ValueSet |
| Depends On | Value Set Prevention services offered and referrals - HIV.C.DE131 Choices | Prevention services offered and referrals ValueSet |
| Depends On | Value Set Condom type Choices | Condom type ValueSet |
| Depends On | Value Set HIV self-test distributed for use by Choices | HIV self-test distributed for use by ValueSet |
| Depends On | Value Set Sexual and reproductive health integrated services - HIV.C.DE149 Choices | Sexual and reproductive health integrated services ValueSet |
| Depends On | Value Set Offer other clinical services - HIV.C.DE157 Choices | Offer other clinical services ValueSet |
| Depends On | Value Set Other support services - HIV.C.DE164 Choices | Other support services ValueSet |
| Depends On | Value Set Reason for visit - HIV.D.DE1 Choices | Reason for visit ValueSet |
| Depends On | Value Set Signs of serious illness Choices | Signs of serious illness ValueSet |
| Depends On | Value Set ART start type Choices | ART start type ValueSet |
| Depends On | Value Set Facility transferred from Choices | Facility transferred from ValueSet |
| Depends On | Value Set Facility where client first enrolled in HIV care Choices | Facility where client first enrolled in HIV care ValueSet |
| Depends On | Value Set Antiretroviral ARV drugs received prior to enrolment Choices | Antiretroviral (ARV) drugs received prior to enrolment ValueSet |
| Depends On | Value Set Location ARV drugs received prior to enrolment Choices | Location ARV drugs received prior to enrolment ValueSet |
| Depends On | Value Set ARV drug regimen received prior to enrolment Choices | ARV drug regimen received prior to enrolment ValueSet |
| Depends On | Value Set Existing chronic health conditions Choices | Existing chronic health conditions ValueSet |
| Depends On | Value Set Original first-line ART regimen Choices | Original first-line ART regimen ValueSet |
| Depends On | Value Set Current ART regimen Choices | Current ART regimen ValueSet |
| Depends On | Value Set Preferred first-line ART regimen Choices | Preferred first-line ART regimen ValueSet |
| Depends On | Value Set Alternative first-line ART regimen Choices | Alternative first-line ART regimen ValueSet |
| Depends On | Value Set First-line ART regimen under special circumstances Choices | First-line ART regimen under special circumstances ValueSet |
| Depends On | Value Set Preferred second-line ART regimen Choices | Preferred second-line ART regimen ValueSet |
| Depends On | Value Set Alternative second-line ART regimen Choices | Alternative second-line ART regimen ValueSet |
| Depends On | Value Set Optimal regimen for transition Choices | Optimal regimen for transition ValueSet |
| Depends On | Value Set Current ART regimen first-, second-, or third-line Choices | Current ART regimen (first-, second-, or third-line) ValueSet |
| Depends On | Value Set ART regimen Choices | ART regimen ValueSet |
| Depends On | Value Set ART regimen composition Choices | ART regimen composition ValueSet |
| Depends On | Value Set ART regimen drug class Choices | ART regimen drug class ValueSet |
| Depends On | Value Set Prevention services offered and referrals - HIV.D.DE152 Choices | Prevention services offered and referrals ValueSet |
| Depends On | Value Set Sexual and reproductive health integrated services - HIV.D.DE156 Choices | Sexual and reproductive health integrated services ValueSet |
| Depends On | Value Set HBsAg test result - HIV.D.DE162 Choices | HBsAg test result ValueSet |
| Depends On | Value Set HBV treatment regimen prescribed Choices | HBV treatment regimen prescribed ValueSet |
| Depends On | Value Set HCV test result - HIV.D.DE170 Choices | HCV test result ValueSet |
| Depends On | Value Set HCV treatment regimen prescribed Choices | HCV treatment regimen prescribed ValueSet |
| Depends On | Value Set HCV viral load test result - HIV.D.DE179 Choices | HCV viral load test result ValueSet |
| Depends On | Value Set HCV medicine type Choices | HCV medicine type ValueSet |
| Depends On | Value Set HIV clinical stage - HIV.D.DE186 Choices | HIV clinical stage ValueSet |
| Depends On | Value Set Reasons for adherence problem - HIV.D.DE197 Choices | Reason(s) for adherence problem ValueSet |
| Depends On | Value Set Reason ART stopped - HIV.D.DE217 Choices | Reason ART stopped ValueSet |
| Depends On | Value Set Treatment failure Choices | Treatment failure ValueSet |
| Depends On | Value Set General care activities recommended Choices | General care activities recommended ValueSet |
| Depends On | Value Set Preventing and treating coinfections Choices | Preventing and treating coinfections ValueSet |
| Depends On | Value Set Risk factors, comorbidities and coinfections signs and symptoms Choices | Risk factors, comorbidities and coinfections signs and symptoms ValueSet |
| Depends On | Value Set WHO HIV clinical stage condition or symptom - HIV.D.DE289 Choices | WHO HIV clinical stage condition or symptom ValueSet |
| Depends On | Value Set Clinical stage at start of ART Choices | Clinical stage at start of ART ValueSet |
| Depends On | Value Set Reasons for delayed ART initiation Choices | Reasons for delayed ART initiation ValueSet |
| Depends On | Value Set Time to start ART Choices | Time to start ART ValueSet |
| Depends On | Value Set Reason for HIV viral load test Choices | Reason for HIV viral load test ValueSet |
| Depends On | Value Set Monitoring examinations Choices | Monitoring examinations ValueSet |
| Depends On | Value Set Reason for ARV drug regimen substitution Choices | Reason for ARV drug regimen substitution ValueSet |
| Depends On | Value Set Reason for regimen switch Choices | Reason for regimen switch ValueSet |
| Depends On | Value Set ART regimen prescribed Choices | ART regimen prescribed ValueSet |
| Depends On | Value Set Coinfection status at ART start Choices | Coinfection status at ART start ValueSet |
| Depends On | Value Set Pregnant and breastfeeding status at ART start Choices | Pregnant and breastfeeding status at ART start ValueSet |
| Depends On | Value Set Medications prescribed - HIV.D.DE457 Choices | Medications prescribed ValueSet |
| Depends On | Value Set Medications dispensed Choices | Medications dispensed ValueSet |
| Depends On | Value Set Type of treatment-limiting toxicity Choices | Type of treatment-limiting toxicity ValueSet |
| Depends On | Value Set Reasons for substitution within first-line regimen Choices | Reason(s) for substitution within first-line regimen ValueSet |
| Depends On | Value Set New antiretroviral regimen after substitution within first-line regimen Choices | New antiretroviral regimen after substitution within first-line regimen ValueSet |
| Depends On | Value Set New regimen after switch to second-line regimen Choices | New regimen after switch to second-line regimen ValueSet |
| Depends On | Value Set Reason for switch to second-line regimen Choices | Reason for switch to second-line regimen ValueSet |
| Depends On | Value Set Reasons for substitution within second-line regimen Choices | Reason(s) for substitution within second-line regimen ValueSet |
| Depends On | Value Set New regimens after substitution within second-line regimen Choices | New regimen(s) after substitution within second-line regimen ValueSet |
| Depends On | Value Set New regimen after switch to third-line regimen Choices | New regimen after switch to third-line regimen ValueSet |
| Depends On | Value Set Reason for switch to third-line regimen Choices | Reason for switch to third-line regimen ValueSet |
| Depends On | Value Set Reasons for substitution within third-line regimen Choices | Reason(s) for substitution within third-line regimen ValueSet |
| Depends On | Value Set New regimens after substitution within third-line regimen Choices | New regimen(s) after substitution within third-line regimen ValueSet |
| Depends On | Value Set HIV status of family member Choices | HIV status of family member ValueSet |
| Depends On | Value Set Other support services - HIV.D.DE519 Choices | Other support services ValueSet |
| Depends On | Value Set Type of follow-up appointment - HIV.D.DE525 Choices | Type of follow-up appointment ValueSet |
| Depends On | Value Set Reason blood pressure reading not done Choices | Reason blood pressure reading not done ValueSet |
| Depends On | Value Set Current medications Choices | Current medications ValueSet |
| Depends On | Value Set Allergies Choices | Allergies ValueSet |
| Depends On | Value Set Family planning method used Choices | Family planning method used ValueSet |
| Depends On | Value Set Medication status Choices | Medication status ValueSet |
| Depends On | Value Set Vaccine brand Choices | Vaccine brand ValueSet |
| Depends On | Value Set Vaccine type Choices | Vaccine type ValueSet |
| Depends On | Value Set Vaccination location Choices | Vaccination location ValueSet |
| Depends On | Value Set Disease targeted Choices | Disease targeted ValueSet |
| Depends On | Value Set Reason immunization was not provided Choices | Reason immunization was not provided ValueSet |
| Depends On | Value Set Reason malaria prophylaxis not provided Choices | Reason malaria prophylaxis not provided ValueSet |
| Depends On | Value Set Cervical cancer primary screening test type Choices | Cervical cancer primary screening test type ValueSet |
| Depends On | Value Set HPV-DNA cervical cancer screening test result Choices | HPV-DNA cervical cancer screening test result ValueSet |
| Depends On | Value Set VIA cervical cancer screening test result Choices | VIA cervical cancer screening test result ValueSet |
| Depends On | Value Set Cervical cytology screening test result Choices | Cervical cytology screening test result ValueSet |
| Depends On | Value Set Cervical cancer triage test type Choices | Cervical cancer triage test type ValueSet |
| Depends On | Value Set HPV16/18 test result Choices | HPV16/18 test result ValueSet |
| Depends On | Value Set Cervical cancer colposcopy result Choices | Cervical cancer colposcopy result ValueSet |
| Depends On | Value Set Cervical cancer histopathology result Choices | Cervical cancer histopathology result ValueSet |
| Depends On | Value Set Cervical cancer screening outcome Choices | Cervical cancer screening outcome ValueSet |
| Depends On | Value Set Cervical cancer diagnosis Choices | Cervical cancer diagnosis ValueSet |
| Depends On | Value Set Cervical cancer stage at diagnosis Choices | Cervical cancer stage at diagnosis ValueSet |
| Depends On | Value Set Treatment method for cervical precancer lesions Choices | Treatment method for cervical precancer lesions ValueSet |
| Depends On | Value Set Invasive cervical cancer treatment method Choices | Invasive cervical cancer treatment method ValueSet |
| Depends On | Value Set Entry point for facility-level testing - HIV.D.DE746 Choices | Entry point for facility-level testing ValueSet |
| Depends On | Value Set Offer other clinical services - HIV.D.DE753 Choices | Offer other clinical services ValueSet |
| Depends On | Value Set DSD ART models Choices | DSD ART model(s) ValueSet |
| Depends On | Value Set Syndrome/STI diagnosed - HIV.D.DE778 Choices | Syndrome/STI diagnosed ValueSet |
| Depends On | Value Set STI tested for - HIV.D.DE789 Choices | STI tested for ValueSet |
| Depends On | Value Set Syphilis test result - HIV.D.DE802 Choices | Syphilis test result ValueSet |
| Depends On | Value Set Gonorrhoea test result - HIV.D.DE808 Choices | Gonorrhoea test result ValueSet |
| Depends On | Value Set Type of specimen - HIV.D.DE813 Choices | Type of specimen ValueSet |
| Depends On | Value Set Syphilis test type - HIV.D.DE821 Choices | Syphilis test type ValueSet |
| Depends On | Value Set Neisseria gonorrhoeae test type - HIV.D.DE828 Choices | Neisseria gonorrhoeae test type ValueSet |
| Depends On | Value Set Chlamydia trachomatis test type - HIV.D.DE836 Choices | Chlamydia trachomatis test type ValueSet |
| Depends On | Value Set Trichomonas vaginalis test type - HIV.D.DE845 Choices | Trichomonas vaginalis test type ValueSet |
| Depends On | Value Set Herpes simplex virus HSV test type - HIV.D.DE853 Choices | Herpes simplex virus (HSV) test type ValueSet |
| Depends On | Value Set Mycoplasma genitalium test type - HIV.D.DE858 Choices | Mycoplasma genitalium test type ValueSet |
| Depends On | Value Set STI test result - HIV.D.DE864 Choices | STI test result ValueSet |
| Depends On | Value Set Confirmatory syphilis test type - HIV.D.DE869 Choices | Confirmatory syphilis test type ValueSet |
| Depends On | Value Set Confirmatory STI test result - HIV.D.DE877 Choices | Confirmatory STI test result ValueSet |
| Depends On | Value Set Staging of liver disease Choices | Staging of liver disease ValueSet |
| Depends On | Value Set WHO functional status Choices | WHO functional status ValueSet |
| Depends On | Value Set Medication/drug Choices | Medication/drug ValueSet |
| Depends On | Value Set WHO HIV clinical stage condition or symptom - HIV.D.DE934 Choices | WHO HIV clinical stage condition or symptom ValueSet |
| Depends On | Value Set TB diagnosis result Choices | TB diagnosis result ValueSet |
| Depends On | Value Set Method of TB diagnosis Choices | Method of TB diagnosis ValueSet |
| Depends On | Value Set TB treatment history Choices | TB treatment history ValueSet |
| Depends On | Value Set TB screening algorithm Choices | TB screening algorithm ValueSet |
| Depends On | Value Set Symptoms of TB Choices | Symptoms of TB ValueSet |
| Depends On | Value Set TB screening result Choices | TB screening result ValueSet |
| Depends On | Value Set TB diagnostic test category Choices | TB diagnostic test category ValueSet |
| Depends On | Value Set TB treatment outcome Choices | TB treatment outcome ValueSet |
| Depends On | Value Set TB treatment regimen composition Choices | TB treatment regimen composition ValueSet |
| Depends On | Value Set TB status at ART start Choices | TB status at ART start ValueSet |
| Depends On | Value Set TPT regimen type Choices | TPT regimen type ValueSet |
| Depends On | Value Set TB preventive treatment TPT status Choices | TB preventive treatment (TPT) status ValueSet |
| Depends On | Value Set Source of gestational age Choices | Source of gestational age ValueSet |
| Depends On | Value Set Past pregnancy complications Choices | Past pregnancy complications ValueSet |
| Depends On | Value Set Timing of ART initiation Choices | Timing of ART initiation ValueSet |
| Depends On | Value Set Pregnancy outcome Choices | Pregnancy outcome ValueSet |
| Depends On | Value Set Delivery mode Choices | Delivery mode ValueSet |
| Depends On | Value Set Preterm birth status Choices | Preterm birth status ValueSet |
| Depends On | Value Set Place of delivery Choices | Place of delivery ValueSet |
| Depends On | Value Set Cause of death of mother Choices | Cause of death of mother ValueSet |
| Depends On | Value Set Gender of infant Choices | Gender of infant ValueSet |
| Depends On | Value Set Maternal HIV test result Choices | Maternal HIV test result ValueSet |
| Depends On | Value Set Infant or child exposure to HIV Choices | Infant or child exposure to HIV ValueSet |
| Depends On | Value Set Key population member type - HIV.E.DE114 Choices | Key population member type ValueSet |
| Depends On | Value Set Infant feeding practice Choices | Infant feeding practice ValueSet |
| Depends On | Value Set Type of iron supplement dosage provided Choices | Type of iron supplement dosage provided ValueSet |
| Depends On | Value Set Maternal HIV status Choices | Maternal HIV status ValueSet |
| Depends On | Value Set Maternal HIV status at first ANC visit - HIV.E.DE145 Choices | Maternal HIV status at first ANC visit ValueSet |
| Depends On | Value Set Maternal syphilis test result Choices | Maternal syphilis test result ValueSet |
| Depends On | Value Set Signs of substantial risk of HIV infection - HIV.E.DE155 Choices | Signs of substantial risk of HIV infection ValueSet |
| Depends On | Value Set HIV test type - HIV.E.DE168 Choices | HIV test type ValueSet |
| Depends On | Value Set Maternal and child health service visit Choices | Maternal and child health service visit ValueSet |
| Depends On | Value Set EID sample number Choices | EID sample number ValueSet |
| Depends On | Value Set EID test number Choices | EID test number ValueSet |
| Depends On | Value Set EID test number 1 test result Choices | EID test number 1 test result ValueSet |
| Depends On | Value Set EID test number 2 test result Choices | EID test number 2 test result ValueSet |
| Depends On | Value Set Assay number in testing strategy - HIV.E.DE194 Choices | Assay number in testing strategy ValueSet |
| Depends On | Value Set Test result of HIV assay 1 - HIV.E.DE200 Choices | Test result of HIV assay 1 ValueSet |
| Depends On | Value Set Test result of HIV assay 2 - HIV.E.DE204 Choices | Test result of HIV assay 2 ValueSet |
| Depends On | Value Set Test result of HIV assay 3 - HIV.E.DE208 Choices | Test result of HIV assay 3 ValueSet |
| Depends On | Value Set Test result of HIV assay 1 repeated - HIV.E.DE212 Choices | Test result of HIV assay 1 repeated ValueSet |
| Depends On | Value Set Test result of syphilis assay 1 Choices | Test result of syphilis assay 1 ValueSet |
| Depends On | Value Set Test result of syphilis assay 1 repeated Choices | Test result of syphilis assay 1 repeated ValueSet |
| Depends On | Value Set Infant HIV status Choices | Infant HIV status ValueSet |
| Depends On | Value Set Final diagnosis of HIV-exposed infant - HIV.E.DE230 Choices | Final diagnosis of HIV-exposed infant ValueSet |
| Depends On | Value Set HIV-exposed infant reason for unknown final status Choices | HIV-exposed infant reason for unknown final status ValueSet |
| Depends On | Value Set Cause of death of infant Choices | Cause of death of infant ValueSet |
| Depends On | Value Set Blood group and Rh factor Choices | Blood group and Rh factor ValueSet |
| Depends On | Value Set Asymptomatic bacteriuria ASB test result Choices | Asymptomatic bacteriuria (ASB) test result ValueSet |
| Depends On | Value Set Urine protein test result Choices | Urine protein test result ValueSet |
| Depends On | Value Set Type of hypertensive disorder Choices | Type of hypertensive disorder ValueSet |
| Depends On | Value Set HIV viral load specimen type Choices | HIV viral load specimen type ValueSet |
| Depends On | Value Set HBsAg test result - HIV.G.DE18 Choices | HBsAg test result ValueSet |
| Depends On | Value Set Reason Hepatitis B test not conducted Choices | Reason Hepatitis B test not conducted ValueSet |
| Depends On | Value Set Hepatitis B diagnosis Choices | Hepatitis B diagnosis ValueSet |
| Depends On | Value Set Reason Hepatitis C test not done Choices | Reason Hepatitis C test not done ValueSet |
| Depends On | Value Set HCV test result - HIV.G.DE43 Choices | HCV test result ValueSet |
| Depends On | Value Set HCV viral load test result - HIV.G.DE48 Choices | HCV viral load test result ValueSet |
| Depends On | Value Set Hepatitis C diagnosis Choices | Hepatitis C diagnosis ValueSet |
| Depends On | Value Set Syphilis test type - HIV.G.DE55 Choices | Syphilis test type ValueSet |
| Depends On | Value Set Reason syphilis test not done Choices | Reason syphilis test not done ValueSet |
| Depends On | Value Set Syphilis test result - HIV.G.DE70 Choices | Syphilis test result ValueSet |
| Depends On | Value Set Syphilis diagnosis Choices | Syphilis diagnosis ValueSet |
| Depends On | Value Set Reason for follow-up Choices | Reason for follow-up ValueSet |
| Depends On | Value Set Contact method Choices | Contact method ValueSet |
| Depends On | Value Set Source of information Choices | Source of information ValueSet |
| Depends On | Value Set Outcome from outreach attempt Choices | Outcome from outreach attempt ValueSet |
| Depends On | Value Set HIV status of partner or contact Choices | HIV status of partner or contact ValueSet |
| Depends On | Value Set HIV treatment outcome Choices | HIV treatment outcome ValueSet |
| Depends On | Value Set Transfer to facility Choices | Transfer to facility ValueSet |
| Depends On | Value Set Reasons for adherence problem - HIV.H.DE53 Choices | Reason(s) for adherence problem ValueSet |
| Depends On | Value Set Reason ART stopped - HIV.H.DE74 Choices | Reason ART stopped ValueSet |
| Depends On | Value Set Reason for referral Choices | Reason for referral ValueSet |
| Depends On | Value Set HIV prevention intervention Choices | HIV prevention intervention ValueSet |
| Depends On | Value Set HIV status of contact Choices | HIV status of contact ValueSet |
| Depends On | Value Set HIV test result - HIV.SRV.DE2 Choices | http://smart.who.int/hiv/ValueSet/HIV.SRV.DE2 |
| Depends On | Value Set HIV clinical stage - HIV.SRV.DE5 Choices | http://smart.who.int/hiv/ValueSet/HIV.SRV.DE5 |
| Depends On | Value Set Maternal HIV status at first ANC visit - HIV.SRV.DE19 Choices | http://smart.who.int/hiv/ValueSet/HIV.SRV.DE19 |
| Depends On | Value Set Test result of HIV assay 1 - HIV.SRV.DE21 Choices | http://smart.who.int/hiv/ValueSet/HIV.SRV.DE21 |
| Depends On | Value Set Final diagnosis of HIV-exposed infant - HIV.SRV.DE22 Choices | http://smart.who.int/hiv/ValueSet/HIV.SRV.DE22 |
| Depends On | Value Set HIV burden of the setting Choices | HIV burden of the setting ValueSet |
| Depends On | Value Set Other priority populations Choices | Other priority populations ValueSet |
text/cql
// **Automatically generated from DAK Data Dictionary**\n\n// This file contains all concepts from the Data Dictionary that are labeled\n// as linked to Aggregate Indicators in the indicator CQL files and CDS CQL files.\n\n// Valuesets reference the IG ValueSet definitions and are labeled with `Choices`\n// Codes are provided for each Data Dictionary concept\n// Specific Data Element IDs are appended to the label if the label is not unique within the DAK\n\nlibrary HIVConcepts\ncodesystem "HIVConcepts": 'http://smart.who.int/hiv/CodeSystem/HIVConcepts'\n\nvalueset "Referred by Choices": 'http://smart.who.int/hiv/ValueSet/HIV.A.DE5'\nvalueset "Country of birth Choices": 'http://smart.who.int/hiv/ValueSet/HIV.A.DE13'\nvalueset "Gender Choices": 'http://smart.who.int/hiv/ValueSet/HIV.A.DE18'\nvalueset "Sex Choices": 'http://smart.who.int/hiv/ValueSet/HIV.A.DE25'\nvalueset "Marital Status Choices": 'http://smart.who.int/hiv/ValueSet/HIV.A.DE30'\nvalueset "Administrative Area Choices": 'http://smart.who.int/hiv/ValueSet/HIV.A.DE43'\nvalueset "Communication preferences Choices": 'http://smart.who.int/hiv/ValueSet/HIV.A.DE46'\nvalueset "Reason for visit - HIV.B.DE1 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE1'\nvalueset "Referred through partner services Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE5'\nvalueset "Type of contact or partner for partner services Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE8'\nvalueset "Testing entry point Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE15'\nvalueset "Entry point for community-level testing Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE18'\nvalueset "Entry point for facility-level testing - HIV.B.DE22 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE22'\nvalueset "Partner HIV status reported Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE33'\nvalueset "Partner is from a key population Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE37'\nvalueset "HIV self-test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE44'\nvalueset "Key population member type - HIV.B.DE50 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE50'\nvalueset "HIV exposure type Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE61'\nvalueset "HIV diagnosing facility Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE66'\nvalueset "HIV serotype Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE68'\nvalueset "Type of contact elicited Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE74'\nvalueset "HIV test type - HIV.B.DE81 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE81'\nvalueset "Assay number in testing strategy - HIV.B.DE88 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE88'\nvalueset "Test result of HIV assay 1 - HIV.B.DE94 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE94'\nvalueset "Test result of HIV assay 2 - HIV.B.DE98 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE98'\nvalueset "Test result of HIV assay 3 - HIV.B.DE102 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE102'\nvalueset "Test result of HIV assay 1 repeated - HIV.B.DE106 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE106'\nvalueset "HIV test result - HIV.B.DE111 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE111'\nvalueset "HIV status Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE115'\nvalueset "Site where positive HIV test confirmed Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE120'\nvalueset "Probable route of transmission Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE121'\nvalueset "Partner HIV test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE132'\nvalueset "Partner HIV status confirmed Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE136'\nvalueset "Counselling provided Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE142'\nvalueset "Prevention services offered and referrals - HIV.B.DE149 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE149'\nvalueset "Sexual and reproductive health integrated services - HIV.B.DE158 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE158'\nvalueset "Offer other clinical services - HIV.B.DE165 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE165'\nvalueset "Other support services - HIV.B.DE172 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE172'\nvalueset "Intimate partner violence enquiry results Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE179'\nvalueset "Type of follow-up appointment - HIV.B.DE191 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE191'\nvalueset "Adverse event severity Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE201'\nvalueset "Timing of adverse event Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE204'\nvalueset "Type of adverse VMMC event Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE207'\nvalueset "Syndrome/STI diagnosed - HIV.B.DE226 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE226'\nvalueset "STI tested for - HIV.B.DE237 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE237'\nvalueset "Syphilis test result - HIV.B.DE250 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE250'\nvalueset "Gonorrhoea test result - HIV.B.DE256 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE256'\nvalueset "Type of specimen - HIV.B.DE261 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE261'\nvalueset "Syphilis test type - HIV.B.DE269 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE269'\nvalueset "Neisseria gonorrhoeae test type - HIV.B.DE276 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE276'\nvalueset "Chlamydia trachomatis test type - HIV.B.DE284 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE284'\nvalueset "Trichomonas vaginalis test type - HIV.B.DE293 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE293'\nvalueset "Herpes simplex virus HSV test type - HIV.B.DE301 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE301'\nvalueset "Mycoplasma genitalium test type - HIV.B.DE306 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE306'\nvalueset "STI test result - HIV.B.DE312 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE312'\nvalueset "Confirmatory syphilis test type - HIV.B.DE317 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE317'\nvalueset "Confirmatory STI test result - HIV.B.DE325 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.B.DE325'\nvalueset "Reason for PrEP visit Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE1'\nvalueset "PrEP dosing type Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE11'\nvalueset "Current PrEP regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE17'\nvalueset "Experience with PrEP Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE24'\nvalueset "PEP history Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE31'\nvalueset "Signs of substantial risk of HIV infection - HIV.C.DE36 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE36'\nvalueset "Pregnancy intention in serodiscordant partnerships Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE41'\nvalueset "Acute HIV infection symptoms - HIV.C.DE46 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE46'\nvalueset "Sex partners HIV treatment status Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE55'\nvalueset "Screenings and diagnostics for PrEP users Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE63'\nvalueset "Medications prescribed - HIV.C.DE75 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE75'\nvalueset "PrEP product prescribed Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE80'\nvalueset "Preferred PEP backbone regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE91'\nvalueset "Alternative PEP backbone regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE95'\nvalueset "Preferred third PEP drug Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE99'\nvalueset "Alternative third PEP drug Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE101'\nvalueset "Sex factor for estimating creatinine clearance Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE107'\nvalueset "Contraindications to PrEP usage Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE112'\nvalueset "PrEP regimen prescribed Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE122'\nvalueset "Type of follow-up appointment - HIV.C.DE125 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE125'\nvalueset "Prevention services offered and referrals - HIV.C.DE131 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE131'\nvalueset "Condom type Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE138'\nvalueset "HIV self-test distributed for use by Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE143'\nvalueset "Sexual and reproductive health integrated services - HIV.C.DE149 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE149'\nvalueset "Offer other clinical services - HIV.C.DE157 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE157'\nvalueset "Other support services - HIV.C.DE164 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.C.DE164'\nvalueset "Reason for visit - HIV.D.DE1 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE1'\nvalueset "Signs of serious illness Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE17'\nvalueset "ART start type Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE43'\nvalueset "Facility transferred from Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE52'\nvalueset "Facility where client first enrolled in HIV care Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE55'\nvalueset "Antiretroviral ARV drugs received prior to enrolment Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE56'\nvalueset "Location ARV drugs received prior to enrolment Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE63'\nvalueset "ARV drug regimen received prior to enrolment Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE64'\nvalueset "Existing chronic health conditions Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE65'\nvalueset "Original first-line ART regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE74'\nvalueset "Current ART regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE75'\nvalueset "Preferred first-line ART regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE77'\nvalueset "Alternative first-line ART regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE78'\nvalueset "First-line ART regimen under special circumstances Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE79'\nvalueset "Preferred second-line ART regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE80'\nvalueset "Alternative second-line ART regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE81'\nvalueset "Optimal regimen for transition Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE82'\nvalueset "Current ART regimen first-, second-, or third-line Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE83'\nvalueset "ART regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE90'\nvalueset "ART regimen composition Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE128'\nvalueset "ART regimen drug class Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE146'\nvalueset "Prevention services offered and referrals - HIV.D.DE152 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE152'\nvalueset "Sexual and reproductive health integrated services - HIV.D.DE156 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE156'\nvalueset "HBsAg test result - HIV.D.DE162 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE162'\nvalueset "HBV treatment regimen prescribed Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE168'\nvalueset "HCV test result - HIV.D.DE170 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE170'\nvalueset "HCV treatment regimen prescribed Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE177'\nvalueset "HCV viral load test result - HIV.D.DE179 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE179'\nvalueset "HCV medicine type Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE182'\nvalueset "HIV clinical stage - HIV.D.DE186 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE186'\nvalueset "Reasons for adherence problem - HIV.D.DE197 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE197'\nvalueset "Reason ART stopped - HIV.D.DE217 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE217'\nvalueset "Treatment failure Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE225'\nvalueset "General care activities recommended Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE229'\nvalueset "Preventing and treating coinfections Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE247'\nvalueset "Risk factors, comorbidities and coinfections signs and symptoms Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE259'\nvalueset "WHO HIV clinical stage condition or symptom - HIV.D.DE289 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE289'\nvalueset "Clinical stage at start of ART Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE358'\nvalueset "Reasons for delayed ART initiation Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE370'\nvalueset "Time to start ART Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE383'\nvalueset "Reason for HIV viral load test Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE391'\nvalueset "Monitoring examinations Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE399'\nvalueset "Reason for ARV drug regimen substitution Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE418'\nvalueset "Reason for regimen switch Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE430'\nvalueset "ART regimen prescribed Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE444'\nvalueset "Coinfection status at ART start Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE446'\nvalueset "Pregnant and breastfeeding status at ART start Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE449'\nvalueset "Medications prescribed - HIV.D.DE457 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE457'\nvalueset "Medications dispensed Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE461'\nvalueset "Type of treatment-limiting toxicity Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE466'\nvalueset "Reasons for substitution within first-line regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE482'\nvalueset "New antiretroviral regimen after substitution within first-line regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE483'\nvalueset "New regimen after switch to second-line regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE485'\nvalueset "Reason for switch to second-line regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE486'\nvalueset "Reasons for substitution within second-line regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE488'\nvalueset "New regimens after substitution within second-line regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE489'\nvalueset "New regimen after switch to third-line regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE491'\nvalueset "Reason for switch to third-line regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE492'\nvalueset "Reasons for substitution within third-line regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE494'\nvalueset "New regimens after substitution within third-line regimen Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE495'\nvalueset "HIV status of family member Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE514'\nvalueset "Other support services - HIV.D.DE519 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE519'\nvalueset "Type of follow-up appointment - HIV.D.DE525 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE525'\nvalueset "Reason blood pressure reading not done Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE532'\nvalueset "Current medications Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE537'\nvalueset "Allergies Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE560'\nvalueset "Family planning method used Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE569'\nvalueset "Medication status Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE593'\nvalueset "Vaccine brand Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE603'\nvalueset "Vaccine type Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE604'\nvalueset "Vaccination location Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE606'\nvalueset "Disease targeted Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE610'\nvalueset "Reason immunization was not provided Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE636'\nvalueset "Reason malaria prophylaxis not provided Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE646'\nvalueset "Cervical cancer primary screening test type Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE658'\nvalueset "HPV-DNA cervical cancer screening test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE664'\nvalueset "VIA cervical cancer screening test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE668'\nvalueset "Cervical cytology screening test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE673'\nvalueset "Cervical cancer triage test type Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE681'\nvalueset "HPV16/18 test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE688'\nvalueset "Cervical cancer colposcopy result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE691'\nvalueset "Cervical cancer histopathology result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE697'\nvalueset "Cervical cancer screening outcome Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE706'\nvalueset "Cervical cancer diagnosis Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE709'\nvalueset "Cervical cancer stage at diagnosis Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE712'\nvalueset "Treatment method for cervical precancer lesions Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE719'\nvalueset "Invasive cervical cancer treatment method Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE731'\nvalueset "Entry point for facility-level testing - HIV.D.DE746 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE746'\nvalueset "Offer other clinical services - HIV.D.DE753 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE753'\nvalueset "DSD ART models Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE764'\nvalueset "Syndrome/STI diagnosed - HIV.D.DE778 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE778'\nvalueset "STI tested for - HIV.D.DE789 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE789'\nvalueset "Syphilis test result - HIV.D.DE802 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE802'\nvalueset "Gonorrhoea test result - HIV.D.DE808 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE808'\nvalueset "Type of specimen - HIV.D.DE813 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE813'\nvalueset "Syphilis test type - HIV.D.DE821 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE821'\nvalueset "Neisseria gonorrhoeae test type - HIV.D.DE828 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE828'\nvalueset "Chlamydia trachomatis test type - HIV.D.DE836 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE836'\nvalueset "Trichomonas vaginalis test type - HIV.D.DE845 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE845'\nvalueset "Herpes simplex virus HSV test type - HIV.D.DE853 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE853'\nvalueset "Mycoplasma genitalium test type - HIV.D.DE858 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE858'\nvalueset "STI test result - HIV.D.DE864 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE864'\nvalueset "Confirmatory syphilis test type - HIV.D.DE869 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE869'\nvalueset "Confirmatory STI test result - HIV.D.DE877 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE877'\nvalueset "Staging of liver disease Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE893'\nvalueset "WHO functional status Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE897'\nvalueset "Medication/drug Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE903'\nvalueset "WHO HIV clinical stage condition or symptom - HIV.D.DE934 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE934'\nvalueset "TB diagnosis result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE939'\nvalueset "Method of TB diagnosis Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE942'\nvalueset "TB treatment history Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE947'\nvalueset "TB screening algorithm Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE956'\nvalueset "Symptoms of TB Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE973'\nvalueset "TB screening result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE986'\nvalueset "TB diagnostic test category Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE992'\nvalueset "TB treatment outcome Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE1002'\nvalueset "TB treatment regimen composition Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE1010'\nvalueset "TB status at ART start Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE1019'\nvalueset "TPT regimen type Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE1028'\nvalueset "TB preventive treatment TPT status Choices": 'http://smart.who.int/hiv/ValueSet/HIV.D.DE1034'\nvalueset "Source of gestational age Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE6'\nvalueset "Past pregnancy complications Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE17'\nvalueset "Timing of ART initiation Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE41'\nvalueset "Pregnancy outcome Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE47'\nvalueset "Delivery mode Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE52'\nvalueset "Preterm birth status Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE62'\nvalueset "Place of delivery Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE67'\nvalueset "Cause of death of mother Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE75'\nvalueset "Gender of infant Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE91'\nvalueset "Maternal HIV test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE104'\nvalueset "Infant or child exposure to HIV Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE108'\nvalueset "Key population member type - HIV.E.DE114 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE114'\nvalueset "Infant feeding practice Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE127'\nvalueset "Type of iron supplement dosage provided Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE136'\nvalueset "Maternal HIV status Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE141'\nvalueset "Maternal HIV status at first ANC visit - HIV.E.DE145 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE145'\nvalueset "Maternal syphilis test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE149'\nvalueset "Signs of substantial risk of HIV infection - HIV.E.DE155 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE155'\nvalueset "HIV test type - HIV.E.DE168 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE168'\nvalueset "Maternal and child health service visit Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE173'\nvalueset "EID sample number Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE180'\nvalueset "EID test number Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE183'\nvalueset "EID test number 1 test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE186'\nvalueset "EID test number 2 test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE190'\nvalueset "Assay number in testing strategy - HIV.E.DE194 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE194'\nvalueset "Test result of HIV assay 1 - HIV.E.DE200 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE200'\nvalueset "Test result of HIV assay 2 - HIV.E.DE204 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE204'\nvalueset "Test result of HIV assay 3 - HIV.E.DE208 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE208'\nvalueset "Test result of HIV assay 1 repeated - HIV.E.DE212 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE212'\nvalueset "Test result of syphilis assay 1 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE216'\nvalueset "Test result of syphilis assay 1 repeated Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE220'\nvalueset "Infant HIV status Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE225'\nvalueset "Final diagnosis of HIV-exposed infant - HIV.E.DE230 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE230'\nvalueset "HIV-exposed infant reason for unknown final status Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE234'\nvalueset "Cause of death of infant Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE240'\nvalueset "Blood group and Rh factor Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE246'\nvalueset "Asymptomatic bacteriuria ASB test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE255'\nvalueset "Urine protein test result Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE259'\nvalueset "Type of hypertensive disorder Choices": 'http://smart.who.int/hiv/ValueSet/HIV.E.DE264'\nvalueset "HIV viral load specimen type Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE13'\nvalueset "HBsAg test result - HIV.G.DE18 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE18'\nvalueset "Reason Hepatitis B test not conducted Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE22'\nvalueset "Hepatitis B diagnosis Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE29'\nvalueset "Reason Hepatitis C test not done Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE35'\nvalueset "HCV test result - HIV.G.DE43 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE43'\nvalueset "HCV viral load test result - HIV.G.DE48 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE48'\nvalueset "Hepatitis C diagnosis Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE51'\nvalueset "Syphilis test type - HIV.G.DE55 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE55'\nvalueset "Reason syphilis test not done Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE62'\nvalueset "Syphilis test result - HIV.G.DE70 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE70'\nvalueset "Syphilis diagnosis Choices": 'http://smart.who.int/hiv/ValueSet/HIV.G.DE74'\nvalueset "Reason for follow-up Choices": 'http://smart.who.int/hiv/ValueSet/HIV.H.DE1'\nvalueset "Contact method Choices": 'http://smart.who.int/hiv/ValueSet/HIV.H.DE13'\nvalueset "Source of information Choices": 'http://smart.who.int/hiv/ValueSet/HIV.H.DE17'\nvalueset "Outcome from outreach attempt Choices": 'http://smart.who.int/hiv/ValueSet/HIV.H.DE23'\nvalueset "HIV status of partner or contact Choices": 'http://smart.who.int/hiv/ValueSet/HIV.H.DE34'\nvalueset "HIV treatment outcome Choices": 'http://smart.who.int/hiv/ValueSet/HIV.H.DE41'\nvalueset "Transfer to facility Choices": 'http://smart.who.int/hiv/ValueSet/HIV.H.DE50'\nvalueset "Reasons for adherence problem - HIV.H.DE53 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.H.DE53'\nvalueset "Reason ART stopped - HIV.H.DE74 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.H.DE74'\nvalueset "Reason for referral Choices": 'http://smart.who.int/hiv/ValueSet/HIV.I.DE2'\nvalueset "HIV prevention intervention Choices": 'http://smart.who.int/hiv/ValueSet/HIV.PRV.DE2'\nvalueset "HIV status of contact Choices": 'http://smart.who.int/hiv/ValueSet/HIV.PRV.DE11'\nvalueset "HIV test result - HIV.SRV.DE2 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.SRV.DE2'\nvalueset "HIV clinical stage - HIV.SRV.DE5 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.SRV.DE5'\nvalueset "Maternal HIV status at first ANC visit - HIV.SRV.DE19 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.SRV.DE19'\nvalueset "Test result of HIV assay 1 - HIV.SRV.DE21 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.SRV.DE21'\nvalueset "Final diagnosis of HIV-exposed infant - HIV.SRV.DE22 Choices": 'http://smart.who.int/hiv/ValueSet/HIV.SRV.DE22'\nvalueset "HIV burden of the setting Choices": 'http://smart.who.int/hiv/ValueSet/HIV.Config.DE12'\nvalueset "Other priority populations Choices": 'http://smart.who.int/hiv/ValueSet/HIV.Config.DE19'\n\ncode "Visit date - HIV.A.DE3": 'HIV.A.DE3' from "HIVConcepts" display 'Visit date'\ncode "Estimated age": 'HIV.A.DE16' from "HIVConcepts" display 'Estimated age'\ncode "Age": 'HIV.A.DE17' from "HIVConcepts" display 'Age'\ncode "Gender": 'HIV.A.DE18' from "HIVConcepts" display 'Gender*'\ncode "Female": 'HIV.A.DE19' from "HIVConcepts" display 'Female'\ncode "Male": 'HIV.A.DE20' from "HIVConcepts" display 'Male'\ncode "Transgender male": 'HIV.A.DE21' from "HIVConcepts" display 'Transgender male'\ncode "Transgender female": 'HIV.A.DE22' from "HIVConcepts" display 'Transgender female'\ncode "Other - HIV.A.DE23": 'HIV.A.DE23' from "HIVConcepts" display 'Other'\ncode "Reason for visit - HIV.B.DE1": 'HIV.B.DE1' from "HIVConcepts" display 'Reason for visit'\ncode "First-time HIV test": 'HIV.B.DE2' from "HIVConcepts" display 'First-time HIV test'\ncode "Retesting for HIV - HIV.B.DE3": 'HIV.B.DE3' from "HIVConcepts" display 'Retesting for HIV'\ncode "HIV testing services visit": 'HIV.B.DE4' from "HIVConcepts" display 'HIV testing services visit'\ncode "Referred through partner services": 'HIV.B.DE5' from "HIVConcepts" display 'Referred through partner services'\ncode "Partner or contact of an index case": 'HIV.B.DE6' from "HIVConcepts" display 'Partner or contact of an index case'\ncode "Partner or contact of an HIV testing client non-index case": 'HIV.B.DE7' from "HIVConcepts" display 'Partner or contact of an HIV testing client non-index case'\ncode "Type of contact or partner for partner services": 'HIV.B.DE8' from "HIVConcepts" display 'Type of contact or partner for partner services'\ncode "Biological child": 'HIV.B.DE9' from "HIVConcepts" display 'Biological child'\ncode "Drug-injecting partner - HIV.B.DE10": 'HIV.B.DE10' from "HIVConcepts" display 'Drug-injecting partner'\ncode "Sexual partner - HIV.B.DE11": 'HIV.B.DE11' from "HIVConcepts" display 'Sexual partner'\ncode "Social contact - HIV.B.DE12": 'HIV.B.DE12' from "HIVConcepts" display 'Social contact'\ncode "Date/time of suspected exposure to HIV - HIV.B.DE14": 'HIV.B.DE14' from "HIVConcepts" display 'Date/time of suspected exposure to HIV'\ncode "Testing entry point": 'HIV.B.DE15' from "HIVConcepts" display 'Testing entry point'\ncode "Community-level testing": 'HIV.B.DE16' from "HIVConcepts" display 'Community-level testing'\ncode "Facility-level testing": 'HIV.B.DE17' from "HIVConcepts" display 'Facility-level testing'\ncode "Currently pregnant - HIV.B.DE29": 'HIV.B.DE29' from "HIVConcepts" display 'Currently pregnant'\ncode "Breastfeeding - HIV.B.DE32": 'HIV.B.DE32' from "HIVConcepts" display 'Breastfeeding'\ncode "Partner HIV status reported": 'HIV.B.DE33' from "HIVConcepts" display 'Partner HIV status reported'\ncode "HIV-positive": 'HIV.B.DE34' from "HIVConcepts" display 'HIV-positive'\ncode "HIV-negative": 'HIV.B.DE35' from "HIVConcepts" display 'HIV-negative'\ncode "Unknown": 'HIV.B.DE36' from "HIVConcepts" display 'Unknown'\ncode "Key population member - HIV.B.DE49": 'HIV.B.DE49' from "HIVConcepts" display 'Key population member*'\ncode "Key population member type - HIV.B.DE50": 'HIV.B.DE50' from "HIVConcepts" display 'Key population member type*'\ncode "Sex worker - HIV.B.DE51": 'HIV.B.DE51' from "HIVConcepts" display 'Sex worker'\ncode "Men who have sex with men": 'HIV.B.DE52' from "HIVConcepts" display 'Men who have sex with men'\ncode "Trans and gender-diverse people - HIV.B.DE53": 'HIV.B.DE53' from "HIVConcepts" display 'Trans and gender-diverse people'\ncode "People who inject drugs - HIV.B.DE54": 'HIV.B.DE54' from "HIVConcepts" display 'People who inject drugs'\ncode "People living in prisons and other closed settings": 'HIV.B.DE55' from "HIVConcepts" display 'People living in prisons and other closed settings'\ncode "Date HIV test results returned": 'HIV.B.DE60' from "HIVConcepts" display 'Date HIV test results returned'\ncode "HIV exposure type": 'HIV.B.DE61' from "HIVConcepts" display 'HIV exposure type*'\ncode "Occupational": 'HIV.B.DE62' from "HIVConcepts" display 'Occupational'\ncode "Non-occupational violent": 'HIV.B.DE63' from "HIVConcepts" display 'Non-occupational violent'\ncode "Non-occupational consensual sex": 'HIV.B.DE64' from "HIVConcepts" display 'Non-occupational consensual sex'\ncode "Date informed of HIV-positive diagnosis": 'HIV.B.DE65' from "HIVConcepts" display 'Date informed of HIV-positive diagnosis'\ncode "HIV diagnosis date": 'HIV.B.DE71' from "HIVConcepts" display 'HIV diagnosis date'\ncode "ART start date - HIV.B.DE72": 'HIV.B.DE72' from "HIVConcepts" display 'ART start date'\ncode "HIV test conducted": 'HIV.B.DE80' from "HIVConcepts" display 'HIV test conducted'\ncode "HIV test type - HIV.B.DE81": 'HIV.B.DE81' from "HIVConcepts" display 'HIV test type'\ncode "Rapid diagnostic test for HIV - HIV.B.DE82": 'HIV.B.DE82' from "HIVConcepts" display 'Rapid diagnostic test for HIV'\ncode "Enzyme immunoassay for HIV - HIV.B.DE83": 'HIV.B.DE83' from "HIVConcepts" display 'Enzyme immunoassay for HIV'\ncode "Nucleic acid test for HIV - HIV.B.DE84": 'HIV.B.DE84' from "HIVConcepts" display 'Nucleic acid test for HIV'\ncode "Dual HIV/syphilis rapid diagnostic test - HIV.B.DE85": 'HIV.B.DE85' from "HIVConcepts" display 'Dual HIV/syphilis rapid diagnostic test'\ncode "HIV self-test": 'HIV.B.DE86' from "HIVConcepts" display 'HIV self-test'\ncode "Assay number in testing strategy - HIV.B.DE88": 'HIV.B.DE88' from "HIVConcepts" display 'Assay number in testing strategy'\ncode "Assay 0 - HIV.B.DE89": 'HIV.B.DE89' from "HIVConcepts" display 'Assay 0'\ncode "Assay 1 - HIV.B.DE90": 'HIV.B.DE90' from "HIVConcepts" display 'Assay 1'\ncode "Assay 2 - HIV.B.DE91": 'HIV.B.DE91' from "HIVConcepts" display 'Assay 2'\ncode "Assay 3 - HIV.B.DE92": 'HIV.B.DE92' from "HIVConcepts" display 'Assay 3'\ncode "Assay 1 repeated - HIV.B.DE93": 'HIV.B.DE93' from "HIVConcepts" display 'Assay 1 repeated'\ncode "Test result of HIV assay 1 - HIV.B.DE94": 'HIV.B.DE94' from "HIVConcepts" display 'Test result of HIV assay 1'\ncode "Reactive - HIV.B.DE95": 'HIV.B.DE95' from "HIVConcepts" display 'Reactive'\ncode "Non-reactive - HIV.B.DE96": 'HIV.B.DE96' from "HIVConcepts" display 'Non-reactive'\ncode "Invalid - HIV.B.DE97": 'HIV.B.DE97' from "HIVConcepts" display 'Invalid'\ncode "Test result of HIV assay 2 - HIV.B.DE98": 'HIV.B.DE98' from "HIVConcepts" display 'Test result of HIV assay 2'\ncode "Reactive - HIV.B.DE99": 'HIV.B.DE99' from "HIVConcepts" display 'Reactive'\ncode "Non-reactive - HIV.B.DE100": 'HIV.B.DE100' from "HIVConcepts" display 'Non-reactive'\ncode "Invalid - HIV.B.DE101": 'HIV.B.DE101' from "HIVConcepts" display 'Invalid'\ncode "Test result of HIV assay 3 - HIV.B.DE102": 'HIV.B.DE102' from "HIVConcepts" display 'Test result of HIV assay 3'\ncode "Reactive - HIV.B.DE103": 'HIV.B.DE103' from "HIVConcepts" display 'Reactive'\ncode "Non-reactive - HIV.B.DE104": 'HIV.B.DE104' from "HIVConcepts" display 'Non-reactive'\ncode "Invalid - HIV.B.DE105": 'HIV.B.DE105' from "HIVConcepts" display 'Invalid'\ncode "Test result of HIV assay 1 repeated - HIV.B.DE106": 'HIV.B.DE106' from "HIVConcepts" display 'Test result of HIV assay 1 repeated'\ncode "Reactive - HIV.B.DE107": 'HIV.B.DE107' from "HIVConcepts" display 'Reactive'\ncode "Non-reactive - HIV.B.DE108": 'HIV.B.DE108' from "HIVConcepts" display 'Non-reactive'\ncode "Invalid - HIV.B.DE109": 'HIV.B.DE109' from "HIVConcepts" display 'Invalid'\ncode "HIV test date - HIV.B.DE110": 'HIV.B.DE110' from "HIVConcepts" display 'HIV test date'\ncode "HIV test result - HIV.B.DE111": 'HIV.B.DE111' from "HIVConcepts" display 'HIV test result'\ncode "HIV-positive - HIV.B.DE112": 'HIV.B.DE112' from "HIVConcepts" display 'HIV-positive'\ncode "HIV-negative - HIV.B.DE113": 'HIV.B.DE113' from "HIVConcepts" display 'HIV-negative'\ncode "HIV-inconclusive": 'HIV.B.DE114' from "HIVConcepts" display 'HIV-inconclusive'\ncode "HIV status": 'HIV.B.DE115' from "HIVConcepts" display 'HIV status'\ncode "HIV-positive - HIV.B.DE116": 'HIV.B.DE116' from "HIVConcepts" display 'HIV-positive'\ncode "HIV-negative - HIV.B.DE117": 'HIV.B.DE117' from "HIVConcepts" display 'HIV-negative'\ncode "Unknown - HIV.B.DE118": 'HIV.B.DE118' from "HIVConcepts" display 'Unknown'\ncode "Probable route of transmission": 'HIV.B.DE121' from "HIVConcepts" display 'Probable route of transmission*'\ncode "Heterosexual sex": 'HIV.B.DE122' from "HIVConcepts" display 'Heterosexual sex'\ncode "Sex between men": 'HIV.B.DE123' from "HIVConcepts" display 'Sex between men'\ncode "Unprotected intercourse during sex work": 'HIV.B.DE124' from "HIVConcepts" display 'Unprotected intercourse during sex work'\ncode "Injecting drug use with unsterile equipment": 'HIV.B.DE125' from "HIVConcepts" display 'Injecting drug use with unsterile equipment'\ncode "Nosocomial": 'HIV.B.DE126' from "HIVConcepts" display 'Nosocomial'\ncode "Vertical": 'HIV.B.DE127' from "HIVConcepts" display 'Vertical'\ncode "Other - HIV.B.DE128": 'HIV.B.DE128' from "HIVConcepts" display 'Other'\ncode "Partner virally suppressed on ART": 'HIV.B.DE141' from "HIVConcepts" display 'Partner virally suppressed on ART'\ncode "Counselling provided": 'HIV.B.DE142' from "HIVConcepts" display 'Counselling provided'\ncode "HIV-positive counselling conducted": 'HIV.B.DE143' from "HIVConcepts" display 'HIV-positive counselling conducted'\ncode "Hepatitis B positive counselling conducted": 'HIV.B.DE144' from "HIVConcepts" display 'Hepatitis B positive counselling conducted'\ncode "Hepatitis C positive counselling conducted": 'HIV.B.DE145' from "HIVConcepts" display 'Hepatitis C positive counselling conducted'\ncode "Syphilis counselling, treatment and further testing": 'HIV.B.DE146' from "HIVConcepts" display 'Syphilis counselling, treatment and further testing'\ncode "Linked to enrolment in care and ART initiation": 'HIV.B.DE147' from "HIVConcepts" display 'Linked to enrolment in care and ART initiation'\ncode "VMMC counselling provided": 'HIV.B.DE148' from "HIVConcepts" display 'VMMC counselling provided'\ncode "Prevention services offered and referrals - HIV.B.DE149": 'HIV.B.DE149' from "HIVConcepts" display 'Prevention services offered and referrals'\ncode "Offer male and female condoms and condom-compatible lubricants - HIV.B.DE150": 'HIV.B.DE150' from "HIVConcepts" display 'Offer male and female condoms and condom-compatible lubricants'\ncode "Offer pre-exposure prophylaxis PrEP for people at elevated risk for HIV acquisition": 'HIV.B.DE151' from "HIVConcepts" display 'Offer pre-exposure prophylaxis PrEP for people at elevated risk for HIV acquisition'\ncode "Offer post-exposure prophylaxis PEP following suspected exposure": 'HIV.B.DE152' from "HIVConcepts" display 'Offer post-exposure prophylaxis PEP following suspected exposure'\ncode "Voluntary medical male circumcision VMMC": 'HIV.B.DE153' from "HIVConcepts" display 'Voluntary medical male circumcision VMMC'\ncode "Harm reduction for people who inject drugs - HIV.B.DE154": 'HIV.B.DE154' from "HIVConcepts" display 'Harm reduction for people who inject drugs'\ncode "Behavioural interventions to support risk reduction, particularly for people with HIV and members of key populations": 'HIV.B.DE155' from "HIVConcepts" display 'Behavioural interventions to support risk reduction, particularly for people with HIV and members of key populations'\ncode "HIV testing for partners and biological children - HIV.B.DE156": 'HIV.B.DE156' from "HIVConcepts" display 'HIV testing for partners and biological children'\ncode "HIV testing for partners and social contacts of people from key populations, where appropriate": 'HIV.B.DE157' from "HIVConcepts" display 'HIV testing for partners and social contacts of people from key populations, where appropriate'\ncode "Sexual and reproductive health integrated services - HIV.B.DE158": 'HIV.B.DE158' from "HIVConcepts" display 'Sexual and reproductive health integrated services'\ncode "Contraception and family planning - HIV.B.DE159": 'HIV.B.DE159' from "HIVConcepts" display 'Contraception and family planning'\ncode "Check pregnancy status - HIV.B.DE160": 'HIV.B.DE160' from "HIVConcepts" display 'Check pregnancy status'\ncode "Prevention of mother-to-child transmission counselling": 'HIV.B.DE161' from "HIVConcepts" display 'Prevention of mother-to-child transmission counselling'\ncode "Cervical cancer screening and treatment counselling": 'HIV.B.DE162' from "HIVConcepts" display 'Cervical cancer screening and treatment counselling'\ncode "Anal cancer screening for men who have sex with men - HIV.B.DE163": 'HIV.B.DE163' from "HIVConcepts" display 'Anal cancer screening for men who have sex with men'\ncode "STI testing and treatment services": 'HIV.B.DE164' from "HIVConcepts" display 'STI testing and treatment services'\ncode "Offer other clinical services - HIV.B.DE165": 'HIV.B.DE165' from "HIVConcepts" display 'Offer other clinical services'\ncode "Assessment and provision of vaccinations - HIV.B.DE166": 'HIV.B.DE166' from "HIVConcepts" display 'Assessment and provision of vaccinations'\ncode "Hepatitis B HBV and hepatitis C virus HCV testing and treatment provided": 'HIV.B.DE167' from "HIVConcepts" display 'Hepatitis B HBV and hepatitis C virus HCV testing and treatment provided'\ncode "Co-trimoxazole chemoprophylaxis to prevent Pneumocystis carinii pneumonia provided": 'HIV.B.DE168' from "HIVConcepts" display 'Co-trimoxazole chemoprophylaxis to prevent Pneumocystis carinii pneumonia provided'\ncode "Intensified TB case finding and linkage to TB treatment provided": 'HIV.B.DE169' from "HIVConcepts" display 'Intensified TB case finding and linkage to TB treatment provided'\ncode "Provision of isoniazid preventive therapy if person does not have TB - HIV.B.DE170": 'HIV.B.DE170' from "HIVConcepts" display 'Provision of isoniazid preventive therapy if person does not have TB'\ncode "Malaria prevention such as bed nets and prophylaxis, depending on epidemiology - HIV.B.DE171": 'HIV.B.DE171' from "HIVConcepts" display 'Malaria prevention such as bed nets and prophylaxis, depending on epidemiology'\ncode "Other support services - HIV.B.DE172": 'HIV.B.DE172' from "HIVConcepts" display 'Other support services'\ncode "Mental health services - HIV.B.DE173": 'HIV.B.DE173' from "HIVConcepts" display 'Mental health services'\ncode "Psychosocial counselling, support and treatment adherence counselling - HIV.B.DE174": 'HIV.B.DE174' from "HIVConcepts" display 'Psychosocial counselling, support and treatment adherence counselling'\ncode "Support for disclosure and partner services - HIV.B.DE175": 'HIV.B.DE175' from "HIVConcepts" display 'Support for disclosure and partner services'\ncode "Legal and social services - HIV.B.DE176": 'HIV.B.DE176' from "HIVConcepts" display 'Legal and social services'\ncode "Services for responding to violence against women - HIV.B.DE177": 'HIV.B.DE177' from "HIVConcepts" display 'Services for responding to violence against women'\ncode "Type of follow-up appointment - HIV.B.DE191": 'HIV.B.DE191' from "HIVConcepts" display 'Type of follow-up appointment'\ncode "Retesting for HIV - HIV.B.DE192": 'HIV.B.DE192' from "HIVConcepts" display 'Retesting for HIV'\ncode "Other - HIV.B.DE193": 'HIV.B.DE193' from "HIVConcepts" display 'Other'\ncode "Date/time of follow-up appointment - HIV.B.DE195": 'HIV.B.DE195' from "HIVConcepts" display 'Date/time of follow-up appointment'\ncode "VMMC procedure date": 'HIV.B.DE198' from "HIVConcepts" display 'VMMC procedure date'\ncode "Adverse event severity": 'HIV.B.DE201' from "HIVConcepts" display 'Adverse event severity'\ncode "Moderate": 'HIV.B.DE202' from "HIVConcepts" display 'Moderate'\ncode "Severe": 'HIV.B.DE203' from "HIVConcepts" display 'Severe'\ncode "Timing of adverse event": 'HIV.B.DE204' from "HIVConcepts" display 'Timing of adverse event'\ncode "Intraoperative": 'HIV.B.DE205' from "HIVConcepts" display 'Intraoperative'\ncode "Postoperative": 'HIV.B.DE206' from "HIVConcepts" display 'Postoperative'\ncode "Type of adverse VMMC event": 'HIV.B.DE207' from "HIVConcepts" display 'Type of adverse VMMC event'\ncode "Abnormal pain": 'HIV.B.DE208' from "HIVConcepts" display 'Abnormal pain'\ncode "Anaesthesia-related effects": 'HIV.B.DE209' from "HIVConcepts" display 'Anaesthesia-related effects'\ncode "Bleeding": 'HIV.B.DE210' from "HIVConcepts" display 'Bleeding'\ncode "Damage to the penis": 'HIV.B.DE211' from "HIVConcepts" display 'Damage to the penis'\ncode "Difficulty urinating": 'HIV.B.DE212' from "HIVConcepts" display 'Difficulty urinating'\ncode "Excessive bleeding": 'HIV.B.DE213' from "HIVConcepts" display 'Excessive bleeding'\ncode "Excessive skin removal": 'HIV.B.DE214' from "HIVConcepts" display 'Excessive skin removal'\ncode "Excessive swelling": 'HIV.B.DE215' from "HIVConcepts" display 'Excessive swelling'\ncode "Haematoma": 'HIV.B.DE216' from "HIVConcepts" display 'Haematoma'\ncode "Infection": 'HIV.B.DE217' from "HIVConcepts" display 'Infection'\ncode "Injury to glans": 'HIV.B.DE218' from "HIVConcepts" display 'Injury to glans'\ncode "Scar or disfigurement": 'HIV.B.DE219' from "HIVConcepts" display 'Scar or disfigurement'\ncode "Sharps injury to personnel": 'HIV.B.DE220' from "HIVConcepts" display 'Sharps injury to personnel'\ncode "Wound disruption": 'HIV.B.DE221' from "HIVConcepts" display 'Wound disruption'\ncode "Other - HIV.B.DE222": 'HIV.B.DE222' from "HIVConcepts" display 'Other'\ncode "HIV retest prior to starting ART conducted": 'HIV.B.DE224' from "HIVConcepts" display 'HIV retest prior to starting ART conducted'\ncode "At elevated risk for HIV acquisition - HIV.B.DE225": 'HIV.B.DE225' from "HIVConcepts" display 'At elevated risk for HIV acquisition'\ncode "Syndrome/STI diagnosed - HIV.B.DE226": 'HIV.B.DE226' from "HIVConcepts" display 'Syndrome/STI diagnosed'\ncode "Urethral discharge syndrome - HIV.B.DE227": 'HIV.B.DE227' from "HIVConcepts" display 'Urethral discharge syndrome'\ncode "Vaginal discharge syndrome - HIV.B.DE228": 'HIV.B.DE228' from "HIVConcepts" display 'Vaginal discharge syndrome'\ncode "Lower Abdominal pain - HIV.B.DE229": 'HIV.B.DE229' from "HIVConcepts" display 'Lower Abdominal pain '\ncode "Genital ulcer disease syndrome - HIV.B.DE230": 'HIV.B.DE230' from "HIVConcepts" display 'Genital ulcer disease syndrome'\ncode "Anorectal discharge - HIV.B.DE231": 'HIV.B.DE231' from "HIVConcepts" display 'Anorectal discharge'\ncode "Sent for testing - HIV.B.DE232": 'HIV.B.DE232' from "HIVConcepts" display 'Sent for testing'\ncode "Other - HIV.B.DE233": 'HIV.B.DE233' from "HIVConcepts" display 'Other'\ncode "Any STI syndrome diagnosed - HIV.B.DE235": 'HIV.B.DE235' from "HIVConcepts" display 'Any STI syndrome diagnosed'\ncode "Syphilis test date - HIV.B.DE249": 'HIV.B.DE249' from "HIVConcepts" display 'Syphilis test date'\ncode "Syphilis test result - HIV.B.DE250": 'HIV.B.DE250' from "HIVConcepts" display 'Syphilis test result'\ncode "Positive - HIV.B.DE251": 'HIV.B.DE251' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.B.DE252": 'HIV.B.DE252' from "HIVConcepts" display 'Negative'\ncode "Inconclusive - HIV.B.DE253": 'HIV.B.DE253' from "HIVConcepts" display 'Inconclusive'\ncode "Syphilis treatment start date - HIV.B.DE254": 'HIV.B.DE254' from "HIVConcepts" display 'Syphilis treatment start date'\ncode "Gonorrhoea test date - HIV.B.DE255": 'HIV.B.DE255' from "HIVConcepts" display 'Gonorrhoea test date'\ncode "Gonorrhoea test result - HIV.B.DE256": 'HIV.B.DE256' from "HIVConcepts" display 'Gonorrhoea test result'\ncode "Positive - HIV.B.DE257": 'HIV.B.DE257' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.B.DE258": 'HIV.B.DE258' from "HIVConcepts" display 'Negative'\ncode "Inconclusive - HIV.B.DE259": 'HIV.B.DE259' from "HIVConcepts" display 'Inconclusive'\ncode "Gonorrhoea treatment start date - HIV.B.DE260": 'HIV.B.DE260' from "HIVConcepts" display 'Gonorrhoea treatment start date'\ncode "Type of specimen - HIV.B.DE261": 'HIV.B.DE261' from "HIVConcepts" display 'Type of specimen'\ncode "Blood - HIV.B.DE262": 'HIV.B.DE262' from "HIVConcepts" display 'Blood'\ncode "Urine - HIV.B.DE263": 'HIV.B.DE263' from "HIVConcepts" display 'Urine'\ncode "Cervical or vaginal swab - HIV.B.DE264": 'HIV.B.DE264' from "HIVConcepts" display 'Cervical or vaginal swab'\ncode "Urethral or penile swab - HIV.B.DE265": 'HIV.B.DE265' from "HIVConcepts" display 'Urethral or penile swab'\ncode "Rectal swab - HIV.B.DE266": 'HIV.B.DE266' from "HIVConcepts" display 'Rectal swab'\ncode "Other - HIV.B.DE267": 'HIV.B.DE267' from "HIVConcepts" display 'Other'\ncode "Neisseria gonorrhoeae test type - HIV.B.DE276": 'HIV.B.DE276' from "HIVConcepts" display 'Neisseria gonorrhoeae test type'\ncode "NAAT - HIV.B.DE277": 'HIV.B.DE277' from "HIVConcepts" display 'NAAT'\ncode "POC Test - HIV.B.DE278": 'HIV.B.DE278' from "HIVConcepts" display 'POC Test'\ncode "Culture - HIV.B.DE279": 'HIV.B.DE279' from "HIVConcepts" display 'Culture'\ncode "Microscopy - HIV.B.DE280": 'HIV.B.DE280' from "HIVConcepts" display 'Microscopy'\ncode "Other - HIV.B.DE281": 'HIV.B.DE281' from "HIVConcepts" display 'Other'\ncode "Date/time of suspected exposure to HIV - HIV.C.DE9": 'HIV.C.DE9' from "HIVConcepts" display 'Date/time of suspected exposure to HIV'\ncode "Currently on PrEP": 'HIV.C.DE10' from "HIVConcepts" display 'Currently on PrEP'\ncode "PrEP dosing type": 'HIV.C.DE11' from "HIVConcepts" display 'PrEP dosing type'\ncode "Daily oral PrEP": 'HIV.C.DE12' from "HIVConcepts" display 'Daily oral PrEP'\ncode "Event-driven PrEP 2+1+1": 'HIV.C.DE13' from "HIVConcepts" display 'Event-driven PrEP 2+1+1'\ncode "Other PrEP dosing type": 'HIV.C.DE14' from "HIVConcepts" display 'Other PrEP dosing type'\ncode "Current PrEP regimen": 'HIV.C.DE17' from "HIVConcepts" display 'Current PrEP regimen'\ncode "TDF + FTC - HIV.C.DE18": 'HIV.C.DE18' from "HIVConcepts" display 'TDF + FTC'\ncode "TDF - HIV.C.DE19": 'HIV.C.DE19' from "HIVConcepts" display 'TDF'\ncode "TDF + 3TC - HIV.C.DE20": 'HIV.C.DE20' from "HIVConcepts" display 'TDF + 3TC'\ncode "Other TDF-based regimen": 'HIV.C.DE21' from "HIVConcepts" display 'Other TDF-based regimen'\ncode "Dapivirine vaginal ring DVR - HIV.C.DE22": 'HIV.C.DE22' from "HIVConcepts" display 'Dapivirine vaginal ring DVR'\ncode "CAB-LA - HIV.C.DE23": 'HIV.C.DE23' from "HIVConcepts" display 'CAB-LA'\ncode "Experience with PrEP": 'HIV.C.DE24' from "HIVConcepts" display 'Experience with PrEP'\ncode "First-time user - HIV.C.DE25": 'HIV.C.DE25' from "HIVConcepts" display 'First-time user'\ncode "Continuing user": 'HIV.C.DE26' from "HIVConcepts" display 'Continuing user'\ncode "Restarting following a period of not taking PrEP": 'HIV.C.DE27' from "HIVConcepts" display 'Restarting following a period of not taking PrEP'\ncode "PEP history": 'HIV.C.DE31' from "HIVConcepts" display 'PEP history'\ncode "First-time user - HIV.C.DE32": 'HIV.C.DE32' from "HIVConcepts" display 'First-time user'\ncode "Repeat user": 'HIV.C.DE33' from "HIVConcepts" display 'Repeat user'\ncode "Date client completes PEP course": 'HIV.C.DE35' from "HIVConcepts" display 'Date client completes PEP course'\ncode "Signs of substantial risk of HIV infection - HIV.C.DE36": 'HIV.C.DE36' from "HIVConcepts" display 'Signs of substantial risk of HIV infection'\ncode "No condom use during sex with more than one partner in the past 6 months - HIV.C.DE37": 'HIV.C.DE37' from "HIVConcepts" display 'No condom use during sex with more than one partner in the past 6 months'\ncode "STI in the past 6 months - HIV.C.DE38": 'HIV.C.DE38' from "HIVConcepts" display 'STI in the past 6 months'\ncode "A sexual partner in the past 6 months had one or more HIV risk factors - HIV.C.DE39": 'HIV.C.DE39' from "HIVConcepts" display 'A sexual partner in the past 6 months had one or more HIV risk factors'\ncode "PrEP requested by client - HIV.C.DE40": 'HIV.C.DE40' from "HIVConcepts" display 'PrEP requested by client'\ncode "Acute HIV infection symptoms - HIV.C.DE46": 'HIV.C.DE46' from "HIVConcepts" display 'Acute HIV infection symptoms'\ncode "Fever": 'HIV.C.DE47' from "HIVConcepts" display 'Fever'\ncode "Sore throat": 'HIV.C.DE48' from "HIVConcepts" display 'Sore throat'\ncode "Aches": 'HIV.C.DE49' from "HIVConcepts" display 'Aches'\ncode "Pains": 'HIV.C.DE50' from "HIVConcepts" display 'Pains'\ncode "Swollen glands": 'HIV.C.DE51' from "HIVConcepts" display 'Swollen glands'\ncode "Mouth sores": 'HIV.C.DE52' from "HIVConcepts" display 'Mouth sores'\ncode "Headaches": 'HIV.C.DE53' from "HIVConcepts" display 'Headaches'\ncode "Rash": 'HIV.C.DE54' from "HIVConcepts" display 'Rash'\ncode "Sex partners HIV treatment status": 'HIV.C.DE55' from "HIVConcepts" display 'Sex partners HIV treatment status'\ncode "Not on ART": 'HIV.C.DE56' from "HIVConcepts" display 'Not on ART'\ncode "On ART less than 6 months": 'HIV.C.DE57' from "HIVConcepts" display 'On ART less than 6 months'\ncode "Partner has suspected low adherence to ART": 'HIV.C.DE58' from "HIVConcepts" display 'Partner has suspected low adherence to ART'\ncode "Partner is not virally suppressed": 'HIV.C.DE59' from "HIVConcepts" display 'Partner is not virally suppressed'\ncode "Partner is virally suppressed and has been on ART for 6 months or more": 'HIV.C.DE60' from "HIVConcepts" display 'Partner is virally suppressed and has been on ART for 6 months or more'\ncode "Suitable for PrEP": 'HIV.C.DE61' from "HIVConcepts" display 'Suitable for PrEP'\ncode "Date medications prescribed - HIV.C.DE74": 'HIV.C.DE74' from "HIVConcepts" display 'Date medications prescribed'\ncode "Medications prescribed - HIV.C.DE75": 'HIV.C.DE75' from "HIVConcepts" display 'Medications prescribed'\ncode "PrEP for HIV prevention": 'HIV.C.DE76' from "HIVConcepts" display 'PrEP for HIV prevention'\ncode "PEP for HIV prevention": 'HIV.C.DE77' from "HIVConcepts" display 'PEP for HIV prevention'\ncode "Other - HIV.C.DE78": 'HIV.C.DE78' from "HIVConcepts" display 'Other'\ncode "PrEP product prescribed": 'HIV.C.DE80' from "HIVConcepts" display 'PrEP product prescribed'\ncode "Oral PrEP": 'HIV.C.DE81' from "HIVConcepts" display 'Oral PrEP'\ncode "Dapivirine vaginal ring DVR - HIV.C.DE82": 'HIV.C.DE82' from "HIVConcepts" display 'Dapivirine vaginal ring DVR'\ncode "CAB-LA - HIV.C.DE83": 'HIV.C.DE83' from "HIVConcepts" display 'CAB-LA'\ncode "Other - HIV.C.DE84": 'HIV.C.DE84' from "HIVConcepts" display 'Other'\ncode "Preferred PEP backbone regimen": 'HIV.C.DE91' from "HIVConcepts" display 'Preferred PEP backbone regimen'\ncode "TDF + 3TC - HIV.C.DE92": 'HIV.C.DE92' from "HIVConcepts" display 'TDF + 3TC'\ncode "TDF + FTC - HIV.C.DE93": 'HIV.C.DE93' from "HIVConcepts" display 'TDF + FTC'\ncode "AZT + 3TC": 'HIV.C.DE94' from "HIVConcepts" display 'AZT + 3TC'\ncode "Alternative PEP backbone regimen": 'HIV.C.DE95' from "HIVConcepts" display 'Alternative PEP backbone regimen'\ncode "ABC + 3TC": 'HIV.C.DE96' from "HIVConcepts" display 'ABC + 3TC'\ncode "TDF + 3TC - HIV.C.DE97": 'HIV.C.DE97' from "HIVConcepts" display 'TDF + 3TC'\ncode "TDF + FTC - HIV.C.DE98": 'HIV.C.DE98' from "HIVConcepts" display 'TDF + FTC'\ncode "Preferred third PEP drug": 'HIV.C.DE99' from "HIVConcepts" display 'Preferred third PEP drug'\ncode "DTG - HIV.C.DE100": 'HIV.C.DE100' from "HIVConcepts" display 'DTG'\ncode "Alternative third PEP drug": 'HIV.C.DE101' from "HIVConcepts" display 'Alternative third PEP drug'\ncode "ATV/r - HIV.C.DE102": 'HIV.C.DE102' from "HIVConcepts" display 'ATV/r'\ncode "DRV/r - HIV.C.DE103": 'HIV.C.DE103' from "HIVConcepts" display 'DRV/r'\ncode "LPV/r - HIV.C.DE104": 'HIV.C.DE104' from "HIVConcepts" display 'LPV/r'\ncode "RAL - HIV.C.DE105": 'HIV.C.DE105' from "HIVConcepts" display 'RAL'\ncode "Estimated creatinine clearance": 'HIV.C.DE106' from "HIVConcepts" display 'Estimated creatinine clearance'\ncode "Contraindications to PrEP usage": 'HIV.C.DE112' from "HIVConcepts" display 'Contraindications to PrEP usage'\ncode "Tenofovir disoproxil fumarate TDF allergy or contraindication": 'HIV.C.DE113' from "HIVConcepts" display 'Tenofovir disoproxil fumarate TDF allergy or contraindication'\ncode "HIV-positive - HIV.C.DE114": 'HIV.C.DE114' from "HIVConcepts" display 'HIV-positive'\ncode "Low estimated creatinine clearance": 'HIV.C.DE115' from "HIVConcepts" display 'Low estimated creatinine clearance'\ncode "Acute HIV infection symptoms - HIV.C.DE116": 'HIV.C.DE116' from "HIVConcepts" display 'Acute HIV infection symptoms'\ncode "Probable recent exposure to HIV": 'HIV.C.DE117' from "HIVConcepts" display 'Probable recent exposure to HIV'\ncode "Other allergy or contraindication to a medicine in the PrEP regimen": 'HIV.C.DE118' from "HIVConcepts" display 'Other allergy or contraindication to a medicine in the PrEP regimen'\ncode "Number of days prescribed - HIV.C.DE121": 'HIV.C.DE121' from "HIVConcepts" display 'Number of days prescribed'\ncode "Adherence counselling provided - HIV.C.DE123": 'HIV.C.DE123' from "HIVConcepts" display 'Adherence counselling provided'\ncode "Date/time of follow-up appointment - HIV.C.DE124": 'HIV.C.DE124' from "HIVConcepts" display 'Date/time of follow-up appointment'\ncode "Type of follow-up appointment - HIV.C.DE125": 'HIV.C.DE125' from "HIVConcepts" display 'Type of follow-up appointment'\ncode "Retesting for HIV - HIV.C.DE126": 'HIV.C.DE126' from "HIVConcepts" display 'Retesting for HIV'\ncode "Follow-up appointment for PrEP": 'HIV.C.DE127' from "HIVConcepts" display 'Follow-up appointment for PrEP'\ncode "Other - HIV.C.DE128": 'HIV.C.DE128' from "HIVConcepts" display 'Other'\ncode "Prevention services offered and referrals - HIV.C.DE131": 'HIV.C.DE131' from "HIVConcepts" display 'Prevention services offered and referrals'\ncode "Male and female condoms and condom-compatible lubricants offered": 'HIV.C.DE132' from "HIVConcepts" display 'Male and female condoms and condom-compatible lubricants offered'\ncode "Voluntary medical male circumcision VMMC referral": 'HIV.C.DE133' from "HIVConcepts" display 'Voluntary medical male circumcision VMMC referral'\ncode "Harm reduction for people who inject drugs - HIV.C.DE134": 'HIV.C.DE134' from "HIVConcepts" display 'Harm reduction for people who inject drugs'\ncode "Behavioural interventions to support risk reduction - HIV.C.DE135": 'HIV.C.DE135' from "HIVConcepts" display 'Behavioural interventions to support risk reduction'\ncode "Condom type": 'HIV.C.DE138' from "HIVConcepts" display 'Condom type'\ncode "Male condom": 'HIV.C.DE139' from "HIVConcepts" display 'Male condom'\ncode "Female condom": 'HIV.C.DE140' from "HIVConcepts" display 'Female condom'\ncode "Number of HIV self-test kits distributed": 'HIV.C.DE142' from "HIVConcepts" display 'Number of HIV self-test kits distributed'\ncode "HIV self-test distributed for use by": 'HIV.C.DE143' from "HIVConcepts" display 'HIV self-test distributed for use by'\ncode "Self": 'HIV.C.DE144' from "HIVConcepts" display 'Self'\ncode "Family member": 'HIV.C.DE145' from "HIVConcepts" display 'Family member'\ncode "Drug-injecting partner - HIV.C.DE146": 'HIV.C.DE146' from "HIVConcepts" display 'Drug-injecting partner'\ncode "Sexual partner - HIV.C.DE147": 'HIV.C.DE147' from "HIVConcepts" display 'Sexual partner'\ncode "Social contact - HIV.C.DE148": 'HIV.C.DE148' from "HIVConcepts" display 'Social contact'\ncode "Sexual and reproductive health integrated services - HIV.C.DE149": 'HIV.C.DE149' from "HIVConcepts" display 'Sexual and reproductive health integrated services'\ncode "Contraception and family planning - HIV.C.DE150": 'HIV.C.DE150' from "HIVConcepts" display 'Contraception and family planning'\ncode "Check pregnancy status - HIV.C.DE151": 'HIV.C.DE151' from "HIVConcepts" display 'Check pregnancy status'\ncode "Prevent mother-to-child transmission": 'HIV.C.DE152' from "HIVConcepts" display 'Prevent mother-to-child transmission'\ncode "Cervical cancer screening and treatment": 'HIV.C.DE153' from "HIVConcepts" display 'Cervical cancer screening and treatment'\ncode "Anal cancer screening for men who have sex with men - HIV.C.DE154": 'HIV.C.DE154' from "HIVConcepts" display 'Anal cancer screening for men who have sex with men'\ncode "STI testing and treatment - HIV.C.DE155": 'HIV.C.DE155' from "HIVConcepts" display 'STI testing and treatment'\ncode "HIV testing for partners and biological children - HIV.C.DE156": 'HIV.C.DE156' from "HIVConcepts" display 'HIV testing for partners and biological children'\ncode "Offer other clinical services - HIV.C.DE157": 'HIV.C.DE157' from "HIVConcepts" display 'Offer other clinical services'\ncode "Assessment and provision of vaccinations - HIV.C.DE158": 'HIV.C.DE158' from "HIVConcepts" display 'Assessment and provision of vaccinations'\ncode "Hepatitis B virus HBV and hepatitis C virus HCV testing and treatment": 'HIV.C.DE159' from "HIVConcepts" display 'Hepatitis B virus HBV and hepatitis C virus HCV testing and treatment'\ncode "Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia - HIV.C.DE160": 'HIV.C.DE160' from "HIVConcepts" display 'Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia'\ncode "Intensified TB case finding and linkage to TB treatment - HIV.C.DE161": 'HIV.C.DE161' from "HIVConcepts" display 'Intensified TB case finding and linkage to TB treatment'\ncode "Provision of isoniazid preventive therapy if person does not have TB - HIV.C.DE162": 'HIV.C.DE162' from "HIVConcepts" display 'Provision of isoniazid preventive therapy if person does not have TB'\ncode "Malaria prevention such as bed nets and prophylaxis, depending on epidemiology - HIV.C.DE163": 'HIV.C.DE163' from "HIVConcepts" display 'Malaria prevention such as bed nets and prophylaxis, depending on epidemiology'\ncode "Other support services - HIV.C.DE164": 'HIV.C.DE164' from "HIVConcepts" display 'Other support services'\ncode "Mental health services - HIV.C.DE165": 'HIV.C.DE165' from "HIVConcepts" display 'Mental health services'\ncode "Psychosocial counselling, support and treatment adherence counselling - HIV.C.DE166": 'HIV.C.DE166' from "HIVConcepts" display 'Psychosocial counselling, support and treatment adherence counselling'\ncode "Support for disclosure and partner services - HIV.C.DE167": 'HIV.C.DE167' from "HIVConcepts" display 'Support for disclosure and partner services'\ncode "Legal and social services - HIV.C.DE168": 'HIV.C.DE168' from "HIVConcepts" display 'Legal and social services'\ncode "Services for responding to violence against women - HIV.C.DE169": 'HIV.C.DE169' from "HIVConcepts" display 'Services for responding to violence against women'\ncode "Reason for visit - HIV.D.DE1": 'HIV.D.DE1' from "HIVConcepts" display 'Reason for visit'\ncode "First clinical visit": 'HIV.D.DE2' from "HIVConcepts" display 'First clinical visit'\ncode "Clinical visit - HIV.D.DE3": 'HIV.D.DE3' from "HIVConcepts" display 'Clinical visit'\ncode "ART initiation": 'HIV.D.DE4' from "HIVConcepts" display 'ART initiation'\ncode "ART drug pick up": 'HIV.D.DE5' from "HIVConcepts" display 'ART drug pick up'\ncode "Issues and concerns": 'HIV.D.DE6' from "HIVConcepts" display 'Issues and concerns'\ncode "Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer - HIV.D.DE7": 'HIV.D.DE7' from "HIVConcepts" display 'Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer'\ncode "Body temperature": 'HIV.D.DE9' from "HIVConcepts" display 'Body temperature'\ncode "Body weight": 'HIV.D.DE13' from "HIVConcepts" display 'Body weight'\ncode "Signs of serious illness": 'HIV.D.DE17' from "HIVConcepts" display 'Signs of serious illness'\ncode "Fever of 39 C or greater": 'HIV.D.DE18' from "HIVConcepts" display 'Fever of 39 C or greater'\ncode "Tachycardia": 'HIV.D.DE19' from "HIVConcepts" display 'Tachycardia'\ncode "Tachypnea": 'HIV.D.DE20' from "HIVConcepts" display 'Tachypnea'\ncode "Unable to walk unaided": 'HIV.D.DE21' from "HIVConcepts" display 'Unable to walk unaided'\ncode "Lethargy - HIV.D.DE22": 'HIV.D.DE22' from "HIVConcepts" display 'Lethargy'\ncode "Unconsciousness": 'HIV.D.DE23' from "HIVConcepts" display 'Unconsciousness'\ncode "Convulsions": 'HIV.D.DE24' from "HIVConcepts" display 'Convulsions'\ncode "Unable to drink": 'HIV.D.DE25' from "HIVConcepts" display 'Unable to drink'\ncode "Unable to breastfeed": 'HIV.D.DE26' from "HIVConcepts" display 'Unable to breastfeed'\ncode "Repeated vomiting": 'HIV.D.DE27' from "HIVConcepts" display 'Repeated vomiting'\ncode "Headache - HIV.D.DE28": 'HIV.D.DE28' from "HIVConcepts" display 'Headache'\ncode "Other sign of serious illness": 'HIV.D.DE29' from "HIVConcepts" display 'Other sign of serious illness'\ncode "Currently pregnant - HIV.D.DE31": 'HIV.D.DE31' from "HIVConcepts" display 'Currently pregnant'\ncode "Breastfeeding - HIV.D.DE32": 'HIV.D.DE32' from "HIVConcepts" display 'Breastfeeding'\ncode "Serodiscordant partner - HIV.D.DE37": 'HIV.D.DE37' from "HIVConcepts" display 'Serodiscordant partner'\ncode "On ART - HIV.D.DE38": 'HIV.D.DE38' from "HIVConcepts" display 'On ART'\ncode "ART start date - HIV.D.DE39": 'HIV.D.DE39' from "HIVConcepts" display 'ART start date'\ncode "Date ART stopped - HIV.D.DE41": 'HIV.D.DE41' from "HIVConcepts" display 'Date ART stopped'\ncode "Established on ART": 'HIV.D.DE42' from "HIVConcepts" display 'Established on ART'\ncode "ART start type": 'HIV.D.DE43' from "HIVConcepts" display 'ART start type'\ncode "First-time user of ART": 'HIV.D.DE44' from "HIVConcepts" display 'First-time user of ART'\ncode "Restarting ART": 'HIV.D.DE45' from "HIVConcepts" display 'Restarting ART'\ncode "Current ART regimen": 'HIV.D.DE75' from "HIVConcepts" display 'Current ART regimen'\ncode "Preferred first-line ART regimen": 'HIV.D.DE77' from "HIVConcepts" display 'Preferred first-line ART regimen'\ncode "Alternative first-line ART regimen": 'HIV.D.DE78' from "HIVConcepts" display 'Alternative first-line ART regimen'\ncode "First-line ART regimen under special circumstances": 'HIV.D.DE79' from "HIVConcepts" display 'First-line ART regimen under special circumstances'\ncode "Preferred second-line ART regimen": 'HIV.D.DE80' from "HIVConcepts" display 'Preferred second-line ART regimen'\ncode "Alternative second-line ART regimen": 'HIV.D.DE81' from "HIVConcepts" display 'Alternative second-line ART regimen'\ncode "Optimal regimen for transition": 'HIV.D.DE82' from "HIVConcepts" display 'Optimal regimen for transition'\ncode "Current ART regimen first-, second-, or third-line": 'HIV.D.DE83' from "HIVConcepts" display 'Current ART regimen first-, second-, or third-line'\ncode "First-line ART regimen for adults and adolescents": 'HIV.D.DE84' from "HIVConcepts" display 'First-line ART regimen for adults and adolescents'\ncode "First-line ART regimen for children": 'HIV.D.DE85' from "HIVConcepts" display 'First-line ART regimen for children'\ncode "First-line ART regimen for neonates": 'HIV.D.DE86' from "HIVConcepts" display 'First-line ART regimen for neonates'\ncode "Second-line ART regimen for adults and adolescents": 'HIV.D.DE87' from "HIVConcepts" display 'Second-line ART regimen for adults and adolescents'\ncode "Second-line ART regimen for children": 'HIV.D.DE88' from "HIVConcepts" display 'Second-line ART regimen for children'\ncode "Third-line ART regimen": 'HIV.D.DE89' from "HIVConcepts" display 'Third-line ART regimen'\ncode "ART regimen composition": 'HIV.D.DE128' from "HIVConcepts" display 'ART regimen composition'\ncode "ABC": 'HIV.D.DE129' from "HIVConcepts" display 'ABC'\ncode "FTC": 'HIV.D.DE130' from "HIVConcepts" display 'FTC'\ncode "3TC": 'HIV.D.DE131' from "HIVConcepts" display '3TC'\ncode "AZT": 'HIV.D.DE132' from "HIVConcepts" display 'AZT'\ncode "DDI": 'HIV.D.DE133' from "HIVConcepts" display 'DDI'\ncode "D4T": 'HIV.D.DE134' from "HIVConcepts" display 'D4T'\ncode "TDF - HIV.D.DE135": 'HIV.D.DE135' from "HIVConcepts" display 'TDF'\ncode "EFV": 'HIV.D.DE136' from "HIVConcepts" display 'EFV'\ncode "ETV": 'HIV.D.DE137' from "HIVConcepts" display 'ETV'\ncode "NVP": 'HIV.D.DE138' from "HIVConcepts" display 'NVP'\ncode "RIL": 'HIV.D.DE139' from "HIVConcepts" display 'RIL'\ncode "ATV/r - HIV.D.DE140": 'HIV.D.DE140' from "HIVConcepts" display 'ATV/r'\ncode "LPV/r - HIV.D.DE141": 'HIV.D.DE141' from "HIVConcepts" display 'LPV/r'\ncode "DRV/r - HIV.D.DE142": 'HIV.D.DE142' from "HIVConcepts" display 'DRV/r'\ncode "RTV": 'HIV.D.DE143' from "HIVConcepts" display 'RTV'\ncode "DTG - HIV.D.DE144": 'HIV.D.DE144' from "HIVConcepts" display 'DTG'\ncode "RAL - HIV.D.DE145": 'HIV.D.DE145' from "HIVConcepts" display 'RAL'\ncode "Prevention services offered and referrals - HIV.D.DE152": 'HIV.D.DE152' from "HIVConcepts" display 'Prevention services offered and referrals'\ncode "Offer male and female condoms and condom-compatible lubricants - HIV.D.DE153": 'HIV.D.DE153' from "HIVConcepts" display 'Offer male and female condoms and condom-compatible lubricants'\ncode "Harm reduction for people who inject drugs - HIV.D.DE154": 'HIV.D.DE154' from "HIVConcepts" display 'Harm reduction for people who inject drugs'\ncode "Behavioural interventions to support risk reduction - HIV.D.DE155": 'HIV.D.DE155' from "HIVConcepts" display 'Behavioural interventions to support risk reduction'\ncode "Sexual and reproductive health integrated services - HIV.D.DE156": 'HIV.D.DE156' from "HIVConcepts" display 'Sexual and reproductive health integrated services'\ncode "Contraception and family planning - HIV.D.DE157": 'HIV.D.DE157' from "HIVConcepts" display 'Contraception and family planning'\ncode "Check pregnancy status - HIV.D.DE158": 'HIV.D.DE158' from "HIVConcepts" display 'Check pregnancy status'\ncode "Prevention of mother-to-child transmission": 'HIV.D.DE159' from "HIVConcepts" display 'Prevention of mother-to-child transmission'\ncode "STI testing and treatment - HIV.D.DE160": 'HIV.D.DE160' from "HIVConcepts" display 'STI testing and treatment'\ncode "HBsAg test date - HIV.D.DE161": 'HIV.D.DE161' from "HIVConcepts" display 'HBsAg test date'\ncode "HBsAg test result - HIV.D.DE162": 'HIV.D.DE162' from "HIVConcepts" display 'HBsAg test result'\ncode "Positive - HIV.D.DE163": 'HIV.D.DE163' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.D.DE164": 'HIV.D.DE164' from "HIVConcepts" display 'Negative'\ncode "Indeterminate - HIV.D.DE165": 'HIV.D.DE165' from "HIVConcepts" display 'Indeterminate'\ncode "HBV treatment TDF start date": 'HIV.D.DE167' from "HIVConcepts" display 'HBV treatment TDF start date'\ncode "HCV test date - HIV.D.DE169": 'HIV.D.DE169' from "HIVConcepts" display 'HCV test date'\ncode "HCV test result - HIV.D.DE170": 'HIV.D.DE170' from "HIVConcepts" display 'HCV test result'\ncode "Positive - HIV.D.DE171": 'HIV.D.DE171' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.D.DE172": 'HIV.D.DE172' from "HIVConcepts" display 'Negative'\ncode "Indeterminate - HIV.D.DE173": 'HIV.D.DE173' from "HIVConcepts" display 'Indeterminate'\ncode "HCV treatment start date": 'HIV.D.DE175' from "HIVConcepts" display 'HCV treatment start date'\ncode "HCV treatment completion date": 'HIV.D.DE176' from "HIVConcepts" display 'HCV treatment completion date'\ncode "HCV viral load test date - HIV.D.DE178": 'HIV.D.DE178' from "HIVConcepts" display 'HCV viral load test date'\ncode "HCV viral load test result - HIV.D.DE179": 'HIV.D.DE179' from "HIVConcepts" display 'HCV viral load test result'\ncode "Detected - HIV.D.DE180": 'HIV.D.DE180' from "HIVConcepts" display 'Detected'\ncode "Not detected - HIV.D.DE181": 'HIV.D.DE181' from "HIVConcepts" display 'Not detected'\ncode "HCV medicine type": 'HIV.D.DE182' from "HIVConcepts" display 'HCV medicine type'\ncode "Interferon": 'HIV.D.DE183' from "HIVConcepts" display 'Interferon'\ncode "Direct acting antivirals": 'HIV.D.DE184' from "HIVConcepts" display 'Direct acting antivirals'\ncode "Currently on TDF-based ART": 'HIV.D.DE185' from "HIVConcepts" display 'Currently on TDF-based ART'\ncode "HIV clinical stage - HIV.D.DE186": 'HIV.D.DE186' from "HIVConcepts" display 'HIV clinical stage'\ncode "WHO HIV clinical stage 1": 'HIV.D.DE187' from "HIVConcepts" display 'WHO HIV clinical stage 1'\ncode "WHO HIV clinical stage 2": 'HIV.D.DE188' from "HIVConcepts" display 'WHO HIV clinical stage 2'\ncode "WHO HIV clinical stage 3": 'HIV.D.DE189' from "HIVConcepts" display 'WHO HIV clinical stage 3'\ncode "WHO HIV clinical stage 4": 'HIV.D.DE190' from "HIVConcepts" display 'WHO HIV clinical stage 4'\ncode "Date viral load test results received by client - HIV.D.DE193": 'HIV.D.DE193' from "HIVConcepts" display 'Date viral load test results received by client'\ncode "Date of viral load sample collection - HIV.D.DE194": 'HIV.D.DE194' from "HIVConcepts" display 'Date of viral load sample collection'\ncode "Date of scheduled review of viral load test results": 'HIV.D.DE195' from "HIVConcepts" display 'Date of scheduled review of viral load test results'\ncode "Reason ART stopped - HIV.D.DE217": 'HIV.D.DE217' from "HIVConcepts" display 'Reason ART stopped'\ncode "Toxicity/side effects - HIV.D.DE218": 'HIV.D.DE218' from "HIVConcepts" display 'Toxicity/side effects'\ncode "Severe illness, hospitalization - HIV.D.DE219": 'HIV.D.DE219' from "HIVConcepts" display 'Severe illness, hospitalization'\ncode "Drugs out of stock": 'HIV.D.DE220' from "HIVConcepts" display 'Drugs out of stock'\ncode "Client lacks finances": 'HIV.D.DE221' from "HIVConcepts" display 'Client lacks finances'\ncode "Excluded HIV infection in infant - HIV.D.DE222": 'HIV.D.DE222' from "HIVConcepts" display 'Excluded HIV infection in infant'\ncode "Other reason for stopping ART - HIV.D.DE223": 'HIV.D.DE223' from "HIVConcepts" display 'Other reason for stopping ART'\ncode "Treatment failure": 'HIV.D.DE225' from "HIVConcepts" display 'Treatment failure'\ncode "Clinical failure": 'HIV.D.DE226' from "HIVConcepts" display 'Clinical failure'\ncode "Immunological failure": 'HIV.D.DE227' from "HIVConcepts" display 'Immunological failure'\ncode "Virological failure": 'HIV.D.DE228' from "HIVConcepts" display 'Virological failure'\ncode "Risk factors, comorbidities and coinfections signs and symptoms": 'HIV.D.DE259' from "HIVConcepts" display 'Risk factors, comorbidities and coinfections signs and symptoms'\ncode "Presumptive TB - HIV.D.DE282": 'HIV.D.DE282' from "HIVConcepts" display 'Presumptive TB'\ncode "WHO HIV clinical stage condition or symptom - HIV.D.DE289": 'HIV.D.DE289' from "HIVConcepts" display 'WHO HIV clinical stage condition or symptom'\ncode "Asymptomatic": 'HIV.D.DE290' from "HIVConcepts" display 'Asymptomatic'\ncode "Persistent generalized lymphadenopathy": 'HIV.D.DE291' from "HIVConcepts" display 'Persistent generalized lymphadenopathy'\ncode "Moderate unexplained weight loss": 'HIV.D.DE292' from "HIVConcepts" display 'Moderate unexplained weight loss'\ncode "Recurrent respiratory tract infections": 'HIV.D.DE293' from "HIVConcepts" display 'Recurrent respiratory tract infections'\ncode "Unexplained persistent hepatosplenomegaly": 'HIV.D.DE294' from "HIVConcepts" display 'Unexplained persistent hepatosplenomegaly'\ncode "Herpes zoster": 'HIV.D.DE295' from "HIVConcepts" display 'Herpes zoster'\ncode "Angular cheilitis": 'HIV.D.DE296' from "HIVConcepts" display 'Angular cheilitis'\ncode "Linear gingival erythema": 'HIV.D.DE297' from "HIVConcepts" display 'Linear gingival erythema'\ncode "Recurrent oral ulceration": 'HIV.D.DE298' from "HIVConcepts" display 'Recurrent oral ulceration'\ncode "Papular pruritic eruption": 'HIV.D.DE299' from "HIVConcepts" display 'Papular pruritic eruption'\ncode "Fungal nail infections": 'HIV.D.DE300' from "HIVConcepts" display 'Fungal nail infections'\ncode "Seborrhoeic dermatitis": 'HIV.D.DE301' from "HIVConcepts" display 'Seborrhoeic dermatitis'\ncode "Extensive wart virus infection": 'HIV.D.DE302' from "HIVConcepts" display 'Extensive wart virus infection'\ncode "Extensive molluscum contagiosum": 'HIV.D.DE303' from "HIVConcepts" display 'Extensive molluscum contagiosum'\ncode "Unexplained persistent parotid enlargement": 'HIV.D.DE304' from "HIVConcepts" display 'Unexplained persistent parotid enlargement'\ncode "Unexplained severe weight loss in adults": 'HIV.D.DE305' from "HIVConcepts" display 'Unexplained severe weight loss in adults'\ncode "Unexplained moderate malnutrition not adequately responding to standard therapy": 'HIV.D.DE306' from "HIVConcepts" display 'Unexplained moderate malnutrition not adequately responding to standard therapy'\ncode "Unexplained chronic diarrhoea for longer than 1 month": 'HIV.D.DE307' from "HIVConcepts" display 'Unexplained chronic diarrhoea for longer than 1 month'\ncode "Unexplained persistent diarrhoea 14 days or more": 'HIV.D.DE308' from "HIVConcepts" display 'Unexplained persistent diarrhoea 14 days or more'\ncode "Unexplained persistent fever above 37.5 C, intermittent or constant, for longer than one 1 month": 'HIV.D.DE309' from "HIVConcepts" display 'Unexplained persistent fever above 37.5 C, intermittent or constant, for longer than one 1 month'\ncode "Persistent oral candidiasis": 'HIV.D.DE310' from "HIVConcepts" display 'Persistent oral candidiasis'\ncode "Oral hairy leukoplakia": 'HIV.D.DE311' from "HIVConcepts" display 'Oral hairy leukoplakia'\ncode "Pulmonary TB - HIV.D.DE312": 'HIV.D.DE312' from "HIVConcepts" display 'Pulmonary TB'\ncode "Lymph node TB - HIV.D.DE313": 'HIV.D.DE313' from "HIVConcepts" display 'Lymph node TB'\ncode "Severe bacterial infections such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia": 'HIV.D.DE314' from "HIVConcepts" display 'Severe bacterial infections such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia'\ncode "Severe recurrent bacterial pneumonia": 'HIV.D.DE315' from "HIVConcepts" display 'Severe recurrent bacterial pneumonia'\ncode "Acute necrotizing ulcerative stomatitis": 'HIV.D.DE316' from "HIVConcepts" display 'Acute necrotizing ulcerative stomatitis'\ncode "Acute necrotizing ulcerative gingivitis": 'HIV.D.DE317' from "HIVConcepts" display 'Acute necrotizing ulcerative gingivitis'\ncode "Acute necrotizing ulcerative periodontitis": 'HIV.D.DE318' from "HIVConcepts" display 'Acute necrotizing ulcerative periodontitis'\ncode "Unexplained anaemia <8 g/dL": 'HIV.D.DE319' from "HIVConcepts" display 'Unexplained anaemia <8 g/dL'\ncode "Neutropaenia <0.5 x 10^9/L": 'HIV.D.DE320' from "HIVConcepts" display 'Neutropaenia <0.5 x 10^9/L'\ncode "Chronic thrombocytopaenia <50 x 10^9/L": 'HIV.D.DE321' from "HIVConcepts" display 'Chronic thrombocytopaenia <50 x 10^9/L'\ncode "Symptomatic lymphoid interstitial pneumonitis": 'HIV.D.DE322' from "HIVConcepts" display 'Symptomatic lymphoid interstitial pneumonitis'\ncode "Chronic HIV-associated lung disease, including bronchiectasis": 'HIV.D.DE323' from "HIVConcepts" display 'Chronic HIV-associated lung disease, including bronchiectasis'\ncode "HIV wasting syndrome": 'HIV.D.DE324' from "HIVConcepts" display 'HIV wasting syndrome'\ncode "Unexplained severe wasting not responding to standard therapy": 'HIV.D.DE325' from "HIVConcepts" display 'Unexplained severe wasting not responding to standard therapy'\ncode "Unexplained stunting not responding to standard therapy": 'HIV.D.DE326' from "HIVConcepts" display 'Unexplained stunting not responding to standard therapy'\ncode "Unexplained severe malnutrition not responding to standard therapy": 'HIV.D.DE327' from "HIVConcepts" display 'Unexplained severe malnutrition not responding to standard therapy'\ncode "Pneumocystis jirovecii pneumonia": 'HIV.D.DE328' from "HIVConcepts" display 'Pneumocystis jirovecii pneumonia'\ncode "Recurrent severe bacterial pneumonia": 'HIV.D.DE329' from "HIVConcepts" display 'Recurrent severe bacterial pneumonia'\ncode "Recurrent severe bacterial infections such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia": 'HIV.D.DE330' from "HIVConcepts" display 'Recurrent severe bacterial infections such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia'\ncode "Empyema": 'HIV.D.DE331' from "HIVConcepts" display 'Empyema'\ncode "Pyomyositis": 'HIV.D.DE332' from "HIVConcepts" display 'Pyomyositis'\ncode "Bone or joint infection": 'HIV.D.DE333' from "HIVConcepts" display 'Bone or joint infection'\ncode "Meningitis": 'HIV.D.DE334' from "HIVConcepts" display 'Meningitis'\ncode "Chronic herpes simplex infection orolabial or cutaneous of more than 1 month duration or visceral at any site": 'HIV.D.DE335' from "HIVConcepts" display 'Chronic herpes simplex infection orolabial or cutaneous of more than 1 month duration or visceral at any site'\ncode "Chronic herpes simplex infection orolabial, genital or anorectal of more than 1 month in duration or visceral at any site": 'HIV.D.DE336' from "HIVConcepts" display 'Chronic herpes simplex infection orolabial, genital or anorectal of more than 1 month in duration or visceral at any site'\ncode "Oesophageal candidiasis or candidiasis of trachea, bronchi or lungs": 'HIV.D.DE337' from "HIVConcepts" display 'Oesophageal candidiasis or candidiasis of trachea, bronchi or lungs'\ncode "Extrapulmonary TB - HIV.D.DE338": 'HIV.D.DE338' from "HIVConcepts" display 'Extrapulmonary TB'\ncode "Kaposi sarcoma": 'HIV.D.DE339' from "HIVConcepts" display 'Kaposi sarcoma'\ncode "Cytomegalovirus infection retinitis or infection of other organs": 'HIV.D.DE340' from "HIVConcepts" display 'Cytomegalovirus infection retinitis or infection of other organs'\ncode "Central nervous system toxoplasmosis": 'HIV.D.DE341' from "HIVConcepts" display 'Central nervous system toxoplasmosis'\ncode "HIV encephalopathy": 'HIV.D.DE342' from "HIVConcepts" display 'HIV encephalopathy'\ncode "Extrapulmonary cryptococcosis, including meningitis": 'HIV.D.DE343' from "HIVConcepts" display 'Extrapulmonary cryptococcosis, including meningitis'\ncode "Disseminated nontuberculous mycobacterial infection": 'HIV.D.DE344' from "HIVConcepts" display 'Disseminated nontuberculous mycobacterial infection'\ncode "Progressive multifocal leukoencephalopathy": 'HIV.D.DE345' from "HIVConcepts" display 'Progressive multifocal leukoencephalopathy'\ncode "Chronic cryptosporidiosis": 'HIV.D.DE346' from "HIVConcepts" display 'Chronic cryptosporidiosis'\ncode "Chronic cryptosporidiosis with diarrhoea": 'HIV.D.DE347' from "HIVConcepts" display 'Chronic cryptosporidiosis with diarrhoea'\ncode "Chronic isosporiasis": 'HIV.D.DE348' from "HIVConcepts" display 'Chronic isosporiasis'\ncode "Disseminated mycosis extrapulmonary histoplasmosis, coccidioidomycosis": 'HIV.D.DE349' from "HIVConcepts" display 'Disseminated mycosis extrapulmonary histoplasmosis, coccidioidomycosis'\ncode "Disseminated endemic mycosis extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis": 'HIV.D.DE350' from "HIVConcepts" display 'Disseminated endemic mycosis extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis'\ncode "Cerebral lymphoma": 'HIV.D.DE351' from "HIVConcepts" display 'Cerebral lymphoma'\ncode "B-cell non-Hodgkin lymphoma": 'HIV.D.DE352' from "HIVConcepts" display 'B-cell non-Hodgkin lymphoma'\ncode "HIV-associated nephropathy or cardiomyopathy": 'HIV.D.DE353' from "HIVConcepts" display 'HIV-associated nephropathy or cardiomyopathy'\ncode "Recurrent septicaemia including nontyphoidal Salmonella": 'HIV.D.DE354' from "HIVConcepts" display 'Recurrent septicaemia including nontyphoidal Salmonella'\ncode "Invasive cervical carcinoma": 'HIV.D.DE355' from "HIVConcepts" display 'Invasive cervical carcinoma'\ncode "Atypical disseminated leishmaniasis": 'HIV.D.DE356' from "HIVConcepts" display 'Atypical disseminated leishmaniasis'\ncode "Neutropenia": 'HIV.D.DE357' from "HIVConcepts" display 'Neutropenia'\ncode "CD4 count - HIV.D.DE364": 'HIV.D.DE364' from "HIVConcepts" display 'CD4 count'\ncode "Baseline CD4 count - HIV.D.DE367": 'HIV.D.DE367' from "HIVConcepts" display 'Baseline CD4 count'\ncode "Date of baseline CD4 count test - HIV.D.DE368": 'HIV.D.DE368' from "HIVConcepts" display 'Date of baseline CD4 count test'\ncode "Time to start ART": 'HIV.D.DE383' from "HIVConcepts" display 'Time to start ART'\ncode "Within 7 days of HIV diagnosis": 'HIV.D.DE384' from "HIVConcepts" display 'Within 7 days of HIV diagnosis'\ncode "Within 30 days of HIV diagnosis": 'HIV.D.DE385' from "HIVConcepts" display 'Within 30 days of HIV diagnosis'\ncode "Within 90 days of HIV diagnosis": 'HIV.D.DE386' from "HIVConcepts" display 'Within 90 days of HIV diagnosis'\ncode "Viral load test result - HIV.D.DE387": 'HIV.D.DE387' from "HIVConcepts" display 'Viral load test result'\ncode "Reason for HIV viral load test": 'HIV.D.DE391' from "HIVConcepts" display 'Reason for HIV viral load test'\ncode "Routine viral load test": 'HIV.D.DE392' from "HIVConcepts" display 'Routine viral load test'\ncode "Targeted viral load monitoring": 'HIV.D.DE393' from "HIVConcepts" display 'Targeted viral load monitoring'\ncode "Initial viral load test": 'HIV.D.DE394' from "HIVConcepts" display 'Initial viral load test'\ncode "Follow-up viral load test after receiving enhanced adherence counselling": 'HIV.D.DE395' from "HIVConcepts" display 'Follow-up viral load test after receiving enhanced adherence counselling'\ncode "Monitoring examinations": 'HIV.D.DE399' from "HIVConcepts" display 'Monitoring examinations'\ncode "Haemoglobin Hb": 'HIV.D.DE400' from "HIVConcepts" display 'Haemoglobin Hb'\ncode "Pregnancy test": 'HIV.D.DE401' from "HIVConcepts" display 'Pregnancy test'\ncode "Syphilis test": 'HIV.D.DE402' from "HIVConcepts" display 'Syphilis test'\ncode "Chest X-ray CXR": 'HIV.D.DE403' from "HIVConcepts" display 'Chest X-ray CXR'\ncode "Sputum or culture for TB": 'HIV.D.DE404' from "HIVConcepts" display 'Sputum or culture for TB'\ncode "HBsAg test HBV": 'HIV.D.DE405' from "HIVConcepts" display 'HBsAg test HBV'\ncode "HIV viral load test ordered": 'HIV.D.DE406' from "HIVConcepts" display 'HIV viral load test ordered'\ncode "HIV viral load test scheduled": 'HIV.D.DE407' from "HIVConcepts" display 'HIV viral load test scheduled'\ncode "CD4 count ordered": 'HIV.D.DE408' from "HIVConcepts" display 'CD4 count ordered'\ncode "CD4 count test scheduled": 'HIV.D.DE409' from "HIVConcepts" display 'CD4 count test scheduled'\ncode "Cryptococcal antigen test": 'HIV.D.DE410' from "HIVConcepts" display 'Cryptococcal antigen test'\ncode "Histoplasmosis antigen test": 'HIV.D.DE411' from "HIVConcepts" display 'Histoplasmosis antigen test'\ncode "Cervical cancer screening scheduled": 'HIV.D.DE412' from "HIVConcepts" display 'Cervical cancer screening scheduled'\ncode "Date of scheduled monitoring examination": 'HIV.D.DE413' from "HIVConcepts" display 'Date of scheduled monitoring examination'\ncode "Date viral load test results received by client - HIV.D.DE417": 'HIV.D.DE417' from "HIVConcepts" display 'Date viral load test results received by client'\ncode "Reason for ARV drug regimen substitution": 'HIV.D.DE418' from "HIVConcepts" display 'Reason for ARV drug regimen substitution'\ncode "Toxicity/side effects - HIV.D.DE419": 'HIV.D.DE419' from "HIVConcepts" display 'Toxicity/side effects'\ncode "Drug-drug interaction": 'HIV.D.DE420' from "HIVConcepts" display 'Drug-drug interaction'\ncode "Pregnancy": 'HIV.D.DE421' from "HIVConcepts" display 'Pregnancy'\ncode "New TB": 'HIV.D.DE422' from "HIVConcepts" display 'New TB'\ncode "New drug available": 'HIV.D.DE423' from "HIVConcepts" display 'New drug available'\ncode "Drug out of stock": 'HIV.D.DE424' from "HIVConcepts" display 'Drug out of stock'\ncode "Other reason for regimen substitution": 'HIV.D.DE425' from "HIVConcepts" display 'Other reason for regimen substitution'\ncode "Switch to second-line ART regimen recommended": 'HIV.D.DE427' from "HIVConcepts" display 'Switch to second-line ART regimen recommended'\ncode "Regimen substitution recommended": 'HIV.D.DE436' from "HIVConcepts" display 'Regimen substitution recommended'\ncode "Dose adjustment recommended": 'HIV.D.DE437' from "HIVConcepts" display 'Dose adjustment recommended'\ncode "Suspicion of treatment failure or interruption": 'HIV.D.DE443' from "HIVConcepts" display 'Suspicion of treatment failure or interruption'\ncode "Medications prescribed - HIV.D.DE457": 'HIV.D.DE457' from "HIVConcepts" display 'Medications prescribed'\ncode "Date medications prescribed - HIV.D.DE458": 'HIV.D.DE458' from "HIVConcepts" display 'Date medications prescribed'\ncode "Dose of medications prescribed": 'HIV.D.DE459' from "HIVConcepts" display 'Dose of medications prescribed'\ncode "Number of days medications prescribed": 'HIV.D.DE460' from "HIVConcepts" display 'Number of days medications prescribed'\ncode "Adherence counselling provided - HIV.D.DE465": 'HIV.D.DE465' from "HIVConcepts" display 'Adherence counselling provided'\ncode "Type of treatment-limiting toxicity": 'HIV.D.DE466' from "HIVConcepts" display 'Type of treatment-limiting toxicity'\ncode "Gastrointestinal": 'HIV.D.DE467' from "HIVConcepts" display 'Gastrointestinal'\ncode "Skin issues": 'HIV.D.DE468' from "HIVConcepts" display 'Skin issues'\ncode "Peripheral neuropathy": 'HIV.D.DE469' from "HIVConcepts" display 'Peripheral neuropathy'\ncode "Central nervous system symptoms": 'HIV.D.DE470' from "HIVConcepts" display 'Central nervous system symptoms'\ncode "Weight gain": 'HIV.D.DE471' from "HIVConcepts" display 'Weight gain'\ncode "Hepatic dysfunction": 'HIV.D.DE472' from "HIVConcepts" display 'Hepatic dysfunction'\ncode "Haematological disorders": 'HIV.D.DE473' from "HIVConcepts" display 'Haematological disorders'\ncode "Fatigue": 'HIV.D.DE474' from "HIVConcepts" display 'Fatigue'\ncode "Headache - HIV.D.DE475": 'HIV.D.DE475' from "HIVConcepts" display 'Headache'\ncode "Bone dysfunction": 'HIV.D.DE476' from "HIVConcepts" display 'Bone dysfunction'\ncode "Metabolic symptoms": 'HIV.D.DE477' from "HIVConcepts" display 'Metabolic symptoms'\ncode "Kidney dysfunction": 'HIV.D.DE478' from "HIVConcepts" display 'Kidney dysfunction'\ncode "Unexpected adverse drug reaction": 'HIV.D.DE479' from "HIVConcepts" display 'Unexpected adverse drug reaction'\n\ncode "Dates of substitution within second-line regimen": 'HIV.D.DE487' from "HIVConcepts" display 'Dates of substitution within second-line regimen'\ncode "Dates of substitution within third-line regimen": 'HIV.D.DE493' from "HIVConcepts" display 'Dates of substitution within third-line regimen'\ncode "Enhanced adherence counselling provided": 'HIV.D.DE496' from "HIVConcepts" display 'Enhanced adherence counselling provided'\ncode "Counselling provided on diagnoses": 'HIV.D.DE507' from "HIVConcepts" display 'Counselling provided on diagnoses'\ncode "Syphilis counselling and treatment": 'HIV.D.DE510' from "HIVConcepts" display 'Syphilis counselling and treatment'\ncode "Other support services - HIV.D.DE519": 'HIV.D.DE519' from "HIVConcepts" display 'Other support services'\ncode "Mental health services - HIV.D.DE520": 'HIV.D.DE520' from "HIVConcepts" display 'Mental health services'\ncode "Psychosocial counselling, support and treatment adherence counselling - HIV.D.DE521": 'HIV.D.DE521' from "HIVConcepts" display 'Psychosocial counselling, support and treatment adherence counselling'\ncode "Legal and social services - HIV.D.DE522": 'HIV.D.DE522' from "HIVConcepts" display 'Legal and social services'\ncode "Services for responding to violence against women - HIV.D.DE523": 'HIV.D.DE523' from "HIVConcepts" display 'Services for responding to violence against women'\ncode "Date/time of follow-up appointment - HIV.D.DE524": 'HIV.D.DE524' from "HIVConcepts" display 'Date/time of follow-up appointment'\ncode "Type of follow-up appointment - HIV.D.DE525": 'HIV.D.DE525' from "HIVConcepts" display 'Type of follow-up appointment'\ncode "Clinical visit - HIV.D.DE526": 'HIV.D.DE526' from "HIVConcepts" display 'Clinical visit'\ncode "Antiretroviral drug pick up": 'HIV.D.DE527' from "HIVConcepts" display 'Antiretroviral drug pick up'\ncode "Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer - HIV.D.DE528": 'HIV.D.DE528' from "HIVConcepts" display 'Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer'\ncode "Other - HIV.D.DE529": 'HIV.D.DE529' from "HIVConcepts" display 'Other'\ncode "Follow-up test recommended date": 'HIV.D.DE531' from "HIVConcepts" display 'Follow-up test recommended date'\ncode "Current medications": 'HIV.D.DE537' from "HIVConcepts" display 'Current medications'\ncode "No medications": 'HIV.D.DE538' from "HIVConcepts" display 'No medications'\ncode "Dont know of any current medications": 'HIV.D.DE539' from "HIVConcepts" display 'Dont know of any current medications'\ncode "Analgesic": 'HIV.D.DE540' from "HIVConcepts" display 'Analgesic'\ncode "Antacids": 'HIV.D.DE541' from "HIVConcepts" display 'Antacids'\ncode "Antibiotics broad-spectrum": 'HIV.D.DE542' from "HIVConcepts" display 'Antibiotics broad-spectrum'\ncode "Anticonvulsive": 'HIV.D.DE543' from "HIVConcepts" display 'Anticonvulsive'\ncode "Antidiabetic": 'HIV.D.DE544' from "HIVConcepts" display 'Antidiabetic'\ncode "Antifungals": 'HIV.D.DE545' from "HIVConcepts" display 'Antifungals'\ncode "Antihelmintic": 'HIV.D.DE546' from "HIVConcepts" display 'Antihelmintic'\ncode "Antihypertensive": 'HIV.D.DE547' from "HIVConcepts" display 'Antihypertensive'\ncode "Antimalarials": 'HIV.D.DE548' from "HIVConcepts" display 'Antimalarials'\ncode "Antiretrovirals ARVs": 'HIV.D.DE549' from "HIVConcepts" display 'Antiretrovirals ARVs'\ncode "Antiparasitics": 'HIV.D.DE550' from "HIVConcepts" display 'Antiparasitics'\ncode "Antivirals": 'HIV.D.DE551' from "HIVConcepts" display 'Antivirals'\ncode "Buprenorphine - HIV.D.DE552": 'HIV.D.DE552' from "HIVConcepts" display 'Buprenorphine'\ncode "Co-trimoxazole preventive therapy CPT": 'HIV.D.DE553' from "HIVConcepts" display 'Co-trimoxazole preventive therapy CPT'\ncode "Hormonal family planning method": 'HIV.D.DE554' from "HIVConcepts" display 'Hormonal family planning method'\ncode "Methadone - HIV.D.DE555": 'HIV.D.DE555' from "HIVConcepts" display 'Methadone'\ncode "PrEP to prevent HIV": 'HIV.D.DE556' from "HIVConcepts" display 'PrEP to prevent HIV'\ncode "Other antibiotics": 'HIV.D.DE557' from "HIVConcepts" display 'Other antibiotics'\ncode "Other medications": 'HIV.D.DE558' from "HIVConcepts" display 'Other medications'\ncode "Date of cervical cancer screening test": 'HIV.D.DE656' from "HIVConcepts" display 'Date of cervical cancer screening test'\ncode "Lifetime screening test number": 'HIV.D.DE657' from "HIVConcepts" display 'Lifetime screening test number'\ncode "Cervical cancer primary screening test type": 'HIV.D.DE658' from "HIVConcepts" display 'Cervical cancer primary screening test type'\ncode "HPV-DNA": 'HIV.D.DE659' from "HIVConcepts" display 'HPV-DNA'\ncode "VIA": 'HIV.D.DE660' from "HIVConcepts" display 'VIA'\ncode "New regimen after switch to second-line regimen": 'HIV.D.DE485' from "HIVConcepts"\ncode "New regimen after switch to third-line regimen": 'HIV.D.DE491' from "HIVConcepts"\ncode "New regimen after substitution within second-line regimen": 'HIV.D.DE489' from "HIVConcepts"\ncode "New regimen after substitution within third-line regimen": 'HIV.D.DE495' from "HIVConcepts"\ncode "Cervical cytology": 'HIV.D.DE661' from "HIVConcepts" display 'Cervical cytology'\ncode "Other - HIV.D.DE662": 'HIV.D.DE662' from "HIVConcepts" display 'Other'\ncode "Date of diagnosis of cervical precancer lesions or invasive cervical cancer": 'HIV.D.DE705' from "HIVConcepts" display 'Date of diagnosis of cervical precancer lesions or invasive cervical cancer'\ncode "Cervical cancer screening outcome": 'HIV.D.DE706' from "HIVConcepts" display 'Cervical cancer screening outcome'\ncode "Positive for cervical precancer lesions": 'HIV.D.DE707' from "HIVConcepts" display 'Positive for cervical precancer lesions'\ncode "Negative for cervical precancer lesions": 'HIV.D.DE708' from "HIVConcepts" display 'Negative for cervical precancer lesions'\ncode "Cervical cancer diagnosis": 'HIV.D.DE709' from "HIVConcepts" display 'Cervical cancer diagnosis'\ncode "Cervical precancer lesions": 'HIV.D.DE710' from "HIVConcepts" display 'Cervical precancer lesions'\ncode "Invasive cervical cancer": 'HIV.D.DE711' from "HIVConcepts" display 'Invasive cervical cancer'\ncode "Cervical cancer stage at diagnosis": 'HIV.D.DE712' from "HIVConcepts" display 'Cervical cancer stage at diagnosis'\ncode "Stage 0": 'HIV.D.DE713' from "HIVConcepts" display 'Stage 0'\ncode "Stage I": 'HIV.D.DE714' from "HIVConcepts" display 'Stage I'\ncode "Stage II": 'HIV.D.DE715' from "HIVConcepts" display 'Stage II'\ncode "Stage III": 'HIV.D.DE716' from "HIVConcepts" display 'Stage III'\ncode "Stage IV": 'HIV.D.DE717' from "HIVConcepts" display 'Stage IV'\ncode "Date of treatment for cervical precancer lesions": 'HIV.D.DE718' from "HIVConcepts" display 'Date of treatment for cervical precancer lesions'\ncode "Invasive cervical cancer treatment episode": 'HIV.D.DE730' from "HIVConcepts" display 'Invasive cervical cancer treatment episode'\ncode "Invasive cervical cancer treatment method": 'HIV.D.DE731' from "HIVConcepts" display 'Invasive cervical cancer treatment method'\ncode "Conization": 'HIV.D.DE732' from "HIVConcepts" display 'Conization'\ncode "Trachelectomy": 'HIV.D.DE733' from "HIVConcepts" display 'Trachelectomy'\ncode "Hysterectomy": 'HIV.D.DE734' from "HIVConcepts" display 'Hysterectomy'\ncode "Management of invasive cervical cancer": 'HIV.D.DE735' from "HIVConcepts" display 'Management of invasive cervical cancer'\ncode "Radiotherapy": 'HIV.D.DE736' from "HIVConcepts" display 'Radiotherapy'\ncode "Chemotherapy": 'HIV.D.DE737' from "HIVConcepts" display 'Chemotherapy'\ncode "Chemoradiation": 'HIV.D.DE738' from "HIVConcepts" display 'Chemoradiation'\ncode "Other - HIV.D.DE739": 'HIV.D.DE739' from "HIVConcepts" display 'Other'\ncode "Cervical cancer screening interval amongst WLHIV": 'HIV.D.DE745' from "HIVConcepts" display 'Cervical cancer screening interval amongst WLHIV'\ncode "Offer other clinical services - HIV.D.DE753": 'HIV.D.DE753' from "HIVConcepts" display 'Offer other clinical services'\ncode "Assessment and provision of vaccinations - HIV.D.DE754": 'HIV.D.DE754' from "HIVConcepts" display 'Assessment and provision of vaccinations'\ncode "Hepatitis B HBV and hepatitis C virus HCV testing and treatment": 'HIV.D.DE755' from "HIVConcepts" display 'Hepatitis B HBV and hepatitis C virus HCV testing and treatment'\ncode "Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia - HIV.D.DE756": 'HIV.D.DE756' from "HIVConcepts" display 'Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia'\ncode "Intensified TB case finding and linkage to TB treatment - HIV.D.DE757": 'HIV.D.DE757' from "HIVConcepts" display 'Intensified TB case finding and linkage to TB treatment'\ncode "Provision of isoniazid preventive therapy if person does not have TB - HIV.D.DE758": 'HIV.D.DE758' from "HIVConcepts" display 'Provision of isoniazid preventive therapy if person does not have TB'\ncode "Malaria prevention such as bed nets and prophylaxis, depending on epidemiology - HIV.D.DE759": 'HIV.D.DE759' from "HIVConcepts" display 'Malaria prevention such as bed nets and prophylaxis, depending on epidemiology'\ncode "Eligible for DSD ART": 'HIV.D.DE760' from "HIVConcepts" display 'Eligible for DSD ART'\ncode "Date DSD ART eligibility assessed": 'HIV.D.DE761' from "HIVConcepts" display 'Date DSD ART eligibility assessed'\ncode "Currently enrolled in DSD ART model": 'HIV.D.DE762' from "HIVConcepts" display 'Currently enrolled in DSD ART model'\ncode "DSD ART start date": 'HIV.D.DE763' from "HIVConcepts" display 'DSD ART start date'\ncode "DSD ART models": 'HIV.D.DE764' from "HIVConcepts" display 'DSD ART models'\ncode "Fast track ART refill": 'HIV.D.DE765' from "HIVConcepts" display 'Fast track ART refill'\ncode "Facility adherence club": 'HIV.D.DE766' from "HIVConcepts" display 'Facility adherence club'\ncode "Community ART distribution point": 'HIV.D.DE767' from "HIVConcepts" display 'Community ART distribution point'\ncode "CHW/peer educator community ART group": 'HIV.D.DE768' from "HIVConcepts" display 'CHW/peer educator community ART group'\ncode "Patient/client community ART group": 'HIV.D.DE769' from "HIVConcepts" display 'Patient/client community ART group'\ncode "Other DSD ART model": 'HIV.D.DE770' from "HIVConcepts" display 'Other DSD ART model'\ncode "Syndrome/STI diagnosed - HIV.D.DE778": 'HIV.D.DE778' from "HIVConcepts" display 'Syndrome/STI diagnosed'\ncode "Urethral discharge syndrome - HIV.D.DE779": 'HIV.D.DE779' from "HIVConcepts" display 'Urethral discharge syndrome'\ncode "Vaginal discharge syndrome - HIV.D.DE780": 'HIV.D.DE780' from "HIVConcepts" display 'Vaginal discharge syndrome'\ncode "Lower Abdominal pain - HIV.D.DE781": 'HIV.D.DE781' from "HIVConcepts" display 'Lower Abdominal pain '\ncode "Genital ulcer disease syndrome - HIV.D.DE782": 'HIV.D.DE782' from "HIVConcepts" display 'Genital ulcer disease syndrome'\ncode "Anorectal discharge - HIV.D.DE783": 'HIV.D.DE783' from "HIVConcepts" display 'Anorectal discharge'\ncode "Sent for testing - HIV.D.DE784": 'HIV.D.DE784' from "HIVConcepts" display 'Sent for testing'\ncode "Other - HIV.D.DE785": 'HIV.D.DE785' from "HIVConcepts" display 'Other'\ncode "Any STI syndrome diagnosed - HIV.D.DE787": 'HIV.D.DE787' from "HIVConcepts" display 'Any STI syndrome diagnosed'\ncode "Syphilis test date - HIV.D.DE801": 'HIV.D.DE801' from "HIVConcepts" display 'Syphilis test date'\ncode "Syphilis test result - HIV.D.DE802": 'HIV.D.DE802' from "HIVConcepts" display 'Syphilis test result'\ncode "Positive - HIV.D.DE803": 'HIV.D.DE803' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.D.DE804": 'HIV.D.DE804' from "HIVConcepts" display 'Negative'\ncode "Inconclusive - HIV.D.DE805": 'HIV.D.DE805' from "HIVConcepts" display 'Inconclusive'\ncode "Syphilis treatment start date - HIV.D.DE806": 'HIV.D.DE806' from "HIVConcepts" display 'Syphilis treatment start date'\ncode "Gonorrhoea test date - HIV.D.DE807": 'HIV.D.DE807' from "HIVConcepts" display 'Gonorrhoea test date'\ncode "Gonorrhoea test result - HIV.D.DE808": 'HIV.D.DE808' from "HIVConcepts" display 'Gonorrhoea test result'\ncode "Positive - HIV.D.DE809": 'HIV.D.DE809' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.D.DE810": 'HIV.D.DE810' from "HIVConcepts" display 'Negative'\ncode "Inconclusive - HIV.D.DE811": 'HIV.D.DE811' from "HIVConcepts" display 'Inconclusive'\ncode "Gonorrhoea treatment start date - HIV.D.DE812": 'HIV.D.DE812' from "HIVConcepts" display 'Gonorrhoea treatment start date'\ncode "Type of specimen - HIV.D.DE813": 'HIV.D.DE813' from "HIVConcepts" display 'Type of specimen'\ncode "Blood - HIV.D.DE814": 'HIV.D.DE814' from "HIVConcepts" display 'Blood'\ncode "Urine - HIV.D.DE815": 'HIV.D.DE815' from "HIVConcepts" display 'Urine'\ncode "Cervical or vaginal swab - HIV.D.DE816": 'HIV.D.DE816' from "HIVConcepts" display 'Cervical or vaginal swab'\ncode "Urethral or penile swab - HIV.D.DE817": 'HIV.D.DE817' from "HIVConcepts" display 'Urethral or penile swab'\ncode "Rectal swab - HIV.D.DE818": 'HIV.D.DE818' from "HIVConcepts" display 'Rectal swab'\ncode "Other - HIV.D.DE819": 'HIV.D.DE819' from "HIVConcepts" display 'Other'\ncode "Neisseria gonorrhoeae test type - HIV.D.DE828": 'HIV.D.DE828' from "HIVConcepts" display 'Neisseria gonorrhoeae test type'\ncode "NAAT - HIV.D.DE829": 'HIV.D.DE829' from "HIVConcepts" display 'NAAT'\ncode "POC Test - HIV.D.DE830": 'HIV.D.DE830' from "HIVConcepts" display 'POC Test'\ncode "Culture - HIV.D.DE831": 'HIV.D.DE831' from "HIVConcepts" display 'Culture'\ncode "Microscopy - HIV.D.DE832": 'HIV.D.DE832' from "HIVConcepts" display 'Microscopy'\ncode "Other - HIV.D.DE833": 'HIV.D.DE833' from "HIVConcepts" display 'Other'\ncode "Medication/drug": 'HIV.D.DE903' from "HIVConcepts" display 'Medication/drug'\ncode "Rifampicin": 'HIV.D.DE904' from "HIVConcepts" display 'Rifampicin'\ncode "Halofantrine": 'HIV.D.DE905' from "HIVConcepts" display 'Halofantrine'\ncode "Lovastatin": 'HIV.D.DE906' from "HIVConcepts" display 'Lovastatin'\ncode "Simvastatin": 'HIV.D.DE907' from "HIVConcepts" display 'Simvastatin'\ncode "Hormonal contraception": 'HIV.D.DE908' from "HIVConcepts" display 'Hormonal contraception'\ncode "Metformin": 'HIV.D.DE909' from "HIVConcepts" display 'Metformin'\ncode "Astemizole": 'HIV.D.DE910' from "HIVConcepts" display 'Astemizole'\ncode "Terfenadine": 'HIV.D.DE911' from "HIVConcepts" display 'Terfenadine'\ncode "TDF - HIV.D.DE912": 'HIV.D.DE912' from "HIVConcepts" display 'TDF'\ncode "Simeprevir": 'HIV.D.DE913' from "HIVConcepts" display 'Simeprevir'\ncode "Ombitasvir + paritaprevir/ritonavir + dasabuvir": 'HIV.D.DE914' from "HIVConcepts" display 'Ombitasvir + paritaprevir/ritonavir + dasabuvir'\ncode "Methadone - HIV.D.DE915": 'HIV.D.DE915' from "HIVConcepts" display 'Methadone'\ncode "Buprenorphine - HIV.D.DE916": 'HIV.D.DE916' from "HIVConcepts" display 'Buprenorphine'\ncode "Dofetilide": 'HIV.D.DE917' from "HIVConcepts" display 'Dofetilide'\ncode "Carbamazepine": 'HIV.D.DE918' from "HIVConcepts" display 'Carbamazepine'\ncode "Phenobarbital": 'HIV.D.DE919' from "HIVConcepts" display 'Phenobarbital'\ncode "Phenytoin": 'HIV.D.DE920' from "HIVConcepts" display 'Phenytoin'\ncode "Polyvalent cation products containing Mg, Al, Fe, Ca and Zn": 'HIV.D.DE921' from "HIVConcepts" display 'Polyvalent cation products containing Mg, Al, Fe, Ca and Zn'\ncode "Amodiaquine": 'HIV.D.DE922' from "HIVConcepts" display 'Amodiaquine'\ncode "Cisapride": 'HIV.D.DE923' from "HIVConcepts" display 'Cisapride'\ncode "Ergotamine": 'HIV.D.DE924' from "HIVConcepts" display 'Ergotamine'\ncode "Dihydroergotamine": 'HIV.D.DE925' from "HIVConcepts" display 'Dihydroergotamine'\ncode "Midazolam": 'HIV.D.DE926' from "HIVConcepts" display 'Midazolam'\ncode "Triazolam": 'HIV.D.DE927' from "HIVConcepts" display 'Triazolam'\ncode "Estrogen-based hormonal contraception": 'HIV.D.DE928' from "HIVConcepts" display 'Estrogen-based hormonal contraception'\ncode "Ribavirin": 'HIV.D.DE929' from "HIVConcepts" display 'Ribavirin'\ncode "Peginterferon alfa-2a": 'HIV.D.DE930' from "HIVConcepts" display 'Peginterferon alfa-2a'\ncode "Other - HIV.D.DE931": 'HIV.D.DE931' from "HIVConcepts" display 'Other'\ncode "Medication change recommended": 'HIV.D.DE933' from "HIVConcepts" display 'Medication change recommended'\ncode "WHO HIV clinical stage condition or symptom - HIV.D.DE934": 'HIV.D.DE934' from "HIVConcepts" display 'WHO HIV clinical stage condition or symptom'\ncode "Pulmonary TB - HIV.D.DE935": 'HIV.D.DE935' from "HIVConcepts" display 'Pulmonary TB'\ncode "Lymph node TB - HIV.D.DE936": 'HIV.D.DE936' from "HIVConcepts" display 'Lymph node TB'\ncode "Extrapulmonary TB - HIV.D.DE937": 'HIV.D.DE937' from "HIVConcepts" display 'Extrapulmonary TB'\ncode "TB diagnosis result": 'HIV.D.DE939' from "HIVConcepts" display 'TB diagnosis result'\ncode "Diagnosed TB": 'HIV.D.DE940' from "HIVConcepts" display 'Diagnosed TB'\ncode "TB excluded": 'HIV.D.DE941' from "HIVConcepts" display 'TB excluded'\ncode "Presumptive TB - HIV.D.DE945": 'HIV.D.DE945' from "HIVConcepts" display 'Presumptive TB'\ncode "Date of TB diagnosis": 'HIV.D.DE952' from "HIVConcepts" display 'Date of TB diagnosis'\ncode "TB preventive treatment TPT start date": 'HIV.D.DE954' from "HIVConcepts" display 'TB preventive treatment TPT start date'\ncode "TB screening algorithm": 'HIV.D.DE956' from "HIVConcepts" display 'TB screening algorithm'\ncode "Screening with cough": 'HIV.D.DE957' from "HIVConcepts" display 'Screening with cough'\ncode "Screening with any TB symptom": 'HIV.D.DE958' from "HIVConcepts" display 'Screening with any TB symptom'\ncode "W4SS single screening algorithm": 'HIV.D.DE959' from "HIVConcepts" display 'W4SS single screening algorithm'\ncode "CRP single screening algorithm": 'HIV.D.DE960' from "HIVConcepts" display 'CRP single screening algorithm'\ncode "CXR single screening algorithm": 'HIV.D.DE961' from "HIVConcepts" display 'CXR single screening algorithm'\ncode "Parallel screening algorithm with W4SS and CRP": 'HIV.D.DE962' from "HIVConcepts" display 'Parallel screening algorithm with W4SS and CRP'\ncode "Sequential positive screening algorithm with W4SS and CRP": 'HIV.D.DE963' from "HIVConcepts" display 'Sequential positive screening algorithm with W4SS and CRP'\ncode "Sequential negative screening algorithm with W4SS and CRP": 'HIV.D.DE964' from "HIVConcepts" display 'Sequential negative screening algorithm with W4SS and CRP'\ncode "Parallel screening algorithm with W4SS and CXR": 'HIV.D.DE965' from "HIVConcepts" display 'Parallel screening algorithm with W4SS and CXR'\ncode "Sequential positive screening algorithm with W4SS and CXR": 'HIV.D.DE966' from "HIVConcepts" display 'Sequential positive screening algorithm with W4SS and CXR'\ncode "Sequential negative screening algorithm with W4SS and CXR": 'HIV.D.DE967' from "HIVConcepts" display 'Sequential negative screening algorithm with W4SS and CXR'\ncode "Screening with mWRD": 'HIV.D.DE968' from "HIVConcepts" display 'Screening with mWRD'\ncode "Clinical assessment": 'HIV.D.DE969' from "HIVConcepts" display 'Clinical assessment'\ncode "Other TB screening algorithm": 'HIV.D.DE970' from "HIVConcepts" display 'Other TB screening algorithm'\ncode "Symptoms of TB": 'HIV.D.DE973' from "HIVConcepts" display 'Symptoms of TB'\ncode "Current cough": 'HIV.D.DE974' from "HIVConcepts" display 'Current cough'\ncode "Prolonged cough >=2w": 'HIV.D.DE975' from "HIVConcepts" display 'Prolonged cough >=2w'\ncode "Fever of 39 °C or greater": 'HIV.D.DE976' from "HIVConcepts" display 'Fever of 39 °C or greater'\ncode "Weight loss reported": 'HIV.D.DE977' from "HIVConcepts" display 'Weight loss reported'\ncode "Night sweats": 'HIV.D.DE978' from "HIVConcepts" display 'Night sweats'\ncode "Poor weight gain": 'HIV.D.DE979' from "HIVConcepts" display 'Poor weight gain'\ncode "Reduced playfulness": 'HIV.D.DE980' from "HIVConcepts" display 'Reduced playfulness'\ncode "Chest pain": 'HIV.D.DE981' from "HIVConcepts" display 'Chest pain'\ncode "Haemoptysis": 'HIV.D.DE982' from "HIVConcepts" display 'Haemoptysis'\ncode "Lethargy - HIV.D.DE983": 'HIV.D.DE983' from "HIVConcepts" display 'Lethargy'\ncode "None": 'HIV.D.DE984' from "HIVConcepts" display 'None'\ncode "History of contact with a person with TB": 'HIV.D.DE985' from "HIVConcepts" display 'History of contact with a person with TB'\ncode "TB screening result": 'HIV.D.DE986' from "HIVConcepts" display 'TB screening result'\ncode "Screen positive for TB": 'HIV.D.DE987' from "HIVConcepts" display 'Screen positive for TB'\ncode "Screen negative for TB": 'HIV.D.DE988' from "HIVConcepts" display 'Screen negative for TB'\ncode "Inconclusive - HIV.D.DE989": 'HIV.D.DE989' from "HIVConcepts" display 'Inconclusive'\ncode "TB screening date": 'HIV.D.DE990' from "HIVConcepts" display 'TB screening date'\ncode "TB diagnostic test category": 'HIV.D.DE992' from "HIVConcepts" display 'TB diagnostic test category'\ncode "LF-LAM": 'HIV.D.DE993' from "HIVConcepts" display 'LF-LAM'\ncode "mWRD test for TB": 'HIV.D.DE994' from "HIVConcepts" display 'mWRD test for TB'\ncode "Microscopy - Sputum acid-fast bacilli AFB": 'HIV.D.DE995' from "HIVConcepts" display 'Microscopy - Sputum acid-fast bacilli AFB'\ncode "TB Culture": 'HIV.D.DE996' from "HIVConcepts" display 'TB Culture'\ncode "TB diagnostic test date": 'HIV.D.DE997' from "HIVConcepts" display 'TB diagnostic test date'\ncode "TB treatment start date": 'HIV.D.DE1001' from "HIVConcepts" display 'TB treatment start date'\ncode "Eligible for TB preventive treatment": 'HIV.D.DE1017' from "HIVConcepts" display 'Eligible for TB preventive treatment'\ncode "TB prevention services accepted": 'HIV.D.DE1023' from "HIVConcepts" display 'TB prevention services accepted'\ncode "C reactive protein test result": 'HIV.D.DE1026' from "HIVConcepts" display 'C reactive protein test result'\ncode "TPT regimen type": 'HIV.D.DE1028' from "HIVConcepts" display 'TPT regimen type'\ncode "3HP": 'HIV.D.DE1029' from "HIVConcepts" display '3HP'\ncode "1HP": 'HIV.D.DE1030' from "HIVConcepts" display '1HP'\ncode "6H": 'HIV.D.DE1031' from "HIVConcepts" display '6H'\ncode "Six months of levofloxacin daily": 'HIV.D.DE1032' from "HIVConcepts" display 'Six months of levofloxacin daily'\ncode "Other TB preventive treatment TPT regimen": 'HIV.D.DE1033' from "HIVConcepts" display 'Other TB preventive treatment TPT regimen'\ncode "TB preventive treatment TPT status": 'HIV.D.DE1034' from "HIVConcepts" display 'TB preventive treatment TPT status'\ncode "Not started": 'HIV.D.DE1035' from "HIVConcepts" display 'Not started'\ncode "On TPT": 'HIV.D.DE1036' from "HIVConcepts" display 'On TPT'\ncode "On TPT with interruptions": 'HIV.D.DE1037' from "HIVConcepts" display 'On TPT with interruptions'\ncode "On hold": 'HIV.D.DE1038' from "HIVConcepts" display 'On hold'\ncode "Completed": 'HIV.D.DE1039' from "HIVConcepts" display 'Completed'\ncode "Timing of ART initiation": 'HIV.E.DE41' from "HIVConcepts" display 'Timing of ART initiation'\ncode "Already on ART at first antenatal care visit": 'HIV.E.DE42' from "HIVConcepts" display 'Already on ART at first antenatal care visit'\ncode "Newly on ART during pregnancy": 'HIV.E.DE43' from "HIVConcepts" display 'Newly on ART during pregnancy'\ncode "Newly on ART during labour and delivery": 'HIV.E.DE44' from "HIVConcepts" display 'Newly on ART during labour and delivery'\ncode "Delivery date": 'HIV.E.DE46' from "HIVConcepts" display 'Delivery date'\ncode "Place of delivery": 'HIV.E.DE67' from "HIVConcepts" display 'Place of delivery'\ncode "Health facility": 'HIV.E.DE68' from "HIVConcepts" display 'Health facility'\ncode "Home": 'HIV.E.DE69' from "HIVConcepts" display 'Home'\ncode "Other - HIV.E.DE70": 'HIV.E.DE70' from "HIVConcepts" display 'Other'\ncode "ANC contact date - HIV.E.DE85": 'HIV.E.DE85' from "HIVConcepts" display 'ANC contact date'\ncode "Infant date of birth": 'HIV.E.DE87' from "HIVConcepts" display 'Infant date of birth'\ncode "Age of infant": 'HIV.E.DE90' from "HIVConcepts" display 'Age of infant'\ncode "HIV-exposed infant or child - HIV.E.DE112": 'HIV.E.DE112' from "HIVConcepts" display 'HIV-exposed infant or child'\ncode "Key population member - HIV.E.DE113": 'HIV.E.DE113' from "HIVConcepts" display 'Key population member*'\ncode "Key population member type - HIV.E.DE114": 'HIV.E.DE114' from "HIVConcepts" display 'Key population member type*'\ncode "Sex worker - HIV.E.DE115": 'HIV.E.DE115' from "HIVConcepts" display 'Sex worker'\ncode "People who inject drugs - HIV.E.DE116": 'HIV.E.DE116' from "HIVConcepts" display 'People who inject drugs'\ncode "Trans and gender-diverse people - HIV.E.DE117": 'HIV.E.DE117' from "HIVConcepts" display 'Trans and gender-diverse people'\ncode "People living in prisons and other closed setting": 'HIV.E.DE118' from "HIVConcepts" display 'People living in prisons and other closed setting'\ncode "Signs of substantial risk of HIV infection - HIV.E.DE155": 'HIV.E.DE155' from "HIVConcepts" display 'Signs of substantial risk of HIV infection'\ncode "No condom use during sex with more than one partner in the past 6 months - HIV.E.DE156": 'HIV.E.DE156' from "HIVConcepts" display 'No condom use during sex with more than one partner in the past 6 months'\ncode "STI in the past 6 months - HIV.E.DE157": 'HIV.E.DE157' from "HIVConcepts" display 'STI in the past 6 months'\ncode "A sexual partner in the past 6 months had one or more HIV risk factors - HIV.E.DE158": 'HIV.E.DE158' from "HIVConcepts" display 'A sexual partner in the past 6 months had one or more HIV risk factors'\ncode "PrEP requested by client - HIV.E.DE159": 'HIV.E.DE159' from "HIVConcepts" display 'PrEP requested by client'\ncode "Serodiscordant partner - HIV.E.DE160": 'HIV.E.DE160' from "HIVConcepts" display 'Serodiscordant partner'\ncode "HIV test type - HIV.E.DE168": 'HIV.E.DE168' from "HIVConcepts" display 'HIV test type'\ncode "Rapid diagnostic test for HIV - HIV.E.DE169": 'HIV.E.DE169' from "HIVConcepts" display 'Rapid diagnostic test for HIV'\ncode "Enzyme immunoassay for HIV - HIV.E.DE170": 'HIV.E.DE170' from "HIVConcepts" display 'Enzyme immunoassay for HIV'\ncode "Nucleic acid test for HIV - HIV.E.DE171": 'HIV.E.DE171' from "HIVConcepts" display 'Nucleic acid test for HIV'\ncode "Dual HIV/syphilis rapid diagnostic test - HIV.E.DE172": 'HIV.E.DE172' from "HIVConcepts" display 'Dual HIV/syphilis rapid diagnostic test'\ncode "Maternal and child health service visit": 'HIV.E.DE173' from "HIVConcepts" display 'Maternal and child health service visit'\ncode "12-month visit": 'HIV.E.DE174' from "HIVConcepts" display '12-month visit'\ncode "24-month visit": 'HIV.E.DE175' from "HIVConcepts" display '24-month visit'\ncode "First visit after the end of breastfeeding": 'HIV.E.DE176' from "HIVConcepts" display 'First visit after the end of breastfeeding'\ncode "Registered in birth cohort": 'HIV.E.DE179' from "HIVConcepts" display 'Registered in birth cohort'\ncode "EID sample number": 'HIV.E.DE180' from "HIVConcepts" display 'EID sample number'\ncode "EID sample 1": 'HIV.E.DE181' from "HIVConcepts" display 'EID sample 1'\ncode "EID sample 2": 'HIV.E.DE182' from "HIVConcepts" display 'EID sample 2'\ncode "EID test number": 'HIV.E.DE183' from "HIVConcepts" display 'EID test number'\ncode "EID test number 1": 'HIV.E.DE184' from "HIVConcepts" display 'EID test number 1'\ncode "EID test number 2": 'HIV.E.DE185' from "HIVConcepts" display 'EID test number 2'\ncode "EID test number 1 test result": 'HIV.E.DE186' from "HIVConcepts" display 'EID test number 1 test result'\ncode "Positive - HIV.E.DE187": 'HIV.E.DE187' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.E.DE188": 'HIV.E.DE188' from "HIVConcepts" display 'Negative'\ncode "Indeterminate - HIV.E.DE189": 'HIV.E.DE189' from "HIVConcepts" display 'Indeterminate'\ncode "EID test number 2 test result": 'HIV.E.DE190' from "HIVConcepts" display 'EID test number 2 test result'\ncode "Positive - HIV.E.DE191": 'HIV.E.DE191' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.E.DE192": 'HIV.E.DE192' from "HIVConcepts" display 'Negative'\ncode "Indeterminate - HIV.E.DE193": 'HIV.E.DE193' from "HIVConcepts" display 'Indeterminate'\ncode "Assay number in testing strategy - HIV.E.DE194": 'HIV.E.DE194' from "HIVConcepts" display 'Assay number in testing strategy'\ncode "Assay 0 - HIV.E.DE195": 'HIV.E.DE195' from "HIVConcepts" display 'Assay 0'\ncode "Assay 1 - HIV.E.DE196": 'HIV.E.DE196' from "HIVConcepts" display 'Assay 1'\ncode "Assay 2 - HIV.E.DE197": 'HIV.E.DE197' from "HIVConcepts" display 'Assay 2'\ncode "Assay 3 - HIV.E.DE198": 'HIV.E.DE198' from "HIVConcepts" display 'Assay 3'\ncode "Assay 1 repeated - HIV.E.DE199": 'HIV.E.DE199' from "HIVConcepts" display 'Assay 1 repeated'\ncode "Test result of HIV assay 1 - HIV.E.DE200": 'HIV.E.DE200' from "HIVConcepts" display 'Test result of HIV assay 1'\ncode "Reactive - HIV.E.DE201": 'HIV.E.DE201' from "HIVConcepts" display 'Reactive'\ncode "Non-reactive - HIV.E.DE202": 'HIV.E.DE202' from "HIVConcepts" display 'Non-reactive'\ncode "Invalid - HIV.E.DE203": 'HIV.E.DE203' from "HIVConcepts" display 'Invalid'\ncode "Test result of HIV assay 2 - HIV.E.DE204": 'HIV.E.DE204' from "HIVConcepts" display 'Test result of HIV assay 2'\ncode "Reactive - HIV.E.DE205": 'HIV.E.DE205' from "HIVConcepts" display 'Reactive'\ncode "Non-reactive - HIV.E.DE206": 'HIV.E.DE206' from "HIVConcepts" display 'Non-reactive'\ncode "Invalid - HIV.E.DE207": 'HIV.E.DE207' from "HIVConcepts" display 'Invalid'\ncode "Test result of HIV assay 3 - HIV.E.DE208": 'HIV.E.DE208' from "HIVConcepts" display 'Test result of HIV assay 3'\ncode "Reactive - HIV.E.DE209": 'HIV.E.DE209' from "HIVConcepts" display 'Reactive'\ncode "Non-reactive - HIV.E.DE210": 'HIV.E.DE210' from "HIVConcepts" display 'Non-reactive'\ncode "Invalid - HIV.E.DE211": 'HIV.E.DE211' from "HIVConcepts" display 'Invalid'\ncode "Test result of HIV assay 1 repeated - HIV.E.DE212": 'HIV.E.DE212' from "HIVConcepts" display 'Test result of HIV assay 1 repeated'\ncode "Reactive - HIV.E.DE213": 'HIV.E.DE213' from "HIVConcepts" display 'Reactive'\ncode "Non-reactive - HIV.E.DE214": 'HIV.E.DE214' from "HIVConcepts" display 'Non-reactive'\ncode "Invalid - HIV.E.DE215": 'HIV.E.DE215' from "HIVConcepts" display 'Invalid'\ncode "Test result of syphilis assay 1": 'HIV.E.DE216' from "HIVConcepts" display 'Test result of syphilis assay 1'\ncode "Reactive - HIV.E.DE217": 'HIV.E.DE217' from "HIVConcepts" display 'Reactive'\ncode "Non-reactive - HIV.E.DE218": 'HIV.E.DE218' from "HIVConcepts" display 'Non-reactive'\ncode "Invalid - HIV.E.DE219": 'HIV.E.DE219' from "HIVConcepts" display 'Invalid'\ncode "Test result of syphilis assay 1 repeated": 'HIV.E.DE220' from "HIVConcepts" display 'Test result of syphilis assay 1 repeated'\ncode "Reactive - HIV.E.DE221": 'HIV.E.DE221' from "HIVConcepts" display 'Reactive'\ncode "Non-reactive - HIV.E.DE222": 'HIV.E.DE222' from "HIVConcepts" display 'Non-reactive'\ncode "Invalid - HIV.E.DE223": 'HIV.E.DE223' from "HIVConcepts" display 'Invalid'\ncode "HIV test date - HIV.E.DE224": 'HIV.E.DE224' from "HIVConcepts" display 'HIV test date'\ncode "Infant HIV status": 'HIV.E.DE225' from "HIVConcepts" display 'Infant HIV status'\ncode "HIV-positive - HIV.E.DE226": 'HIV.E.DE226' from "HIVConcepts" display 'HIV-positive'\ncode "HIV-negative - HIV.E.DE227": 'HIV.E.DE227' from "HIVConcepts" display 'HIV-negative'\ncode "Unknown - HIV.E.DE228": 'HIV.E.DE228' from "HIVConcepts" display 'Unknown'\ncode "Infant ART start date": 'HIV.E.DE229' from "HIVConcepts" display 'Infant ART start date'\ncode "Final diagnosis of HIV-exposed infant - HIV.E.DE230": 'HIV.E.DE230' from "HIVConcepts" display 'Final diagnosis of HIV-exposed infant'\ncode "HIV-positive - HIV.E.DE231": 'HIV.E.DE231' from "HIVConcepts" display 'HIV-positive'\ncode "HIV-negative and no longer breastfeeding": 'HIV.E.DE232' from "HIVConcepts" display 'HIV-negative and no longer breastfeeding'\ncode "HIV status unknown": 'HIV.E.DE233' from "HIVConcepts" display 'HIV status unknown'\ncode "CD4 count - HIV.G.DE1": 'HIV.G.DE1' from "HIVConcepts" display 'CD4 count'\ncode "Baseline CD4 count - HIV.G.DE3": 'HIV.G.DE3' from "HIVConcepts" display 'Baseline CD4 count'\ncode "Date of viral load sample collection - HIV.G.DE8": 'HIV.G.DE8' from "HIVConcepts" display 'Date of viral load sample collection'\ncode "Viral load test result - HIV.G.DE12": 'HIV.G.DE12' from "HIVConcepts" display 'Viral load test result'\ncode "HBsAg test date - HIV.G.DE17": 'HIV.G.DE17' from "HIVConcepts" display 'HBsAg test date'\ncode "HBsAg test result - HIV.G.DE18": 'HIV.G.DE18' from "HIVConcepts" display 'HBsAg test result'\ncode "Positive - HIV.G.DE19": 'HIV.G.DE19' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.G.DE20": 'HIV.G.DE20' from "HIVConcepts" display 'Negative'\ncode "Indeterminate - HIV.G.DE21": 'HIV.G.DE21' from "HIVConcepts" display 'Indeterminate'\ncode "HCV test date - HIV.G.DE42": 'HIV.G.DE42' from "HIVConcepts" display 'HCV test date'\ncode "HCV test result - HIV.G.DE43": 'HIV.G.DE43' from "HIVConcepts" display 'HCV test result'\ncode "Positive - HIV.G.DE44": 'HIV.G.DE44' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.G.DE45": 'HIV.G.DE45' from "HIVConcepts" display 'Negative'\ncode "Indeterminate - HIV.G.DE46": 'HIV.G.DE46' from "HIVConcepts" display 'Indeterminate'\ncode "HCV viral load test date - HIV.G.DE47": 'HIV.G.DE47' from "HIVConcepts" display 'HCV viral load test date'\ncode "HCV viral load test result - HIV.G.DE48": 'HIV.G.DE48' from "HIVConcepts" display 'HCV viral load test result'\ncode "Detected - HIV.G.DE49": 'HIV.G.DE49' from "HIVConcepts" display 'Detected'\ncode "Not detected - HIV.G.DE50": 'HIV.G.DE50' from "HIVConcepts" display 'Not detected'\ncode "Syphilis test date - HIV.G.DE69": 'HIV.G.DE69' from "HIVConcepts" display 'Syphilis test date'\ncode "Syphilis test result - HIV.G.DE70": 'HIV.G.DE70' from "HIVConcepts" display 'Syphilis test result'\ncode "Positive - HIV.G.DE71": 'HIV.G.DE71' from "HIVConcepts" display 'Positive'\ncode "Negative - HIV.G.DE72": 'HIV.G.DE72' from "HIVConcepts" display 'Negative'\ncode "Inconclusive - HIV.G.DE73": 'HIV.G.DE73' from "HIVConcepts" display 'Inconclusive'\ncode "HIV status of partner or contact": 'HIV.H.DE34' from "HIVConcepts" display 'HIV status of partner or contact'\ncode "Already knew positive": 'HIV.H.DE35' from "HIVConcepts" display 'Already knew positive'\ncode "Newly diagnosed": 'HIV.H.DE36' from "HIVConcepts" display 'Newly diagnosed'\ncode "Negative - HIV.H.DE37": 'HIV.H.DE37' from "HIVConcepts" display 'Negative'\ncode "HIV treatment outcome": 'HIV.H.DE41' from "HIVConcepts" display 'HIV treatment outcome'\ncode "Lost to follow-up": 'HIV.H.DE42' from "HIVConcepts" display 'Lost to follow-up'\ncode "Transferred out": 'HIV.H.DE43' from "HIVConcepts" display 'Transferred out'\ncode "Death documented": 'HIV.H.DE44' from "HIVConcepts" display 'Death documented'\ncode "Refused stopped treatment": 'HIV.H.DE45' from "HIVConcepts" display 'Refused stopped treatment'\ncode "On ART - HIV.H.DE47": 'HIV.H.DE47' from "HIVConcepts" display 'On ART'\ncode "Date ART stopped - HIV.H.DE73": 'HIV.H.DE73' from "HIVConcepts" display 'Date ART stopped'\ncode "Reason ART stopped - HIV.H.DE74": 'HIV.H.DE74' from "HIVConcepts" display 'Reason ART stopped'\ncode "Toxicity/side effects - HIV.H.DE75": 'HIV.H.DE75' from "HIVConcepts" display 'Toxicity/side effects'\ncode "Severe illness, hospitalization - HIV.H.DE76": 'HIV.H.DE76' from "HIVConcepts" display 'Severe illness, hospitalization'\ncode "Drugs out of stock ": 'HIV.H.DE77' from "HIVConcepts" display 'Drugs out of stock '\ncode "Client lacks finances ": 'HIV.H.DE78' from "HIVConcepts" display 'Client lacks finances '\ncode "Excluded HIV infection in infant - HIV.H.DE79": 'HIV.H.DE79' from "HIVConcepts" display 'Excluded HIV infection in infant'\ncode "Other reason for stopping ART - HIV.H.DE80": 'HIV.H.DE80' from "HIVConcepts" display 'Other reason for stopping ART'\ncode "At elevated risk for HIV acquisition - HIV.PRV.DE1": 'HIV.PRV.DE1' from "HIVConcepts" display 'At elevated risk for HIV acquisition'\ncode "HIV prevention intervention": 'HIV.PRV.DE2' from "HIVConcepts" display 'HIV prevention intervention'\ncode "PrEP service": 'HIV.PRV.DE3' from "HIVConcepts" display 'PrEP service'\ncode "OAMT": 'HIV.PRV.DE4' from "HIVConcepts" display 'OAMT'\ncode "NSP": 'HIV.PRV.DE5' from "HIVConcepts" display 'NSP'\ncode "STI services": 'HIV.PRV.DE6' from "HIVConcepts" display 'STI services'\ncode "VMMC": 'HIV.PRV.DE7' from "HIVConcepts" display 'VMMC'\ncode "Other - HIV.PRV.DE8": 'HIV.PRV.DE8' from "HIVConcepts" display 'Other'\ncode "Date accessed HIV prevention intervention": 'HIV.PRV.DE10' from "HIVConcepts" display 'Date accessed HIV prevention intervention'\ncode "HIV status of contact": 'HIV.PRV.DE11' from "HIVConcepts" display 'HIV status of contact'\ncode "HIV-positive - HIV.PRV.DE12": 'HIV.PRV.DE12' from "HIVConcepts" display 'HIV-positive'\ncode "HIV-negative - HIV.PRV.DE13": 'HIV.PRV.DE13' from "HIVConcepts" display 'HIV-negative'\ncode "Unknown - HIV.PRV.DE14": 'HIV.PRV.DE14' from "HIVConcepts" display 'Unknown'\ncode "Date injecting equipment provided": 'HIV.PRV.DE15' from "HIVConcepts" display 'Date injecting equipment provided'\ncode "Date OAMT initiated": 'HIV.PRV.DE17' from "HIVConcepts" display 'Date OAMT initiated'\ncode "Currently on OAMT": 'HIV.PRV.DE20' from "HIVConcepts" display 'Currently on OAMT'\ncode "Retained on OAMT": 'HIV.PRV.DE21' from "HIVConcepts" display 'Retained on OAMT'\ncode "Date of loss to follow-up or OAMT stopped": 'HIV.PRV.DE25' from "HIVConcepts" display 'Date of loss to follow-up or OAMT stopped'\ncode "Date medications prescribed - HIV.PRV.DE27": 'HIV.PRV.DE27' from "HIVConcepts" display 'Date medications prescribed'\ncode "Number of days prescribed - HIV.PRV.DE28": 'HIV.PRV.DE28' from "HIVConcepts" display 'Number of days prescribed'\ncode "HIV test date - HIV.SRV.DE1": 'HIV.SRV.DE1' from "HIVConcepts" display 'HIV test date'\ncode "HIV test result - HIV.SRV.DE2": 'HIV.SRV.DE2' from "HIVConcepts" display 'HIV test result'\ncode "Baseline CD4 count - HIV.SRV.DE3": 'HIV.SRV.DE3' from "HIVConcepts" display 'Baseline CD4 count'\ncode "Date of baseline CD4 count test - HIV.SRV.DE4": 'HIV.SRV.DE4' from "HIVConcepts" display 'Date of baseline CD4 count test'\ncode "HIV clinical stage - HIV.SRV.DE5": 'HIV.SRV.DE5' from "HIVConcepts" display 'HIV clinical stage'\ncode "ART start date - HIV.SRV.DE6": 'HIV.SRV.DE6' from "HIVConcepts" display 'ART start date'\ncode "Currently pregnant - HIV.SRV.DE7": 'HIV.SRV.DE7' from "HIVConcepts" display 'Currently pregnant'\ncode "CD4 count - HIV.SRV.DE8": 'HIV.SRV.DE8' from "HIVConcepts" display 'CD4 count'\ncode "Date of viral load sample collection - HIV.SRV.DE12": 'HIV.SRV.DE12' from "HIVConcepts" display 'Date of viral load sample collection'\ncode "Viral load test result - HIV.SRV.DE13": 'HIV.SRV.DE13' from "HIVConcepts" display 'Viral load test result'\ncode "Visit date - HIV.SRV.DE15": 'HIV.SRV.DE15' from "HIVConcepts" display 'Visit date'\ncode "ANC contact date - HIV.SRV.DE18": 'HIV.SRV.DE18' from "HIVConcepts" display 'ANC contact date'\ncode "HIV-exposed infant or child - HIV.SRV.DE20": 'HIV.SRV.DE20' from "HIVConcepts" display 'HIV-exposed infant or child'\ncode "Test result of HIV assay 1 - HIV.SRV.DE21": 'HIV.SRV.DE21' from "HIVConcepts" display 'Test result of HIV assay 1'\ncode "Final diagnosis of HIV-exposed infant - HIV.SRV.DE22": 'HIV.SRV.DE22' from "HIVConcepts" display 'Final diagnosis of HIV-exposed infant'\ncode "Malaria-endemic setting": 'HIV.Config.DE6' from "HIVConcepts" display 'Malaria-endemic setting'\ncode "HIV burden of the setting": 'HIV.Config.DE12' from "HIVConcepts" display 'HIV burden of the setting'\ncode "High HIV burden setting": 'HIV.Config.DE13' from "HIVConcepts" display 'High HIV burden setting'\ncode "Low HIV burden setting": 'HIV.Config.DE14' from "HIVConcepts" display 'Low HIV burden setting'\ncode "HPV DNA testing operational at the health facility": 'HIV.Config.DE15' from "HIVConcepts" display 'HPV DNA testing operational at the health facility'\ncode "Other priority populations": 'HIV.Config.DE19' from "HIVConcepts" display 'Other priority populations'\ncode "Reporting period end date": 'HIV.Config.DE20' from "HIVConcepts" display 'Reporting period end date'\ncode "Reporting period start date": 'HIV.Config.DE21' from "HIVConcepts" display 'Reporting period start date'\ncode "Reporting date": 'HIV.Config.DE22' from "HIVConcepts" display 'Reporting date'\nContent not shown - (application/elm+xml, size = 703Kb )
Generated Narrative: PlanDefinition HIVB2DT
url: PlanDefinition HIV.B2.DT Check for signs of serious illness
version: 0.2.0
name: HIVB2DT
title: HIV.B2.DT Check for signs of serious illness
type: ECA Rule
status: Draft
experimental: true
date: 2024-08-14 10:49:52+0000
publisher: WHO
contact: WHO: http://who.int
description:
Check for signs of serious illness
\n| - | Type | Citation |
| * | Citation | Consolidated Guidelines on HIV Testing Services (2019) \n |
library: HIV.B2.DT Logic
action
textEquivalent: Check for signs of serious illness
action
Generated Narrative: ValueSet HIV.A.DE13
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.A.DE18
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.A.DE19 | Female | Client identifies as female |
| HIV.A.DE20 | Male | Client identifies as male |
| HIV.A.DE21 | Transgender male | Client identifies as transgender male |
| HIV.A.DE22 | Transgender female | Client identifies as transgender female |
| HIV.A.DE23 | Other | Additional category |
Generated Narrative: ValueSet HIV.A.DE25
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.A.DE26 | Female | Client identifies as female |
| HIV.A.DE27 | Male | Client identifies as male |
| HIV.A.DE28 | Other | Client identifies in non-binary way or as a sexual and gender minority (or minorities) |
Generated Narrative: ValueSet HIV.A.DE30
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.A.DE31 | Unmarried | Client does not have an active marriage contract |
| HIV.A.DE32 | Never married | Client has never entered into a marriage contract |
| HIV.A.DE33 | Married | A current marriage contract is active |
| HIV.A.DE34 | Polygamous | Client is in a polygamous union |
| HIV.A.DE35 | Divorced | Client is divorced, whereby marriage contract has been declared dissolved and inactive |
| HIV.A.DE36 | Widowed | Client's spouse has died |
| HIV.A.DE37 | Unknown | Client does not wish to disclose marital status |
| HIV.A.DE38 | Domestic partner | Client reports that they are in a domestic partnership |
| HIV.A.DE39 | Annulled | Client's marriage contract has been declared null and to have not existed |
| HIV.A.DE40 | Legally separated | Client is legally separated from their spouse |
| HIV.A.DE41 | Interlocutory | Client is subject to an interlocutory decree |
Generated Narrative: ValueSet HIV.A.DE43
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.A.DE46
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.A.DE47 | Text message/SMS | The client would like to receive communications via Text message/SMS |
| HIV.A.DE48 | Voice call | Client would like to receive communications via voice call |
Generated Narrative: ValueSet HIV.A.DE5
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.A.DE6 | Community | Referred by the community level services |
| HIV.A.DE7 | Facility | Referred by the health facility |
Generated Narrative: ValueSet HIV.A.DE5
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.A.DE6 | Community | Referred by the community level services |
| HIV.A.DE7 | Facility | Referred by the health facility |
Generated Narrative: ValueSet HIV.B.DE1
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE2 | First-time HIV test | First encounter for screening for human immunodeficiency virus |
| HIV.B.DE3 | Retesting for HIV | Retesting for human immunodeficiency virus |
| HIV.B.DE4 | HIV testing services visit | Client attending facility for HIV testing services visit |
Generated Narrative: ValueSet HIV.B.DE102
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE103 | Reactive | The result of the HIV assay in the testing strategy was reactive |
| HIV.B.DE104 | Non-reactive | The result of the HIV assay in the testing strategy was non-reactive |
| HIV.B.DE105 | Invalid | The result of the HIV assay in the testing strategy was invalid |
Generated Narrative: ValueSet HIV.B.DE106
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE107 | Reactive | The result of the HIV assay in the testing strategy was reactive |
| HIV.B.DE108 | Non-reactive | The result of the HIV assay in the testing strategy was non-reactive |
| HIV.B.DE109 | Invalid | The result of the HIV assay in the testing strategy was invalid |
Generated Narrative: ValueSet HIV.B.DE111
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE112 | HIV-positive | Test result is HIV-positive |
| HIV.B.DE113 | HIV-negative | Test result is HIV-negative |
| HIV.B.DE114 | HIV-inconclusive | Test result is HIV-inconclusive |
Generated Narrative: ValueSet HIV.B.DE115
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE116 | HIV-positive | Client is HIV-positive |
| HIV.B.DE117 | HIV-negative | Client is HIV-negative |
| HIV.B.DE118 | Unknown | Client has unknown HIV status |
Generated Narrative: ValueSet HIV.B.DE120
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.B.DE121
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE122 | Heterosexual sex | Probable route of HIV transmission was through heterosexual sex |
| HIV.B.DE123 | Sex between men | Probable route of HIV transmission was through sex between men |
| HIV.B.DE124 | Unprotected intercourse during sex work | Probable route of HIV transmission was through unprotected intercourse during sex work |
| HIV.B.DE125 | Injecting drug use with unsterile equipment | Probable route of HIV transmission was through injecting drug use with unsterile equipment |
| HIV.B.DE126 | Nosocomial | Probable route of HIV transmission was nosocomial |
| HIV.B.DE127 | Vertical | Probable route of HIV transmission to an infant was during pregnancy, labour, delivery and breastfeeding (vertical transmission) |
| HIV.B.DE128 | Other | Probable route of HIV transmission was other and may include needle accidents, blood transfusion, blood products or organ/tissue donations, tattoos, piercings, circumcision, or acupuncture. |
Generated Narrative: ValueSet HIV.B.DE132
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE133 | HIV-positive | Test result is HIV-positive |
| HIV.B.DE134 | HIV-negative | Test result is HIV-negative |
| HIV.B.DE135 | HIV-inconclusive | Test result is HIV-inconclusive |
Generated Narrative: ValueSet HIV.B.DE136
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE137 | HIV-positive | Client's partner is HIV-positive |
| HIV.B.DE138 | HIV-negative | Client's partner is HIV-negative |
| HIV.B.DE139 | Unknown | Client's partner HIV status is unknown |
Generated Narrative: ValueSet HIV.B.DE142
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE143 | HIV-positive counselling conducted | Whether counselling was provided to a client who has been diagnosed with HIV |
| HIV.B.DE144 | Hepatitis B positive counselling conducted | Whether counselling was provided to a client who has been diagnosed with hepatitis B |
| HIV.B.DE145 | Hepatitis C positive counselling conducted | Whether counselling was provided to a client who has been diagnosed with hepatitis C |
| HIV.B.DE146 | Syphilis counselling, treatment and further testing | Whether counselling and treatment was provided to a client who has been diagnosed with syphilis. Additional testing (RPR test) recommended. |
| HIV.B.DE147 | Linked to enrolment in care and ART initiation | Linkage made from HIV testing to enrolment in care following an HIV diagnosis |
| HIV.B.DE148 | VMMC counselling provided | Whether counselling for voluntary medical male circumcision (VMMC) was provided following an HIV-negative test |
Generated Narrative: ValueSet HIV.B.DE149
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE150 | Offer male and female condoms and condom-compatible lubricants | Offer male and female condoms and condom-compatible lubricants |
| HIV.B.DE151 | Offer pre-exposure prophylaxis (PrEP) for people at elevated risk for HIV acquisition | Offer pre-exposure prophylaxis (PrEP) to people with substantial ongoing risk of HIV infection |
| HIV.B.DE152 | Offer post-exposure prophylaxis (PEP) following suspected exposure | Offer or refer client for PEP following suspected exposure |
| HIV.B.DE153 | Voluntary medical male circumcision (VMMC) | Offer referral for VMMC services |
| HIV.B.DE154 | Harm reduction for people who inject drugs | Offer or refer to harm reduction services for people who inject drugs (needle and syringe programmes, opioid substitution therapy, other drug-dependence treatment and opioid overdose prevention and management) |
| HIV.B.DE155 | Behavioural interventions to support risk reduction, particularly for people with HIV and members of key populations | Offer or refer to behavioural interventions to support risk reduction, particularly for people with HIV and members of key populations |
| HIV.B.DE156 | HIV testing for partners and biological children | Offer voluntary testing for all partners and biological children of positive cases (includes partner services and index case testing), as welll as partners and social contacts of people from key populations, where appropriate |
| HIV.B.DE157 | HIV testing for partners and social contacts of people from key populations, where appropriate | Offer voluntary testing for partners and social contacts of people from key populations, where appropriate |
Generated Narrative: ValueSet HIV.B.DE15
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE16 | Community-level testing | Testing is happening in the community, which includes mobile testing |
| HIV.B.DE17 | Facility-level testing | Testing is happening at a facility |
Generated Narrative: ValueSet HIV.B.DE158
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE159 | Contraception and family planning | Offer contraception and family planning services |
| HIV.B.DE160 | Check pregnancy status | Check women's pregnancy status |
| HIV.B.DE161 | Prevention of mother-to-child transmission counselling | Offer services for prevention of mother-to-child transmission (counselling) |
| HIV.B.DE162 | Cervical cancer screening and treatment counselling | Offer cervical cancer screening and treatment counselling and services |
| HIV.B.DE163 | Anal cancer screening (for men who have sex with men) | Offer services for anal cancer screening (for men who have sex with men) |
| HIV.B.DE164 | STI testing and treatment services | Offer sexually transmitted infection (STI) testing and treatment services |
Generated Narrative: ValueSet HIV.B.DE165
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE166 | Assessment and provision of vaccinations | Assessment and provision of vaccinations, such as for people from key populations, pregnant women and infants; and, where appropriate, tetanus vaccination for adolescent boys and men receiving VMMC |
| HIV.B.DE167 | Hepatitis B (HBV) and hepatitis C virus (HCV) testing and treatment provided | Offer or refer for HBV and/or HCV testing and treatment |
| HIV.B.DE168 | Co-trimoxazole chemoprophylaxis to prevent Pneumocystis carinii pneumonia provided | Offer or refer for co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia |
| HIV.B.DE169 | Intensified TB case finding and linkage to TB treatment provided | Offer or refer for intensified TB case finding and linkage to TB treatment |
| HIV.B.DE170 | Provision of isoniazid preventive therapy if person does not have TB | Offer or refer for provision of isoniazid preventive therapy if person does not have TB |
| HIV.B.DE171 | Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology | Offer or refer for malaria prevention (such as bed nets and prophylaxis), depending on epidemiology |
Generated Narrative: ValueSet HIV.B.DE172
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE173 | Mental health services | Offer or refer for mental health services |
| HIV.B.DE174 | Psychosocial counselling, support and treatment adherence counselling | Offer or refer for psychosocial counselling, support and treatment adherence counselling |
| HIV.B.DE175 | Support for disclosure and partner services | Offer or refer for support for disclosure and partner services |
| HIV.B.DE176 | Legal and social services | Offer or refer for legal and social services |
| HIV.B.DE177 | Services for responding to violence against women | Offer or refer for services for responding to violence against women, including first-line support and psychosocial support, post-rape care and other support services including shelters, legal services and women and child protection services |
Generated Narrative: ValueSet HIV.B.DE179
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE180 | Client received treatment and/or counselling as needed | Client received treatment and/or counselling as needed |
| HIV.B.DE181 | Client was referred | Client was referred to another provider/facility |
| HIV.B.DE182 | No action necessary | No additional action was deemed necessary |
| HIV.B.DE183 | Other IPV result | Other intimate partner violence (IPV) result not described above |
Generated Narrative: ValueSet HIV.B.DE18
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE19 | Mobile testing (e.g. through vans or temporary testing facilities) | The client tested through mobile testing, such as through vans or temporary testing facilities |
| HIV.B.DE20 | Voluntary counselling and testing centres (not within a health facility setting) | The client tested at a voluntary counselling and testing centre (not in a health facility setting) |
| HIV.B.DE21 | Other community-based testing | The client tested through another type of community-based testing |
Generated Narrative: ValueSet HIV.B.DE191
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE192 | Retesting for HIV | Retesting follow-up appointment |
| HIV.B.DE193 | Other | Other reason for the follow-up appointment |
Generated Narrative: ValueSet HIV.B.DE201
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.B.DE204
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE205 | Intraoperative | The adverse event associated with VMMC procedure occurred during the procedure |
| HIV.B.DE206 | Postoperative | The adverse event associated with VMMC procedure occurred within the first 30 days after the procedure |
Generated Narrative: ValueSet HIV.B.DE207
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE208 | Abnormal pain | Client experienced abnormal pain |
| HIV.B.DE209 | Anaesthesia-related effects | Client had anaesthesia-related effects |
| HIV.B.DE210 | Bleeding | Client had bleeding |
| HIV.B.DE211 | Damage to the penis | Client had damage to the penis |
| HIV.B.DE212 | Difficulty urinating | Client had difficulty urinating |
| HIV.B.DE213 | Excessive bleeding | Client experienced excessive bleeding |
| HIV.B.DE214 | Excessive skin removal | Client experienced excessive skin removal |
| HIV.B.DE215 | Excessive swelling | Client experienced excessive swelling |
| HIV.B.DE216 | Haematoma | Client experienced haematoma |
| HIV.B.DE217 | Infection | Client experienced infection |
| HIV.B.DE218 | Injury to glans | Client experienced injury to glans |
| HIV.B.DE219 | Scar or disfigurement | Client experienced scar or disfigurement |
| HIV.B.DE220 | Sharps injury to personnel | During VMMC procedure there was sharps injury to personnel |
| HIV.B.DE221 | Wound disruption | Client experienced wound disruption |
| HIV.B.DE222 | Other | Client experienced other adverse VMMC event |
Generated Narrative: ValueSet HIV.B.DE22
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE23 | Provider-initiated tested in a clinic or emergency facility | The client tested though provider-initiated HIV testing & counselling, which could be at an emergency facility |
| HIV.B.DE24 | Antenatal care clinic | The client tested at an antenatal care clinic, including labour and delivery |
| HIV.B.DE25 | Voluntary counselling and testing (within a health facility setting) | The client tested through voluntary counselling and testing (within a health facility setting) |
| HIV.B.DE26 | Family planning clinic | The client tested at a family planning clinic |
| HIV.B.DE27 | Other facility-level testing | The client tested at another type of facility |
| HIV.B.DE28 | Tuberculosis (TB) clinic | The client tested at a TB clinic |
Generated Narrative: ValueSet HIV.B.DE226
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE227 | Urethral discharge syndrome | Client diagnosed with urethral discharge syndrome |
| HIV.B.DE228 | Vaginal discharge syndrome | Client diagnosed with vaginal discharge syndrome |
| HIV.B.DE229 | Lower Abdominal pain | Client diagnosed with lower abdominal pain |
| HIV.B.DE230 | Genital ulcer disease syndrome | Client diagnosed with genital ulcer disease syndrome |
| HIV.B.DE231 | Anorectal discharge | Client diagnosed with anorectal discharge |
| HIV.B.DE232 | Sent for testing | Specimen sent for testing |
| HIV.B.DE233 | Other | Other syndrome/STI diagnosed |
Generated Narrative: ValueSet HIV.B.DE237
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE238 | Neisseria gonorrhoeae | Client tested for Neisseria gonorrhoeae |
| HIV.B.DE239 | Chlamydia trachomatis | Client tested for Chlamydia trachomatis |
| HIV.B.DE240 | Trichomonas vaginalis | Client tested for Trichomonas vaginalis |
| HIV.B.DE241 | Syphilis (Treponema pallidum) | Client tested for Syphilis (treponema pallidum) |
| HIV.B.DE242 | Herpes simplex virus (HSV1, HSV2) | Client tested for herpes simplex virus (HSV1, HSV2) |
| HIV.B.DE243 | Mycoplasma genitalium | Client tested for Mycoplasma genitalium |
| HIV.B.DE244 | Mpox | Client tested for Mpox |
| HIV.B.DE245 | Hepatitis B | Client tested for Hepatitis B |
| HIV.B.DE246 | Hepatitis C | Client tested for Hepatitis C |
| HIV.B.DE247 | Other | Client tested for other STI |
Generated Narrative: ValueSet HIV.B.DE250
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE251 | Positive | Test result is positive for syphilis |
| HIV.B.DE252 | Negative | Test result is negative for syphilis |
| HIV.B.DE253 | Inconclusive | Test result is inconclusive |
Generated Narrative: ValueSet HIV.B.DE256
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE257 | Positive | Test result is positive for Neisseria gonorrhoeae |
| HIV.B.DE258 | Negative | Test result is negative for Neisseria gonorrhoeae |
| HIV.B.DE259 | Inconclusive | Test result is inconclusive |
Generated Narrative: ValueSet HIV.B.DE261
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE262 | Blood | Blood specimen to be collected |
| HIV.B.DE263 | Urine | Urine specimen to be collected |
| HIV.B.DE264 | Cervical or vaginal swab | Cervical or vaginal swab to be collected |
| HIV.B.DE265 | Urethral or penile swab | Urethral or penile swab to be collected |
| HIV.B.DE266 | Rectal swab | Rectal swab to be collected |
| HIV.B.DE267 | Other | Other specimen type to be collected |
Generated Narrative: ValueSet HIV.B.DE269
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE270 | Treponemal | Treponemal test used |
| HIV.B.DE271 | Non-treponemal | Non-treponemal test used |
| HIV.B.DE272 | POC Test | Point-of-care (POC) test used |
| HIV.B.DE273 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.B.DE274 | Other | Other test used |
Generated Narrative: ValueSet HIV.B.DE276
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE277 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.B.DE278 | POC Test | Point-of-care (POC) test used |
| HIV.B.DE279 | Culture | Culture test used |
| HIV.B.DE280 | Microscopy | Microscopy test used |
| HIV.B.DE281 | Other | Other type of test used |
Generated Narrative: ValueSet HIV.B.DE284
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE285 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.B.DE286 | POC Test | Point-of-care (POC) test used |
| HIV.B.DE287 | Culture | Culture test used |
| HIV.B.DE288 | ELISA | ELISA test used |
| HIV.B.DE289 | Microscopy | Microscopy test used |
| HIV.B.DE290 | Other | Other type of test used |
Generated Narrative: ValueSet HIV.B.DE293
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE294 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.B.DE295 | POC Test | Point-of-care (POC) test used |
| HIV.B.DE296 | Culture | Culture test used |
| HIV.B.DE297 | Microscopy | Microscopy test used |
| HIV.B.DE298 | Other | Other type of test used |
Generated Narrative: ValueSet HIV.B.DE301
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE302 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.B.DE303 | Antibody test | Antibody test used |
| HIV.B.DE304 | Other | Other type of test used |
Generated Narrative: ValueSet HIV.B.DE306
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE307 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.B.DE308 | Microscopy | Microscopy test used |
| HIV.B.DE309 | Other | Other type of test used |
Generated Narrative: ValueSet HIV.B.DE312
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE313 | Positive | Test result is positive |
| HIV.B.DE314 | Negative | Test result is negative |
| HIV.B.DE315 | Inconclusive | Test result is inconclusive |
Generated Narrative: ValueSet HIV.B.DE317
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE318 | Treponemal | Treponemal test used |
| HIV.B.DE319 | Non-treponemal | Non-treponemal test used |
| HIV.B.DE320 | POC Test | Point-of-care (POC) test used |
| HIV.B.DE321 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.B.DE322 | Other | Other test used |
Generated Narrative: ValueSet HIV.B.DE325
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE326 | Positive | Test result is positive |
| HIV.B.DE327 | Negative | Test result is negative |
| HIV.B.DE328 | Inconclusive | Test result is inconclusive |
Generated Narrative: ValueSet HIV.B.DE33
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE34 | HIV-positive | Client's partner is HIV-positive |
| HIV.B.DE35 | HIV-negative | Client's partner is HIV-negative |
| HIV.B.DE36 | Unknown | Don't know HIV status - client does not know partner's HIV status |
Generated Narrative: ValueSet HIV.B.DE37
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE38 | Sex worker | Client's partner is a sex worker |
| HIV.B.DE39 | Men who have sex with men | Client's partner is a man who has sex with men |
| HIV.B.DE40 | Trans and gender-diverse people | Client's partner identifies as trans and gender-diverse |
| HIV.B.DE41 | People who inject drugs | Client's partner is a person who injects drugs |
| HIV.B.DE42 | People living in prisons and other closed settings | Client's partner lives in a prison or other closed setting |
Generated Narrative: ValueSet HIV.B.DE44
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.B.DE5
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE6 | Partner or contact of an index case | The client is a contact or partner of a person diagnosed with HIV (an index case) |
| HIV.B.DE7 | Partner or contact of an HIV testing client (non-index case) | The client is a contact or partner identified through partner or social network services, but is not known to be a partner of an index-case |
Generated Narrative: ValueSet HIV.B.DE50
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE51 | Sex worker | Client is a sex worker |
| HIV.B.DE52 | Men who have sex with men | Client is a man who has sex with men |
| HIV.B.DE53 | Trans and gender-diverse people | Client identifies as trans and gender-diverse |
| HIV.B.DE54 | People who inject drugs | Client is a person who injects drugs |
| HIV.B.DE55 | People living in prisons and other closed settings | Client lives in a prison or another closed setting |
Generated Narrative: ValueSet HIV.B.DE61
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE62 | Occupational | Occupational exposure to HIV |
| HIV.B.DE63 | Non-occupational violent | Non-occupational violent exposure to HIV |
| HIV.B.DE64 | Non-occupational consensual sex | Exposure to HIV through non-occupational consensual sex |
Generated Narrative: ValueSet HIV.B.DE66
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.B.DE68
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE69 | HIV-1 | The client has HIV-1 |
| HIV.B.DE70 | HIV-2 | The client has HIV-2 |
Generated Narrative: ValueSet HIV.B.DE74
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE75 | Biological child | Contact identified for family services is the biological child of the client |
| HIV.B.DE76 | Drug-injecting partner | Contact identified for partner services is a drug-injecting partner of the client |
| HIV.B.DE77 | Sexual partner | Contact identified for partner services is a sexual partner of the client |
| HIV.B.DE78 | Social contact | Contact identified for social-network services is a social contact of the client |
Generated Narrative: ValueSet HIV.B.DE8
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE9 | Biological child | Client is the biological child of the person that referred the client for family services |
| HIV.B.DE10 | Drug-injecting partner | Client is a drug-injecting partner of the person that referred the client for partner services |
| HIV.B.DE11 | Sexual partner | Client is a sexual partner of the person that referred the client for partner services |
| HIV.B.DE12 | Social contact | Client is a social contact of the person that referred the client for social-network services |
Generated Narrative: ValueSet HIV.B.DE81
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE82 | Rapid diagnostic test for HIV | Antibody test for HIV performed with a rapid diagnostic |
| HIV.B.DE83 | Enzyme immunoassay for HIV | Antibody test for HIV performed with an enzyme immunoassay |
| HIV.B.DE84 | Nucleic acid test for HIV | Virological test, which includes testing for early infant diagnosis |
| HIV.B.DE85 | Dual HIV/syphilis rapid diagnostic test | Antibody test for HIV and syphilis performed with a rapid diagnostic |
| HIV.B.DE86 | HIV self-test | Antibody test for HIV performed by self-tester using a rapid diagnostic |
Generated Narrative: ValueSet HIV.B.DE88
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.B.DE94
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE95 | Reactive | The result of the HIV assay in the testing strategy was reactive |
| HIV.B.DE96 | Non-reactive | The result of the HIV assay in the testing strategy was non-reactive |
| HIV.B.DE97 | Invalid | The result of the HIV assay in the testing strategy was invalid |
Generated Narrative: ValueSet HIV.B.DE98
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.B.DE99 | Reactive | The result of the HIV assay in the testing strategy was reactive |
| HIV.B.DE100 | Non-reactive | The result of the HIV assay in the testing strategy was non-reactive |
| HIV.B.DE101 | Invalid | The result of the HIV assay in the testing strategy was invalid |
Generated Narrative: ValueSet HIV.C.DE1
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE2 | First time counselling on PrEP | The client is interested in discussing pre-exposure prophylaxis (PrEP) for the first time |
| HIV.C.DE3 | Follow-up appointment for PrEP or PEP | Client is at a follow-up or refill pre-exposure prophylaxis (PrEP) appointment |
| HIV.C.DE4 | Restarting PrEP | Client has previously taken pre-exposure prophylaxis (PrEP) and may like to restart taking it |
| HIV.C.DE5 | Counselling on PEP | Counselling on post-exposure prophylaxis (PEP) |
| HIV.C.DE6 | Unscheduled visit for side effects | Patient visit for management of side effects related to PrEP |
Generated Narrative: ValueSet HIV.C.DE101
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE102 | ATV/r | Alternative third drug of atazanavir/ritonavir (ATV/r) |
| HIV.C.DE103 | DRV/r | Alternative third drug of darunavir/ritonavir (DRV/r) |
| HIV.C.DE104 | LPV/r | Alternative third drug of lopinavir/ritonavir (LPV/r) |
| HIV.C.DE105 | RAL | Alternative third drug of raltegravir (RAL) |
Generated Narrative: ValueSet HIV.C.DE107
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE108 | Male | Male client |
| HIV.C.DE109 | Female | Female client |
Generated Narrative: ValueSet HIV.C.DE11
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE12 | Daily oral PrEP | Pre-exposure prophylaxis (PrEP) is taken every day |
| HIV.C.DE13 | Event-driven PrEP (2+1+1) | Event-driven pre-exposure prophylaxis (PrEP) is taken on an even-driven basis (2+1+1) |
| HIV.C.DE14 | Other PrEP dosing type | Other PrEP dosing type |
Generated Narrative: ValueSet HIV.C.DE112
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE113 | Tenofovir disoproxil fumarate (TDF) allergy or contraindication | Allergy to pre-exposure prophylaxis (PrEP) tenofovir disoproxil fumarate (TDF) |
| HIV.C.DE114 | HIV-positive | Client is HIV-positive |
| HIV.C.DE115 | Low estimated creatinine clearance | Estimated creatinine clearance of less than 60 ml/min (if known) |
| HIV.C.DE116 | Acute HIV infection symptoms | Symptoms that could suggest an acute HIV infection |
| HIV.C.DE117 | Probable recent exposure to HIV | When the client is reported to have had probable recent exposure to HIV |
| HIV.C.DE118 | Other allergy or contraindication to a medicine in the PrEP regimen | Client has another allergy or contraindication to a medicine in the pre-exposure prophylaxis (PrEP) regimen |
Generated Narrative: ValueSet HIV.C.DE122
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.C.DE125
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE126 | Retesting for HIV | Retesting follow-up appointment |
| HIV.C.DE127 | Follow-up appointment for PrEP | Retesting follow-up appointment |
| HIV.C.DE128 | Other | Other reason for the follow-up appointment |
Generated Narrative: ValueSet HIV.C.DE131
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE132 | Male and female condoms and condom-compatible lubricants offered | Offer male and female condoms and condom-compatible lubricants |
| HIV.C.DE133 | Voluntary medical male circumcision (VMMC) referral | Offer referral for VMMC services |
| HIV.C.DE134 | Harm reduction for people who inject drugs | Offer or refer to harm reduction for people who inject drugs (needle and syringe programmes, opioid substitution therapy, other drug-dependence treatment and opioid overdose prevention and management) services |
| HIV.C.DE135 | Behavioural interventions to support risk reduction | Offer or refer to services for behavioural interventions to support risk reduction, particularly for people with HIV and members of key populations |
Generated Narrative: ValueSet HIV.C.DE138
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE139 | Male condom | Male condoms were provided to the client |
| HIV.C.DE140 | Female condom | Female condoms were provided to the client |
Generated Narrative: ValueSet HIV.C.DE143
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE144 | Self | Client plans to use the self-test kit |
| HIV.C.DE145 | Family member | Client plans to give the self-test kit to a family member to use |
| HIV.C.DE146 | Drug-injecting partner | Client plans to give the self-test kit to a drug-injecting partner |
| HIV.C.DE147 | Sexual partner | Client plans to give the self-test kit to a sexual partner |
| HIV.C.DE148 | Social contact | Client plans to give the self-test kit to a social contact |
Generated Narrative: ValueSet HIV.C.DE149
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE150 | Contraception and family planning | Offer contraception and family planning services |
| HIV.C.DE151 | Check pregnancy status | Check woman's pregnancy status |
| HIV.C.DE152 | Prevent mother-to-child transmission | Offer services (counselling) to help prevent of mother-to-child transmission |
| HIV.C.DE153 | Cervical cancer screening and treatment | Offer cervical cancer screening and treatment services |
| HIV.C.DE154 | Anal cancer screening (for men who have sex with men) | Offer anal cancer screening (for men who have sex with men) services |
| HIV.C.DE155 | STI testing and treatment | Offer STI testing and treatment services |
Generated Narrative: ValueSet HIV.C.DE157
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE158 | Assessment and provision of vaccinations | Assessment and provision of vaccinations, such as for people from key populations, pregnant women and infants; and, where appropriate, tetanus vaccination for adolescent boys and men receiving VMMC |
| HIV.C.DE159 | Hepatitis B virus (HBV) and hepatitis C virus (HCV) testing and treatment | Offer or refer for HBV testing and vaccination and HCV testing and treatment |
| HIV.C.DE160 | Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia | Offer or refer for co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia |
| HIV.C.DE161 | Intensified TB case finding and linkage to TB treatment | Offer or refer for TB case finding and linkage to TB treatment |
| HIV.C.DE162 | Provision of isoniazid preventive therapy if person does not have TB | Offer or refer for provision of isoniazid preventive therapy if person does not have TB |
| HIV.C.DE163 | Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology | Offer or refer for malaria prevention (such as bed nets and prophylaxis), depending on epidemiology |
Generated Narrative: ValueSet HIV.C.DE164
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE165 | Mental health services | Offer or refer for mental health services |
| HIV.C.DE166 | Psychosocial counselling, support and treatment adherence counselling | Offer or refer for psychosocial counselling, support and treatment adherence counselling |
| HIV.C.DE167 | Support for disclosure and partner services | Offer or refer for support for disclosure and partner services |
| HIV.C.DE168 | Legal and social services | Offer or refer for legal and social services |
| HIV.C.DE169 | Services for responding to violence against women | Offer or refer for services for responding to violence against women, including first-line support and psychosocial support, post-rape care and other support services including shelters, legal services and women and child protection services |
Generated Narrative: ValueSet HIV.C.DE17
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE18 | TDF + FTC | Treated with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP) |
| HIV.C.DE19 | TDF | Treated with single-agent tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis (PrEP) regimen (oral PrEP) |
| HIV.C.DE20 | TDF + 3TC | Treated with tenofovir disoproxil fumarate (TDF) and lamivudine (3TC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP) |
| HIV.C.DE21 | Other TDF-based regimen | Treated with other tenofovir disoproxil fumarate (TDF)-based regimen (oral PrEP) |
| HIV.C.DE22 | Dapivirine vaginal ring (DVR) | Dapivirine vaginal ring (DVR) for HIV prevention |
| HIV.C.DE23 | CAB-LA | Long-acting injectable cabotegravir |
Generated Narrative: ValueSet HIV.C.DE24
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE25 | First-time user | The client has never used pre-exposure prophylaxis (PrEP) before (naive) |
| HIV.C.DE26 | Continuing user | The client has used PrEP before and is continuing to use PrEP |
| HIV.C.DE27 | Restarting following a period of not taking PrEP | The client is restarting PrEP following a period of not taking PrEP |
Generated Narrative: ValueSet HIV.C.DE31
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE32 | First-time user | The client has never used post-exposure prophylaxis (PEP) before |
| HIV.C.DE33 | Repeat user | The client has used post-exposure prophylaxis (PEP) before |
Generated Narrative: ValueSet HIV.C.DE36
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE37 | No condom use during sex with more than one partner in the past 6 months | Recent vaginal or anal sexual intercourse without a condom with more than one partner |
| HIV.C.DE38 | STI in the past 6 months | A recent history (in the last 6 months) of a sexually transmitted infection (STI ) by laboratory testing, self-report or syndromic STI treatment |
| HIV.C.DE39 | A sexual partner in the past 6 months had one or more HIV risk factors | A recent sex partner of the client had HIV risk factors |
| HIV.C.DE40 | PrEP requested by client | Client is requesting PrEP, reflecting a decision-making process has already taken place and suggesting of substantial risk of HIV |
Generated Narrative: ValueSet HIV.C.DE41
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE42 | Yes, I want to become pregnant | Client intends to become pregnant |
| HIV.C.DE43 | I'm OK either way | Client is not intending to become pregnant, but would not be adverse to becoming pregnant |
| HIV.C.DE44 | No, I don't want to become pregnant | Client does not intend to become pregnant |
| HIV.C.DE45 | Unsure | Client is unsure or undecided about her pregnancy intentions |
Generated Narrative: ValueSet HIV.C.DE46
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE47 | Fever | Client's symptoms include a fever |
| HIV.C.DE48 | Sore throat | Client's symptoms include a sore throat |
| HIV.C.DE49 | Aches | Client's symptoms include aches |
| HIV.C.DE50 | Pains | Client's symptoms include pains |
| HIV.C.DE51 | Swollen glands | Client's symptoms include swollen glands |
| HIV.C.DE52 | Mouth sores | Client's symptoms include a mouth sores |
| HIV.C.DE53 | Headaches | Client's symptoms include a headaches |
| HIV.C.DE54 | Rash | Client's symptoms include a rash |
Generated Narrative: ValueSet HIV.C.DE55
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE56 | Not on ART | Sex partner is HIV-positive and not on ART |
| HIV.C.DE57 | On ART less than 6 months | Sex partner is HIV-positive and is on ART less than 6 months. ART may take up to 6 months to suppress viral load. In studies of serodiscordant couples, pre-exposure prophylaxis (PrEP) has provided a useful bridge to full viral suppression by the partner during that time. |
| HIV.C.DE58 | Partner has suspected low adherence to ART | Sex partner is HIV-positive and is suspected to have low adherence to ART. There have been gaps in the partner's treatment adherence or the couple is not communicating openly about treatment adherence and viral load test results. |
| HIV.C.DE59 | Partner is not virally suppressed | Sex partner is HIV-positive and not virally suppressed |
| HIV.C.DE60 | Partner is virally suppressed and has been on ART for 6 months or more | Sex partner is HIV-positive and virally suppressed with 6 months or more on ART |
Generated Narrative: ValueSet HIV.C.DE63
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE64 | Serum creatinine test | Test serum creatinine to identify pre-existing renal disease (estimated creatinine clearance less than 60 ml/min) |
| HIV.C.DE65 | Hepatitis B test | Hepatitis B test recommended for client |
| HIV.C.DE66 | Hepatitis C test | Hepatitis C test recommended for client |
| HIV.C.DE67 | Syphilis test | Syphilis test recommended for client |
| HIV.C.DE68 | Other screening for STIs | Other STI screening recommended for client |
| HIV.C.DE69 | Pregnancy testing | Pregnancy testing for client |
| HIV.C.DE70 | Review vaccination history | Review vaccination history recommended for client |
Generated Narrative: ValueSet HIV.C.DE75
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE76 | PrEP for HIV prevention | Client was prescribed pre-exposure prophylaxis (PrEP) for HIV prevention |
| HIV.C.DE77 | PEP for HIV prevention | Client was prescribed post-exposure prophylaxis (PEP) for HIV prevention |
| HIV.C.DE78 | Other | Client was prescribed other medications |
Generated Narrative: ValueSet HIV.C.DE80
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE81 | Oral PrEP | Client was prescribed oral PrEP |
| HIV.C.DE82 | Dapivirine vaginal ring (DVR) | Client was prescribed dapivirine vaginal ring (DVR) |
| HIV.C.DE83 | CAB-LA | Client was prescribed long-acting cabotegravir (CAB-LA) |
| HIV.C.DE84 | Other | Client was prescribed other PrEP product |
Generated Narrative: ValueSet HIV.C.DE91
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE92 | TDF + 3TC | Preferred backbone containing tenofovir disoproxil fumarate and lamivudine |
| HIV.C.DE93 | TDF + FTC | Preferred backbone containing tenofovir disoproxil fumarate and emtricitabine |
| HIV.C.DE94 | AZT + 3TC | Preferred backbone containing zidovudine and lamivudine |
Generated Narrative: ValueSet HIV.C.DE95
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE96 | ABC + 3TC | Alternative backbone containing abacavir and lamivudine |
| HIV.C.DE97 | TDF + 3TC | Alternative backbone containing tenofovir disoproxil fumarate and lamivudine |
| HIV.C.DE98 | TDF + FTC | Alternative backbone containing tenofovir disoproxil fumarate and emtricitabine |
Generated Narrative: ValueSet HIV.C.DE99
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE100 | DTG | Preferred third drug of dolutegravir |
Generated Narrative: ValueSet HIV.Config.DE12
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.Config.DE13 | High HIV burden setting | Settings with >5% national HIV prevalence and subpopulations and geographic settings where HIV prevalence and/or incidence is higher than nationally. |
| HIV.Config.DE14 | Low HIV burden setting | Settings with <5% HIV national prevalence but where certain populations (primarily key populations and their partners) and geographic settings may have higher HIV prevalence and/or incidence than nationally and, therefore, need priority in the HIV response |
Generated Narrative: ValueSet HIV.Config.DE19
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE1
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE2 | First clinical visit | The client's first appointment for clinical care by a provider at the facility |
| HIV.D.DE3 | Clinical visit | Appointment for clinical care by a provider |
| HIV.D.DE4 | ART initiation | Appointment for initiation of ART |
| HIV.D.DE5 | ART drug pick up | Appointment for an antiretroviral drug pick up |
| HIV.D.DE6 | Issues and concerns | Visit to address issues and concerns |
| HIV.D.DE7 | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | Appointment for a post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer |
Generated Narrative: ValueSet HIV.D.DE1002
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE1003 | Treatment failed | The treatment regimen terminated or permanently changed to a new regimen or treatment strategy. Reasons for the change include:\n- no clinical response or no bacteriological response, or both (see note;\n- adverse drug reaction; or\n- evidence of additional drug-resistance to medicines in the regimen. |
| HIV.D.DE1004 | Cured | Client with pulmonary TB with bacteriologically confirmed TB at the beginning of treatment who completed treatment as recommended by the national policy, with evidence of bacteriological response and no evidence of failure. |
| HIV.D.DE1005 | Treatment completed | Patient completed treatment as recommended by the national policy but the outcome does not meet the definition for cure or treatment failure |
| HIV.D.DE1006 | Died | Client died before starting treatment or during the course of treatment |
| HIV.D.DE1007 | Lost to follow-up | Client was lost to follow-up |
| HIV.D.DE1008 | Not evaluated | No treatment outcome was assigned. This includes cases 'transferred out' to another treatment unit and whose treatment outcome is unknown; however, it excludes those lost to follow-up. |
Generated Narrative: ValueSet HIV.D.DE1010
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE1011 | Isoniazid | Client is currently taking isoniazid |
| HIV.D.DE1012 | Rifampicin | Client is currently taking rifampicin |
| HIV.D.DE1013 | Rifabutin | Client is currently taking rifabutin |
| HIV.D.DE1014 | Ethambutol | Client is currently taking ethambutol |
| HIV.D.DE1015 | Levofloxacin | Client is currently taking levofloxacin |
| HIV.D.DE1016 | Pyrazinamide | Client is currently taking pyrazinamide, a first-line anti-tuberculosis drug |
Generated Narrative: ValueSet HIV.D.DE1019
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE1020 | Symptomatic for TB | Signs or symptoms of tuberculosis (TB) without laboratory confirmation |
| HIV.D.DE1021 | Diagnosed TB | Laboratory confirmed tuberculosis (TB) diagnosis |
| HIV.D.DE1022 | Client has no signs or symptoms of tuberculosis (TB) and is not diagnosed with tuberculosis (TB) |
Generated Narrative: ValueSet HIV.D.DE1028
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE1029 | 3HP | The client's current TPT regimen is 3HP |
| HIV.D.DE1030 | 1HP | The client's current TPT regimen is 1HP |
| HIV.D.DE1031 | 6H | The client's current TPT regimen is 6H |
| HIV.D.DE1032 | Six months of levofloxacin daily | The client's current TPT regimen is six months of levofloxacin daily |
| HIV.D.DE1033 | Other TB preventive treatment (TPT) regimen | The client's current TPT regimen is another regimen than those listed above |
Generated Narrative: ValueSet HIV.D.DE1034
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE1035 | Not started | The client did not start the TB preventive treatment (TPT) |
| HIV.D.DE1036 | On TPT | The client started the TB preventive treatment (TPT) and is currently taking the medication, without treatment interruptions |
| HIV.D.DE1037 | On TPT with interruptions | The client started the TB preventive treatment (TPT) and is currently taking the medication, with treatment interruptions |
| HIV.D.DE1038 | On hold | The health care worker has temporarily stopped the TB preventive treatment (TPT), but TPT is expected to continue again later. May also be called 'suspended'. |
| HIV.D.DE1039 | Completed | TB preventive treatment (TPT) was completed |
Generated Narrative: ValueSet HIV.D.DE128
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE129 | ABC | Treated with abacavir (ABC) |
| HIV.D.DE130 | FTC | Treated with emtricitabine (FTC) |
| HIV.D.DE131 | 3TC | Treated with lamivudine (3TC) |
| HIV.D.DE132 | AZT | Treated with zidovudine (AZT) |
| HIV.D.DE133 | DDI | Treated with didanosine (DDI) |
| HIV.D.DE134 | D4T | Treated with stavudine (D4T) |
| HIV.D.DE135 | TDF | Treated with tenofovir (TDF) |
| HIV.D.DE136 | EFV | Treated with efavirenz (EFV) |
| HIV.D.DE137 | ETV | Treated with etravirine (ETV) |
| HIV.D.DE138 | NVP | Treated with nevirapine (NVP) |
| HIV.D.DE139 | RIL | Treated with rilpivirine (RIL) |
| HIV.D.DE140 | ATV/r | Treated with atazanavir/ritonavir (ATV/r) |
| HIV.D.DE141 | LPV/r | Treated with lopinavir/ritonavir (LPV/r) |
| HIV.D.DE142 | DRV/r | Treated with darunavir/ritonavir (DRV/r) |
| HIV.D.DE143 | RTV | Treated with ritonavir (RTV) |
| HIV.D.DE144 | DTG | Treated with dolutegravir (DTG) |
| HIV.D.DE145 | RAL | Treated with raltegravir (RAL) |
Generated Narrative: ValueSet HIV.D.DE146
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE147 | NRTI | Treated with nucleoside reverse transcriptase inhibitors (NRTIs) |
| HIV.D.DE148 | NtRTI | Treated with nucleotide reverse-transcriptase inhibitors (NtRTIs) |
| HIV.D.DE149 | NNRTI | Treated with non-nucleoside reverse transcriptase inhibitors (NNRTIs) |
| HIV.D.DE150 | PI | Treated with protease inhibitors (PIs) |
| HIV.D.DE151 | INSTI | Treated with integrase strand transfer inhibitors (INSTIs) |
Generated Narrative: ValueSet HIV.D.DE152
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE153 | Offer male and female condoms and condom-compatible lubricants | Offer male and female condoms and condom-compatible lubricants |
| HIV.D.DE154 | Harm reduction for people who inject drugs | Offer or refer people who inject drugs to harm reduction services (needle and syringe programmes, opioid substitution therapy, other drug-dependence treatment and opioid overdose prevention and management) |
| HIV.D.DE155 | Behavioural interventions to support risk reduction | Offer or refer to services for behavioural interventions to support risk reduction, particularly for people with HIV and members of key populations |
Generated Narrative: ValueSet HIV.D.DE156
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE157 | Contraception and family planning | Offer contraception and family planning services |
| HIV.D.DE158 | Check pregnancy status | Check woman's pregnancy status |
| HIV.D.DE159 | Prevention of mother-to-child transmission | Offer prevention of mother-to-child transmission services (counselling) |
| HIV.D.DE160 | STI testing and treatment | Offer STI testing and treatment services |
Generated Narrative: ValueSet HIV.D.DE162
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE163 | Positive | HBsAg test result was positive |
| HIV.D.DE164 | Negative | HBsAg test result was negative |
| HIV.D.DE165 | Indeterminate | HBsAg test result was indeterminate |
Generated Narrative: ValueSet HIV.D.DE168
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE17
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE18 | Fever of 39 C or greater | Client has a fever with a measured temperature of 102.2 F/39 C or greater |
| HIV.D.DE19 | Tachycardia | Heart rate above a rate per minute based on age |
| HIV.D.DE20 | Tachypnea | Respiratory rate above a number of breaths per minute based on age |
| HIV.D.DE21 | Unable to walk unaided | Client is not able to walk without help |
| HIV.D.DE22 | Lethargy | Client is exhibiting lethargy as a sign of serious illness |
| HIV.D.DE23 | Unconsciousness | Client is currently unconscious |
| HIV.D.DE24 | Convulsions | Client is convulsing |
| HIV.D.DE25 | Unable to drink | Child is not able to drink |
| HIV.D.DE26 | Unable to breastfeed | Infant or child is not able to breastfeed |
| HIV.D.DE27 | Repeated vomiting | Client is repeatedly vomiting |
| HIV.D.DE28 | Headache | Client is exhibiting a headache |
| HIV.D.DE29 | Other sign of serious illness | Client is exhibiting another sign of a serious illness |
Generated Narrative: ValueSet HIV.D.DE170
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE171 | Positive | HCV test result was positive |
| HIV.D.DE172 | Negative | HCV test result was negative |
| HIV.D.DE173 | Indeterminate | HCV test result was indeterminate |
Generated Narrative: ValueSet HIV.D.DE177
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE179
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE180 | Detected | HCV was detected |
| HIV.D.DE181 | Not detected | HCV was not detected |
Generated Narrative: ValueSet HIV.D.DE182
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE183 | Interferon | Client is prescribed interferon |
| HIV.D.DE184 | Direct acting antivirals | Client is prescribed direct acting antivirals |
Generated Narrative: ValueSet HIV.D.DE186
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE187 | WHO HIV clinical stage 1 | Client is currently assessed to be at a clinical stage 1, based on clinical assessment and diagnostics |
| HIV.D.DE188 | WHO HIV clinical stage 2 | Client is currently assessed to be at a clinical stage 2, based on clinical assessment and diagnostics |
| HIV.D.DE189 | WHO HIV clinical stage 3 | Client is currently assessed to be at a clinical stage 3, based on clinical assessment and diagnostics |
| HIV.D.DE190 | WHO HIV clinical stage 4 | Client is currently assessed to be at a clinical stage 4, based on clinical assessment and diagnostics |
Generated Narrative: ValueSet HIV.D.DE197
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE198 | Forgot | Client reported not being adherent because they forgot |
| HIV.D.DE199 | Toxicity/side effects | Client reported not being adherent because of toxicity/side effects |
| HIV.D.DE200 | Busy | Client reported not being adherent because they were busy |
| HIV.D.DE201 | Change of routine | Client reported not being adherent because of a change of routine |
| HIV.D.DE202 | Travel cost | Client reported not being adherent because of travel cost |
| HIV.D.DE203 | Distance to clinic | Client reported not being adherent because of distance to clinic |
| HIV.D.DE204 | Client lost/ran out of pills | Client reported not being adherent because client lost/ran out of pills |
| HIV.D.DE205 | Stock-out | Client reported not being adherent because of a stock-out |
| HIV.D.DE206 | Too ill | Client reported not being adherent because of being too ill |
| HIV.D.DE207 | Pill burden | Client reported not being adherent because of the pill burden |
| HIV.D.DE208 | Felt well | Client reported not being adherent because they felt well |
| HIV.D.DE209 | Depression | Client reported not being adherent because of depression |
| HIV.D.DE210 | Alcohol use | Client reported not being adherent because of alcohol use |
| HIV.D.DE211 | Substance use | Client reported not being adherent because of substance use (i.e. drugs) |
| HIV.D.DE212 | Stigma/disclosure concerns | Client reported not being adherent because of stigma/disclosure concerns |
| HIV.D.DE213 | Lack of food | Client reported not being adherent because of a lack of food |
| HIV.D.DE214 | Poor palatability | Client reported not being adherent because of poor palatability |
| HIV.D.DE215 | Other reason for nonadherence | Client reported not being adherent because of other reason for nonadherence |
Generated Narrative: ValueSet HIV.D.DE217
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE218 | Toxicity/side effects | Client stopped ART because of toxicity/side effects |
| HIV.D.DE219 | Severe illness, hospitalization | Client stopped ART because of severe illness, hospitalization |
| HIV.D.DE220 | Drugs out of stock | Client stopped ART because drugs were out of stock |
| HIV.D.DE221 | Client lacks finances | Client stopped ART because of lack of finances |
| HIV.D.DE222 | Excluded HIV infection in infant | Client stopped ART because HIV infection in infant was excluded |
| HIV.D.DE223 | Other reason for stopping ART | Client stopped ART because of other reason |
Generated Narrative: ValueSet HIV.D.DE225
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE226 | Clinical failure | New or recurrent clinical event indicating severe immunodeficiency in adults or advanced or severe immunodeficiency in children |
| HIV.D.DE227 | Immunological failure | CD4 count at or below 250 cells/mm3 following clinical failure |
| HIV.D.DE228 | Virological failure | The inability to achieve or maintain viral suppression below a certain threshold indicated by viral load above 1000 copies/mL based on two consecutive viral load measurements in 3 months, with adherence support following the first viral load test |
Generated Narrative: ValueSet HIV.D.DE229
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE230 | Determine WHO clinical stage | Determine WHO clinical stage based on past and current HIV-related conditions |
| HIV.D.DE231 | Determine if advanced disease | Determine if client is in an advanced stage of HIV, as a special package of services may be provided |
| HIV.D.DE232 | Prepare for ART | Prepare client new to ART |
| HIV.D.DE233 | Prepare, assess and support adherence | Prepare, assess and support adherence |
| HIV.D.DE234 | Manage current medications | Manage current medications being taken by the client |
| HIV.D.DE235 | Check pregnancy status | Check woman's pregnancy status |
| HIV.D.DE236 | Provide family planning and contraception | Provide family planning and contraception counselling |
| HIV.D.DE237 | Support disclosure and partner notification | Support disclosure and partner notification |
| HIV.D.DE238 | Counsel on risk reduction and prevention | Counsel on risk reduction and combination HIV prevention approaches |
| HIV.D.DE239 | Assess, prevent and manage noncommunicable diseases | Assess, prevent and manage noncommunicable diseases |
| HIV.D.DE240 | Screen for and manage mental health problems | Screen for and manage mental health problems |
| HIV.D.DE241 | Screen for and manage and substance use issues | Screen for and manage and substance use issues |
| HIV.D.DE242 | Provide psychosocial counselling and support | Provide psychosocial counselling and support |
| HIV.D.DE243 | Manage pain and symptoms | Manage pain and symptoms client is experiencing |
| HIV.D.DE244 | Conduct a nutritional assessment and counsel on nutrition | Conduct a nutritional assessment and counsel on nutrition |
| HIV.D.DE245 | Conduct a growth and development assessment | Conduct a growth and development assessment |
| HIV.D.DE246 | Provide support on infant and child feeding | Provide support on infant and child feeding to mother or care giver |
Generated Narrative: ValueSet HIV.D.DE247
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE248 | Provide co-trimoxazole preventive therapy (CPT) | Provide co-trimoxazole prophylaxis for clients new to ART or identified as taking it |
| HIV.D.DE249 | Intensified TB case finding and linkage to TB treatment | Offer or refer for intensified TB case finding and linkage to TB treatment |
| HIV.D.DE250 | Provide isoniazid preventive therapy | Provide isoniazid preventive therapy |
| HIV.D.DE251 | Screen for cryptococcal infection and fungal prophylaxis | Screen for cryptococcal infection and fungal prophylaxis |
| HIV.D.DE252 | Screen for hepatitis B | Screen for hepatitis B virus |
| HIV.D.DE253 | Screen for hepatitis C | Screen for hepatitis C virus |
| HIV.D.DE254 | Prevent malaria | Prevent malaria including with insecticide-treated bed-nets and prophylaxis |
| HIV.D.DE255 | Screen for STIs | Screen for STIs |
| HIV.D.DE256 | Prevent and screen for cervical cancer | Prevent and screen for cervical cancer |
| HIV.D.DE257 | Anal cancer screening (for men who have sex with men) | Offer anal cancer screening (for men who have sex with men) |
| HIV.D.DE258 | Assessment and provision of vaccinations | Assessment and provision of vaccinations, such as for people from key populations, pregnant women and infants; and, where appropriate, tetanus vaccination for adolescent boys and men receiving VMMC |
Generated Narrative: ValueSet HIV.D.DE259
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE260 | Oral candidiasis | Client's comorbidities or coinfections or symptoms of these include oral candidiasis (after the first 6-8 weeks of life) |
| HIV.D.DE261 | Vaginal candidiasis | Client's comorbidities or coinfections or symptoms of these include vaginal candidiasis |
| HIV.D.DE262 | Cough | Client's comorbidities or coinfections or symptoms of these include cough |
| HIV.D.DE263 | Prolonged fever | Client's comorbidities or coinfections or symptoms of these include prolonged fever |
| HIV.D.DE264 | Night sweats | Client's comorbidities or coinfections or symptoms of these include night sweats |
| HIV.D.DE265 | Weight loss | Client's comorbidities or coinfections or symptoms of these include weight loss |
| HIV.D.DE266 | Difficulty breathing | Client's comorbidities or coinfections or symptoms of these include difficulty breathing |
| HIV.D.DE267 | Pneumonia | Client's comorbidities or coinfections or symptoms of these include pneumonia |
| HIV.D.DE268 | Urethral discharge | Client's comorbidities or coinfections or symptoms of these include urethral discharge |
| HIV.D.DE269 | Syphilis | Client's comorbidities or coinfections or symptoms of these include syphilis |
| HIV.D.DE270 | Pelvic inflammatory disease | Client's comorbidities or coinfections or symptoms of these include pelvic inflammatory disease |
| HIV.D.DE271 | Ulcers - skin | Client's comorbidities or coinfections or symptoms of these include ulcers - skin |
| HIV.D.DE272 | Ulcers - mouth or other | Client's comorbidities or coinfections or symptoms of these include ulcers - mouth or other |
| HIV.D.DE273 | Ulcers - male genital | Client's comorbidities or coinfections or symptoms of these include ulcers - male genital |
| HIV.D.DE274 | Vaginal discharge | Client's comorbidities or coinfections or symptoms of these include vaginal discharge |
| HIV.D.DE275 | Malaria | Client's comorbidities or coinfections or symptoms of these include malaria |
| HIV.D.DE276 | Chronic obstructive pulmonary disease | Client's comorbidities or coinfections or symptoms of these include chronic obstructive pulmonary disease |
| HIV.D.DE277 | Hypertension | Client's comorbidities or coinfections or symptoms of these include hypertension |
| HIV.D.DE278 | Diabetes | Client's comorbidities or coinfections or symptoms of these include diabetes |
| HIV.D.DE279 | Gestational diabetes | Client's comorbidities or coinfections or symptoms of these include gestational diabetes |
| HIV.D.DE280 | Mental health disorders | Client's comorbidities or coinfections or symptoms of these include mental health disorders (including depression, dementia, encephalitis, seizures) |
| HIV.D.DE281 | Diarrhoea or abdominal pain | Client's comorbidities or coinfections or symptoms of these include diarrhoea or abdominal pain |
| HIV.D.DE282 | Presumptive TB | Client's comorbidities or coinfections or symptoms of these include presumptive TB |
| HIV.D.DE283 | Severe or complicated malnutrition | Client's comorbidities or coinfections or symptoms of these include severe or complicated malnutrition |
| HIV.D.DE284 | Poor growth or development | Client's comorbidities or coinfections or symptoms of these include poor growth or development |
| HIV.D.DE285 | Oedema | Client's comorbidities or coinfections or symptoms of these include oedema |
| HIV.D.DE286 | Previously treated for TB | Client has previously been treated for tuberculosis (TB) |
| HIV.D.DE287 | Other | Other comorbidities or coinfection signs or symptoms |
Generated Narrative: ValueSet HIV.D.DE289
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE290 | Asymptomatic | No HIV-related symptoms reported and no clinical signs on examination |
| HIV.D.DE291 | Persistent generalized lymphadenopathy | Persistent enlarged lymph nodes >1 cm at two or more non-contiguous sites (excluding inguinal) without known cause |
| HIV.D.DE292 | Moderate unexplained weight loss | Moderate unexplained weight loss (<10% of presumed or measured body weight) |
| HIV.D.DE293 | Recurrent respiratory tract infections | Client's symptoms include recurrent respiratory tract infections including sinusitis, tonsillitis, otitis media or pharyngitis |
| HIV.D.DE294 | Unexplained persistent hepatosplenomegaly | Client's symptoms include unexplained persistent hepatosplenomegaly |
| HIV.D.DE295 | Herpes zoster | Client's symptoms include herpes zoster |
| HIV.D.DE296 | Angular cheilitis | Client's symptoms include angular cheilitis |
| HIV.D.DE297 | Linear gingival erythema | Client's symptoms include linear gingival erythema |
| HIV.D.DE298 | Recurrent oral ulceration | Client's symptoms include recurrent oral ulceration |
| HIV.D.DE299 | Papular pruritic eruption | Client's symptoms include papular pruritic eruption |
| HIV.D.DE300 | Fungal nail infections | Client's symptoms include fungal nail infections |
| HIV.D.DE301 | Seborrhoeic dermatitis | Client's symptoms include seborrhoeic dermatitis |
| HIV.D.DE302 | Extensive wart virus infection | Client's symptoms include extensive wart virus infection |
| HIV.D.DE303 | Extensive molluscum contagiosum | Client's symptoms include extensive molluscum contagiosum |
| HIV.D.DE304 | Unexplained persistent parotid enlargement | Client's symptoms include unexplained persistent parotid enlargement |
| HIV.D.DE305 | Unexplained severe weight loss in adults | Unexplained severe weight loss (>10% of presumed or measured body weight) |
| HIV.D.DE306 | Unexplained moderate malnutrition not adequately responding to standard therapy | Defined as weight-for-height < - 2 z-score or mid-upper arm circumference 115 mm to <125 mm. For children younger than five years of age: stunting is defined as severe acute malnutrition - either weight for height < -3 z-score or mid-upper arm circumference <115 mm or the presence of oedema. |
| HIV.D.DE307 | Unexplained chronic diarrhoea for longer than 1 month | Client's symptoms include unexplained chronic diarrhoea for longer than 1 month |
| HIV.D.DE308 | Unexplained persistent diarrhoea (14 days or more) | Client's symptoms include unexplained persistent diarrhoea (14 days or more) |
| HIV.D.DE309 | Unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month) | Client's symptoms include unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month) |
| HIV.D.DE310 | Persistent oral candidiasis | Client's symptoms include persistent oral candidiasis |
| HIV.D.DE311 | Oral hairy leukoplakia | Client has fine white small linear or corrugated lesions on lateral borders of the tongue that do not scrape off |
| HIV.D.DE312 | Pulmonary TB | Client's symptoms include pulmonary TB |
| HIV.D.DE313 | Lymph node TB | Client's symptoms include lymph node TB |
| HIV.D.DE314 | Severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia) | Client's symptoms include severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia) |
| HIV.D.DE315 | Severe recurrent bacterial pneumonia | Client's symptoms include severe recurrent bacterial pneumonia |
| HIV.D.DE316 | Acute necrotizing ulcerative stomatitis | Client's symptoms include acute necrotizing ulcerative stomatitis |
| HIV.D.DE317 | Acute necrotizing ulcerative gingivitis | Client's symptoms include acute necrotizing ulcerative gingivitis |
| HIV.D.DE318 | Acute necrotizing ulcerative periodontitis | Client's symptoms include acute necrotizing ulcerative periodontitis |
| HIV.D.DE319 | Unexplained anaemia (<8 g/dL) | Client's symptoms include unexplained anaemia (<8 g/dL) |
| HIV.D.DE320 | Neutropaenia (<0.5 x 10^9/L) | Client's symptoms include neutropaenia (<0.5 x 10^9/L) |
| HIV.D.DE321 | Chronic thrombocytopaenia (<50 x 10^9/L) | Client's symptoms include chronic thrombocytopaenia (<50 x 10^9/L) |
| HIV.D.DE322 | Symptomatic lymphoid interstitial pneumonitis | Client's symptoms include symptomatic lymphoid interstitial pneumonitis |
| HIV.D.DE323 | Chronic HIV-associated lung disease, including bronchiectasis | Client's symptoms include chronic HIV-associated lung disease, including bronchiectasis |
| HIV.D.DE324 | HIV wasting syndrome | Unexplained involuntary weight loss (>10% baseline body weight), with obvious wasting or body mass index <18.5; PLUS EITHER unexplained chronic reported for longer than one month; OR reports of fever or night sweats for more than one month without other cause and lack of response to antibiotics or antimalarial agents; malaria must be excluded in malarious areas. |
| HIV.D.DE325 | Unexplained severe wasting not responding to standard therapy | Client has unexplained severe wasting not responding to standard therapy . For under 5 years old, defined as weight-for-height < -3 z-score |
| HIV.D.DE326 | Unexplained stunting not responding to standard therapy | Client has unexplained stunting not responding to standard therapy . For under 5 years old, defined as length-for- age/height-for-age < -2 z-score |
| HIV.D.DE327 | Unexplained severe malnutrition not responding to standard therapy | Client has unexplained severe malnutrition not responding to standard therapy . For under 5 years old, weight for height < -3 z-score or mid-upper arm circumference <115 mm or the presence of oedema |
| HIV.D.DE328 | Pneumocystis (jirovecii) pneumonia | Client's symptoms include pneumocystis (jirovecii) pneumonia |
| HIV.D.DE329 | Recurrent severe bacterial pneumonia | Client's symptoms include recurrent severe bacterial pneumonia |
| HIV.D.DE330 | Recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia) | Client's symptoms include recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia) |
| HIV.D.DE331 | Empyema | Client's symptoms include recurrent empyema |
| HIV.D.DE332 | Pyomyositis | Client's symptoms include recurrent pyomyositis |
| HIV.D.DE333 | Bone or joint infection | Client's symptoms include recurrent bone or joint infections |
| HIV.D.DE334 | Meningitis | Client's symptoms include recurrent meningitis |
| HIV.D.DE335 | Chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site) | Client's symptoms include chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site) |
| HIV.D.DE336 | Chronic herpes simplex infection (orolabial, genital or anorectal of more than 1 month in duration or visceral at any site) | Client's symptoms include chronic herpes simplex infection (orolabial, genital or anorectal of more than one month in duration or visceral at any site) |
| HIV.D.DE337 | Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs) | Client's symptoms include oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs) |
| HIV.D.DE338 | Extrapulmonary TB | Client's symptoms include extrapulmonary tuberculosis |
| HIV.D.DE339 | Kaposi sarcoma | Client's symptoms include Kaposi sarcoma |
| HIV.D.DE340 | Cytomegalovirus infection (retinitis or infection of other organs) | Client's symptoms include cytomegalovirus infection (retinitis or infection of other organs) |
| HIV.D.DE341 | Central nervous system toxoplasmosis | Client's symptoms include central nervous system toxoplasmosis |
| HIV.D.DE342 | HIV encephalopathy | Client's symptoms include HIV encephalopathy |
| HIV.D.DE343 | Extrapulmonary cryptococcosis, including meningitis | Client's symptoms include extrapulmonary cryptococcosis, including meningitis |
| HIV.D.DE344 | Disseminated nontuberculous mycobacterial infection | Client's symptoms include disseminated nontuberculous mycobacterial infection |
| HIV.D.DE345 | Progressive multifocal leukoencephalopathy | Client's symptoms include progressive multifocal leukoencephalopathy |
| HIV.D.DE346 | Chronic cryptosporidiosis | Client's symptoms include chronic cryptosporidiosis |
| HIV.D.DE347 | Chronic cryptosporidiosis (with diarrhoea) | Client's symptoms include chronic cryptosporidiosis (with diarrhoea) |
| HIV.D.DE348 | Chronic isosporiasis | Client's symptoms include chronic isosporiasis |
| HIV.D.DE349 | Disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis) | Client's symptoms include disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis) |
| HIV.D.DE350 | Disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis) | Client's symptoms include disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis) |
| HIV.D.DE351 | Cerebral lymphoma | Client's symptoms include cerebral lymphoma |
| HIV.D.DE352 | B-cell non-Hodgkin lymphoma | Client's symptoms include b-cell non-Hodgkin lymphoma |
| HIV.D.DE353 | HIV-associated nephropathy or cardiomyopathy | Client's symptoms include HIV- associated nephropathy or cardiomyopathy |
| HIV.D.DE354 | Recurrent septicaemia (including nontyphoidal Salmonella) | Client's symptoms include recurrent bacteraemia (septicaemia) (including nontyphoidal salmonella) |
| HIV.D.DE355 | Invasive cervical carcinoma | Client's symptoms include invasive cervical carcinoma |
| HIV.D.DE356 | Atypical disseminated leishmaniasis | Client's symptoms include atypical disseminated leishmaniasis |
| HIV.D.DE357 | Neutropenia | Client's symptoms include neutropenia, an abnormally low count of a type of white blood cell (neutrophils) |
Generated Narrative: ValueSet HIV.D.DE358
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE359 | WHO clinical stage 1 | Client is assessed to be at a clinical stage of 1 at the time of starting ART, based on clinical assessment and diagnostics |
| HIV.D.DE360 | WHO clinical stage 2 | Client is assessed to be at a clinical stage of 2 at the time of starting ART, based on clinical assessment and diagnostics |
| HIV.D.DE361 | WHO clinical stage 3 | Client is assessed to be at a clinical stage of 3 at the time of starting ART, based on clinical assessment and diagnostics |
| HIV.D.DE362 | WHO clinical stage 4 | Client is assessed to be at a clinical stage of 4 at the time of starting ART, based on clinical assessment and diagnostics |
Generated Narrative: ValueSet HIV.D.DE370
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE371 | Patient self-reported as not ready/willing | Client did not initiate ART at diagnosis or within 7 days of diagnosis because client self-reported as not ready/willing |
| HIV.D.DE372 | Not completed education, support and preparation for ART | Client did not initiate ART at diagnosis or within 7 days of diagnosis because client had not completed education, support and preparation for ART |
| HIV.D.DE373 | Fear of disclosure | Client did not initiate ART at diagnosis or within 7 days of diagnosis because of client's fear of disclosure |
| HIV.D.DE374 | Patient lacks finances | Client did not initiate ART at diagnosis or within 7 days of diagnosis because client lacks finances |
| HIV.D.DE375 | Initiated on TB treatment | Client did not initiate ART at diagnosis or within 7 days of diagnosis because client initiated on TB treatment |
| HIV.D.DE376 | Patient initiated on treatment for TB meningitis | Client did not initiate ART at diagnosis or within 7 days of diagnosis because client initiated on treatment for TB meningitis |
| HIV.D.DE377 | Patient diagnosed with cryptococcal meningitis | Client did not initiate ART at diagnosis or within 7 days of diagnosis because client diagnosed with cryptococcal meningitis |
| HIV.D.DE378 | Patient diagnosed with histoplasmosis | Client did not initiate ART at diagnosis or within 7 days of diagnosis because client diagnosed with histoplasmosis |
| HIV.D.DE379 | Patient critically/severely ill | Client did not initiate ART at diagnosis or within 7 days of diagnosis because client critically/severely ill |
| HIV.D.DE380 | Other | Client did not initiate ART at diagnosis or within 7 days of diagnosis because of other reason |
Generated Narrative: ValueSet HIV.D.DE383
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE384 | Within 7 days of HIV diagnosis | Client started ART within 7 days |
| HIV.D.DE385 | Within 30 days of HIV diagnosis | Client started ART within 30 days of ART initiation (but over 7 days) |
| HIV.D.DE386 | Within 90 days of HIV diagnosis | Client started ART within 90 days of ART initiation (but over 30 days) |
Generated Narrative: ValueSet HIV.D.DE391
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE392 | Routine viral load test | Routine refers to viral load tests obtained at standard intervals following ART initiation to monitor viral load response to ART |
| HIV.D.DE393 | Targeted viral load monitoring | Targeted refers to viral load tests obtained based on a specific clinical indication (such as concern about disease progression or failure to respond to ART) |
| HIV.D.DE394 | Initial viral load test | The first viral load test of the client |
| HIV.D.DE395 | Follow-up viral load test after receiving enhanced adherence counselling | A follow-up viral load test within 3-6 months after enhanced adherence counselling after client received a high viral load test result |
Generated Narrative: ValueSet HIV.D.DE399
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE400 | Haemoglobin (Hb) | Provider ordered a Haemoglobin (Hb) test, number in g/dL test |
| HIV.D.DE401 | Pregnancy test | Provider ordered a pregnancy test for client |
| HIV.D.DE402 | Syphilis test | Provider ordered a syphilis test |
| HIV.D.DE403 | Chest X-ray (CXR) | Provider ordered a chest X-ray (CXR) |
| HIV.D.DE404 | Sputum or culture for TB | Provider ordered sputum or culture for TB |
| HIV.D.DE405 | HBsAg test (HBV) | Provider ordered an HBsAg test (HBV) test |
| HIV.D.DE406 | HIV viral load test ordered | Provider ordered an HIV viral load test |
| HIV.D.DE407 | HIV viral load test scheduled | Scheduled an HIV viral load test with client |
| HIV.D.DE408 | CD4 count ordered | Provider ordered a CD4 cell count |
| HIV.D.DE409 | CD4 count test scheduled | Scheduled a CD4 test with client |
| HIV.D.DE410 | Cryptococcal antigen test | Provider ordered a cryptococcal antigen test |
| HIV.D.DE411 | Histoplasmosis antigen test | Provider ordered a histoplasmosis antigen test |
| HIV.D.DE412 | Cervical cancer screening scheduled | Scheduled cervical cancer screening with client |
Generated Narrative: ValueSet HIV.D.DE418
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE419 | Toxicity/side effects | A substitution was made to the regimen because of toxicity/side effects |
| HIV.D.DE420 | Drug-drug interaction | A substitution was made to the regimen because of a drug-drug interaction |
| HIV.D.DE421 | Pregnancy | A substitution was made to the regimen because of pregnancy |
| HIV.D.DE422 | New TB | A substitution was made to the regimen because of new tuberculosis (TB) |
| HIV.D.DE423 | New drug available | A substitution was made to the regimen because a new drug was available |
| HIV.D.DE424 | Drug out of stock | A substitution was made to the regimen because drug was out of stock |
| HIV.D.DE425 | Other reason for regimen substitution | A substitution was made for another reason |
Generated Narrative: ValueSet HIV.D.DE43
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE44 | First-time user of ART | Client is ART naive, having never taken ART to treat HIV before |
| HIV.D.DE45 | Restarting ART | Client is restarting ART after stopping treatment for any reason |
Generated Narrative: ValueSet HIV.D.DE430
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE431 | Clinical treatment failure | A switch was made to the regimen because of clinical treatment failure |
| HIV.D.DE432 | Immunological failure | A switch was made to the regimen because of immunological failure |
| HIV.D.DE433 | Virological failure | A switch was made to the regimen because of virological failure |
| HIV.D.DE434 | Other | A switch was made to the regimen for another reason |
Generated Narrative: ValueSet HIV.D.DE444
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE446
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE447 | Hepatitis B | Client was hepatitis B positive at the start of ART |
| HIV.D.DE448 | Hepatitis C | Client was hepatitis C positive at the start of ART |
Generated Narrative: ValueSet HIV.D.DE449
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE450 | Pregnant at ART start | Client was pregnant when ART was initiated |
| HIV.D.DE451 | Postpartum at ART start | Client was postpartum when ART was initiated |
| HIV.D.DE452 | ART start at labour and delivery | Client initiated ART at labour and delivery |
| HIV.D.DE453 | Breastfeeding at ART start | Client was breastfeeding when ART was initiated |
Generated Narrative: ValueSet HIV.D.DE457
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE461
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE466
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE467 | Gastrointestinal | Treatment-limiting toxicity due to GI issues (nausea, diarrhoea, abdominal pain, vomiting) |
| HIV.D.DE468 | Skin issues | Treatment-limiting toxicity due to skin issues (rash, hypersensitivity reaction) |
| HIV.D.DE469 | Peripheral neuropathy | Treatment-limiting toxicity due to peripheral neuropathy (burning/numbness/ tingling) |
| HIV.D.DE470 | Central nervous system symptoms | Treatment-limiting toxicity due to central nervous system symptoms (dizzy, anxiety, nightmare, depression, seizures) |
| HIV.D.DE471 | Weight gain | Treatment-limiting toxicity due to weight gain |
| HIV.D.DE472 | Hepatic dysfunction | Treatment-limiting toxicity due to hepatic dysfunction (jaundice) |
| HIV.D.DE473 | Haematological disorders | Treatment-limiting toxicity due to haematological (anaemia, neutropenia) disorders |
| HIV.D.DE474 | Fatigue | Treatment-limiting toxicity due to fatigue |
| HIV.D.DE475 | Headache | Treatment-limiting toxicity due to headache |
| HIV.D.DE476 | Bone dysfunction | Treatment-limiting toxicity due to bone dysfunction (fractures, osteopenia) |
| HIV.D.DE477 | Metabolic symptoms | Treatment-limiting toxicity due to metabolic symptoms (body fat changes, hyperglycaemia, dyslipidaemia) |
| HIV.D.DE478 | Kidney dysfunction | Treatment-limiting toxicity due to kidney dysfunction (nephrolithiasis, renal insufficiency) |
| HIV.D.DE479 | Unexpected adverse drug reaction | Client experienced an unexpected adverse drug reaction |
Generated Narrative: ValueSet HIV.D.DE482
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE483
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE485
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE486
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE488
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE489
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE491
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE492
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE494
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE495
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE514
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE519
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE520 | Mental health services | Offer or refer for mental health services |
| HIV.D.DE521 | Psychosocial counselling, support and treatment adherence counselling | Offer or refer for psychosocial counselling, support and treatment adherence counselling |
| HIV.D.DE522 | Legal and social services | Offer or refer for legal and social services |
| HIV.D.DE523 | Services for responding to violence against women | Offer or refer for services for responding to violence against women, including first-line support and psychosocial support, post-rape care and other support services including shelters, legal services and women and child protection services |
Generated Narrative: ValueSet HIV.D.DE52
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE525
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE526 | Clinical visit | Appointment for clinical care by a provider |
| HIV.D.DE527 | Antiretroviral drug pick up | Appointment for a drug pick up |
| HIV.D.DE528 | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | Appointment for a post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer |
| HIV.D.DE529 | Other | Other reason for the follow-up appointment |
Generated Narrative: ValueSet HIV.D.DE532
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE533 | BP cuff (sphygmomanometer) not available | Blood pressure cuff is not available |
| HIV.D.DE534 | BP cuff (sphygmomanometer) is broken | Blood pressure cuff is broken |
Generated Narrative: ValueSet HIV.D.DE537
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE538 | No medications | The client is currently not on any medications |
| HIV.D.DE539 | Don't know of any current medications | The client does not know if she is on any medications |
| HIV.D.DE540 | Analgesic | Analgesic medication (painkiller) |
| HIV.D.DE541 | Antacids | Antacids |
| HIV.D.DE542 | Antibiotics (broad-spectrum) | Client is currently taking broad-spectrum antibiotics |
| HIV.D.DE543 | Anticonvulsive | Anticonvulsive medication |
| HIV.D.DE544 | Antidiabetic | Antidiabetic medication |
| HIV.D.DE545 | Antifungals | Client is currently taking antifungals |
| HIV.D.DE546 | Antihelmintic | Antihelmintic or antiparasitic medication |
| HIV.D.DE547 | Antihypertensive | Antihypertensive medication |
| HIV.D.DE548 | Antimalarials | Antimalarial medication |
| HIV.D.DE549 | Antiretrovirals (ARVs) | Antiretrovirals (ARVs) |
| HIV.D.DE550 | Antiparasitics | Client is currently taking antiparasitics |
| HIV.D.DE551 | Antivirals | Antiviral medication |
| HIV.D.DE552 | Buprenorphine | Opioid substitution to treat opioid dependence |
| HIV.D.DE553 | Co-trimoxazole preventive therapy (CPT) | Combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections |
| HIV.D.DE554 | Hormonal family planning method | Hormonal family planning method |
| HIV.D.DE555 | Methadone | Opioid substitution to treat opioid dependence |
| HIV.D.DE556 | PrEP to prevent HIV | Pre-exposure prophylaxis (PrEP) medication for preventing the acquisition of HIV |
| HIV.D.DE557 | Other antibiotics | Other antibiotics not listed above |
| HIV.D.DE558 | Other medications | Other medications or supplements that are not listed above |
Generated Narrative: ValueSet HIV.D.DE55
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE56
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE57 | No prior ARVs | Client received no prior ARVs |
| HIV.D.DE58 | Received ARVs prior without records/documentation | Client received ARVs prior without records/documentation |
| HIV.D.DE59 | Received ARVs during pregnancy or breastfeeding | Client received ARVs during pregnancy or breastfeeding |
| HIV.D.DE60 | Received ARVs for PEP or PrEP | Client received ARVs for post-exposure prophylaxis (PEP) or PrEP |
| HIV.D.DE61 | ARV prophylaxis for an HIV-exposed infant | Client received ARV prophylaxis for an HIV-exposed infant |
Generated Narrative: ValueSet HIV.D.DE560
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE561 | No known allergies | Client does not have any known allergies |
| HIV.D.DE562 | Don't know of any allergies | Client does not know whether or not she has allergies |
| HIV.D.DE563 | Albendazole | Allergy to albendazole |
| HIV.D.DE564 | Malaria medication (sulfadoxine-pyrimethamine) | Allergy to malaria medication (sulfadoxine-pyrimethamine) |
| HIV.D.DE565 | Penicillin | Allergy to penicillin |
| HIV.D.DE566 | Tenofovir disoproxil fumarate (TDF) | Allergy to pre-exposure prophylaxis (PrEP) tenofovir disoproxil fumarate (TDF) |
| HIV.D.DE567 | Other allergies | Client has other allergies not listed here |
Generated Narrative: ValueSet HIV.D.DE569
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE570 | Copper-bearing intrauterine device (Cu-IUD) | A copper-bearing intrauterine device is being used as a family planning method |
| HIV.D.DE571 | Levonorgestrel intrauterine device (LNG-IUD) | A levonorgestrel intrauterine device (hormone-releasing intrauterine contraceptive device) is being used as a family planning method |
| HIV.D.DE572 | Etonogestrel (ETG) one-rod implant | An etonogestrel one-rod implant is being used |
| HIV.D.DE573 | Levonorgestrel (LNG) two-rod implant | A levonorgestrel two-rod implant is being used as a family planning method |
| HIV.D.DE574 | DMPA-IM | Injectable depot medroxyprogesterone acetate (DMPA), administered intramuscularly, is being used as a family planning method |
| HIV.D.DE575 | DMPA-SC | Injectable depot medroxyprogesterone acetate (DMPA), administered subcutaneously is being used |
| HIV.D.DE576 | NET-EN norethisterone enanthate | Injectable norethisterone enanthate (NET-EN) is being used as a family planning method |
| HIV.D.DE577 | Progestogen-only pills (POP) | Progestogen-only pills (POP) are being used as a family planning method |
| HIV.D.DE578 | Combined oral contraceptives (COCs) | Combined oral contraceptives (COCs) pills are being used as a family planning method |
| HIV.D.DE579 | Combined contraceptive patch | Transdermal combined contraceptive patch is being used as a family planning method |
| HIV.D.DE580 | Combined contraceptive vaginal ring (CVR) | Combined contraceptive vaginal ring (CVR) is being used as a family planning method |
| HIV.D.DE581 | Progesterone-releasing vaginal ring (PVR) | Progesterone-releasing vaginal ring (PVR) is being used as a family planning method |
| HIV.D.DE582 | Lactational amenorrhea method (LAM) | Lactational amenorrhea method (LAM) is being used as a family planning method |
| HIV.D.DE583 | Emergency contraceptive pills (ECPs) | Client uses emergency contraceptive pills (ECPs) |
| HIV.D.DE584 | Fertility awareness-based methods (FAB) | Client uses fertility awareness-based methods (FAB) |
| HIV.D.DE585 | Male condoms | Male condoms are being used as a family planning method |
| HIV.D.DE586 | Female condoms | Female condoms are being used as a family planning method |
| HIV.D.DE587 | Withdrawal | Client uses withdrawal method |
| HIV.D.DE588 | Female relying on male method | The female client is relying on her male partner for contraceptive methods (e.g. male condoms, male sterilization, withdrawal) |
| HIV.D.DE589 | Male relying on female method | The male client is relying on his female partner for contraceptive methods |
| HIV.D.DE590 | Male sterilization | Male surgical sterilization (a vasectomy) is the family planning method used |
| HIV.D.DE591 | Female sterilization | Female surgical sterilization procedure is the family planning method used |
| HIV.D.DE592 | No method | Client is not using any family planning methods |
Generated Narrative: ValueSet HIV.D.DE593
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE594 | Currently taking | The medication is still being taken (active) |
| HIV.D.DE595 | Completed | The medication is no longer being taken |
| HIV.D.DE596 | Entered in error | Entered in error |
| HIV.D.DE597 | Intended | The medication may be taken at some time in the future |
| HIV.D.DE598 | Stopped | Actions implied by the statement have been permanently halted, before all of them occurred. This should not be used if the statement was entered in error. |
| HIV.D.DE599 | On hold | The client has temporarily stopped taking the medication, but is expected to continue again later. May also be called 'suspended'. |
| HIV.D.DE600 | Unknown | The state of the medication use is not currently known |
| HIV.D.DE601 | Did not take | The client did not take the medication |
Generated Narrative: ValueSet HIV.D.DE603
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE604
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE606
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE610
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE611 | Hepatitis A | The client is receiving vaccination to prevent against hepatitis A |
| HIV.D.DE612 | Hepatitis B | The client is receiving vaccination to prevent against hepatitis B |
| HIV.D.DE613 | Tetanus | The client is receiving vaccination to prevent against tetanus |
| HIV.D.DE614 | COVID-19 | The client is receiving vaccination to prevent against COVID-19 due to SARS-CoV-2 |
| HIV.D.DE615 | Influenza due to influenza B virus | The client is receiving vaccination to prevent against influenza due to influenza B virus |
| HIV.D.DE616 | Tuberculosis | The client is receiving vaccination to prevent against tuberculosis (e.g. BCG vaccine) |
| HIV.D.DE617 | Acute poliomyelitis | The client is receiving vaccination to prevent against acute poliomyelitis (polio) |
| HIV.D.DE618 | Measles | The client is receiving vaccination to prevent against measles |
| HIV.D.DE619 | Diptheria | The client is receiving vaccination to prevent against diptheria |
| HIV.D.DE620 | Rabies | The client is receiving vaccination to prevent against rabies |
| HIV.D.DE621 | Cholera | The client is receiving vaccination to prevent against cholera |
| HIV.D.DE622 | Mumps | The client is receiving vaccination to prevent against mumps |
| HIV.D.DE623 | HPV infection | The client is receiving vaccination to prevent against human papilloma virus (HPV) infection |
| HIV.D.DE624 | Haemophilus influenzae type B | The client is receiving vaccination to prevent against Haemophilus influenzae type B (Hib) |
| HIV.D.DE625 | Varicella | The client is receiving vaccination to prevent against varicella |
| HIV.D.DE626 | Dengue | The client is receiving vaccination to prevent against dengue |
| HIV.D.DE627 | Yellow fever | The client is receiving vaccination to prevent against yellow fever |
| HIV.D.DE628 | Japanese Encephalitis | The client is receiving vaccination to prevent against Japanese encephalitis |
| HIV.D.DE629 | Rubella | The client is receiving vaccination to prevent against rubella |
| HIV.D.DE630 | Pertussis | The client is receiving vaccination to prevent against pertussis |
| HIV.D.DE631 | Enteritis due to rotavirus | The client is receiving vaccination to prevent against enteritis due to rotavirus |
| HIV.D.DE632 | Pneumococcal disease | The client is receiving vaccination to prevent against pneumococcal disease |
| HIV.D.DE633 | Meningococcal disease | The client is receiving vaccination to prevent against meningococcal disease |
| HIV.D.DE634 | Tick-borne encephalitis | The client is receiving vaccination to prevent against tick-borne encephalitis |
| HIV.D.DE635 | Typhoid | The client is receiving vaccination to prevent against typhoid |
Generated Narrative: ValueSet HIV.D.DE63
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE636
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE637 | Stock-out | Stock-out of vaccine |
| HIV.D.DE638 | Client is ill | Client is ill |
| HIV.D.DE639 | Client refused | Client refused vaccine |
| HIV.D.DE640 | Allergy to vaccine | Client has an allergy to the vaccine |
| HIV.D.DE641 | Other reason immunization not provided | Other reason why the immunization was not provided |
Generated Narrative: ValueSet HIV.D.DE64
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE646
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE647 | Client was referred | Client was referred to another provider/facility |
| HIV.D.DE648 | Stock out | There was a stock out of malaria prophylaxis |
| HIV.D.DE649 | Expired | Malaria prophylaxis in stock was expired |
| HIV.D.DE650 | Other reason not provided | Other reason why the prophylaxis was not provided |
Generated Narrative: ValueSet HIV.D.DE65
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE66 | No chronic or past health conditions | Client does not have chronic diseases or any past health conditions |
| HIV.D.DE67 | Don't know | Client does not know whether she has any chronic diseases or past health conditions |
| HIV.D.DE68 | Diabetes other or unspecified | Client has diabetes of other or unspecified type |
| HIV.D.DE69 | Diabetes pre-existing type 1 | Client has pre-existing type 1 diabetes mellitus |
| HIV.D.DE70 | Diabetes pre-existing type 2 | Client has pre-existing type 2 diabetes mellitus |
| HIV.D.DE71 | Hypertension | High blood pressure |
| HIV.D.DE72 | Other | Other health conditions not included in the list |
Generated Narrative: ValueSet HIV.D.DE658
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE659 | HPV-DNA | Screened for cervical cancer using HPV-DNA test |
| HIV.D.DE660 | VIA | Screened for cervical cancer using visual inspection with acetic acid (VIA) |
| HIV.D.DE661 | Cervical cytology | Screened for cervical cancer using cervical cytology |
| HIV.D.DE662 | Other | Screened for cervical cancer using other method |
Generated Narrative: ValueSet HIV.D.DE664
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE665 | Negative | HPV-DNA screening test was negative |
| HIV.D.DE666 | Positive | HPV-DNA screening test was positive |
| HIV.D.DE667 | Invalid | HPV-DNA screening test was invalid |
Generated Narrative: ValueSet HIV.D.DE668
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE669 | Negative | Screening result is negative |
| HIV.D.DE670 | Positive | Screening result is positive |
| HIV.D.DE671 | Suspected cancer | Screening result is suspected cancer |
| HIV.D.DE672 | Invalid | Screening result is invalid |
Generated Narrative: ValueSet HIV.D.DE673
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE674 | NILM | Negative for Intraepithelial Lesion Malignancy (NILM) |
| HIV.D.DE675 | ASCUS | Atypical squamous cells of undetermined significance (ASCUS) |
| HIV.D.DE676 | LSIL | Low grade squamous intraepithelial lesion (LSIL) |
| HIV.D.DE677 | HSIL | High grade squamous intraepithelial lesion (HSIL) |
| HIV.D.DE678 | Cancer | Result was positive for cancer |
| HIV.D.DE679 | Invalid/inadequate | Screening result was invalid or inadequate |
Generated Narrative: ValueSet HIV.D.DE681
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE682 | VIA | Triage test for cervical cancer using visual inspection with acetic acid (VIA) |
| HIV.D.DE683 | Colposcopy | Triage test for cervical cancer using colposcopy |
| HIV.D.DE684 | Cervical cytology | Triage test for cervical cancer using cervical cytology |
| HIV.D.DE685 | HPV16/18 | Triage test for cervical cancer using test for HPV16/18 |
| HIV.D.DE686 | Other | Triage test for cervical cancer using another test |
Generated Narrative: ValueSet HIV.D.DE688
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE689 | Positive | Test is positive for HPV16/18 |
| HIV.D.DE690 | Negative | Test is negative for HPV16/18 |
Generated Narrative: ValueSet HIV.D.DE691
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE692 | Normal colposcopic findings | Colposcopy has normal colposcopic findings |
| HIV.D.DE693 | Abnormal colposcopic findings | Colposcopy has abnormal colposcopic findings |
| HIV.D.DE694 | Suspicious for invasive cervical cancer | Colposcopy is suspicious for invasive cervical cancer |
| HIV.D.DE695 | Miscellaneous findings | Colposcopy has miscellaneous findings |
| HIV.D.DE696 | Inadequate | Colposcopy exam is inadequate |
Generated Narrative: ValueSet HIV.D.DE697
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE698 | Normal | Result of cervical cancer histopathology was normal |
| HIV.D.DE699 | LSIL (inclusive of LSIL-CIN1) | Result of cervical cancer histopathology was low-grade squamous intraepithelial lesion (LSIL) |
| HIV.D.DE700 | HSIL (inclusive of HSIL-CIN2 or HSIL-CIN3) | Result of cervical cancer histopathology was high-grade squamous intraepithelial lesion (HSIL) |
| HIV.D.DE701 | Invasive cervical cancer | Result of cervical cancer histopathology is invasive cervical cancer |
Generated Narrative: ValueSet HIV.D.DE706
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE707 | Positive for cervical precancer lesions | Screening outcome for cervical precancer lesions is positive |
| HIV.D.DE708 | Negative for cervical precancer lesions | Screening outcome for cervical precancer lesions is negative |
Generated Narrative: ValueSet HIV.D.DE709
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE710 | Cervical precancer lesions | Client is diagnosed with cervical precancer lesions |
| HIV.D.DE711 | Invasive cervical cancer | Client is diagnosed with invasive cervical cancer disease |
Generated Narrative: ValueSet HIV.D.DE712
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE713 | Stage 0 | Stage 0 cervical cancer at diagnosis of cervical cancer |
| HIV.D.DE714 | Stage I | Stage I cervical cancer at diagnosis of cervical cancer |
| HIV.D.DE715 | Stage II | Stage II cervical cancer at diagnosis of cervical cancer |
| HIV.D.DE716 | Stage III | Stage III cervical cancer at diagnosis of cervical cancer |
| HIV.D.DE717 | Stage IV | Stage IV cervical cancer at diagnosis of cervical cancer |
Generated Narrative: ValueSet HIV.D.DE719
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE720 | Cryotherapy | Treatment for cervical precancer lesions is cryotherapy |
| HIV.D.DE721 | Thermal ablation | Treatment for cervical precancer lesions is Thermal ablation |
| HIV.D.DE722 | Laser ablation | Treatment for cervical precancer lesions is Laser ablation |
| HIV.D.DE723 | CKC | Treatment for cervical precancer lesions is Cold knife conization (CKC) |
| HIV.D.DE724 | Laser cone biopsy | Treatment for cervical precancer lesions is Laser cone biopsy |
| HIV.D.DE725 | LLETZ/LEEP | Treatment for cervical precancer lesions is large loop excision of the transformation zone (LLETZ)/loop electrosurgical excision procedure (LEEP) |
| HIV.D.DE726 | Other | Treatment for cervical precancer lesions is not listed |
Generated Narrative: ValueSet HIV.D.DE731
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE732 | Conization | Invasive cervical cancer treatment method is a conization |
| HIV.D.DE733 | Trachelectomy | Invasive cervical cancer treatment method is a trachelectomy |
| HIV.D.DE734 | Hysterectomy | Invasive cervical cancer treatment method is a hysterectomy |
| HIV.D.DE735 | Management of invasive cervical cancer | Invasive cervical cancer treatment method is management of invasive cervical cancer |
| HIV.D.DE736 | Radiotherapy | Invasive cervical cancer treatment method is a radiotherapy |
| HIV.D.DE737 | Chemotherapy | Invasive cervical cancer treatment method is a chemotherapy |
| HIV.D.DE738 | Chemoradiation | Invasive cervical cancer treatment method is a chemoradiation |
| HIV.D.DE739 | Other | Invasive cervical cancer treatment method is a not in list |
Generated Narrative: ValueSet HIV.D.DE74
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE746
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE747 | Provider-initiated tested in a clinic or emergency facility | The client tested though provider-initiated HIV testing & counselling, which could be at an emergency facility |
| HIV.D.DE748 | Antenatal care clinic | The client tested at an antenatal care clinic, including labour and delivery |
| HIV.D.DE749 | Voluntary counselling and testing (within a health facility setting) | The client tested through voluntary counselling and testing (within a health facility setting) |
| HIV.D.DE750 | Family planning clinic | The client tested at a family planning clinic |
| HIV.D.DE751 | Other facility-level testing | The client tested at another type of facility |
| HIV.D.DE752 | Tuberculosis (TB) clinic | The client tested at a TB clinic |
Generated Narrative: ValueSet HIV.D.DE75
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE753
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE754 | Assessment and provision of vaccinations | Assessment and provision of vaccinations, such as for people from Key population member type, pregnant women and infants; and, where appropriate, tetanus vaccination for adolescent boys and men receiving VMMC |
| HIV.D.DE755 | Hepatitis B (HBV) and hepatitis C virus (HCV) testing and treatment | Offer or refer for HBV and/or HCV testing and treatment |
| HIV.D.DE756 | Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia | Offer or refer for co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia |
| HIV.D.DE757 | Intensified TB case finding and linkage to TB treatment | Offer or refer for intensified TB case finding and linkage to TB treatment |
| HIV.D.DE758 | Provision of isoniazid preventive therapy if person does not have TB | Offer or refer for provision of isoniazid preventive therapy if person does not have TB |
| HIV.D.DE759 | Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology | Offer or refer for malaria prevention (such as bed nets and prophylaxis), depending on epidemiology |
Generated Narrative: ValueSet HIV.D.DE764
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE765 | Fast track ART refill | Client is enrolled in fast track ART refill (DSD ART model) |
| HIV.D.DE766 | Facility adherence club | Client is enrolled in facility adherence club (DSD ART model) |
| HIV.D.DE767 | Community ART distribution point | Client is enrolled in community ART distribution point (DSD ART model) |
| HIV.D.DE768 | CHW/peer educator community ART group | Client is enrolled in community health worker/peer educator community ART group (DSD ART model) |
| HIV.D.DE769 | Patient/client community ART group | Client is enrolled in patient/client community ART group (DSD ART model) |
| HIV.D.DE770 | Other DSD ART model | Client is enrolled in another DSD ART model |
Generated Narrative: ValueSet HIV.D.DE77
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE778
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE779 | Urethral discharge syndrome | Client diagnosed with urethral discharge syndrome |
| HIV.D.DE780 | Vaginal discharge syndrome | Client diagnosed with vaginal discharge syndrome |
| HIV.D.DE781 | Lower Abdominal pain | Client diagnosed with lower abdominal pain |
| HIV.D.DE782 | Genital ulcer disease syndrome | Client diagnosed with genital ulcer disease syndrome |
| HIV.D.DE783 | Anorectal discharge | Client diagnosed with anorectal discharge |
| HIV.D.DE784 | Sent for testing | Specimen sent for testing |
| HIV.D.DE785 | Other | Other syndrome/STI diagnosed |
Generated Narrative: ValueSet HIV.D.DE78
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE789
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE790 | Neisseria gonorrhoeae | Client tested for Neisseria gonorrhoeae |
| HIV.D.DE791 | Chlamydia trachomatis | Client tested for Chlamydia trachomatis |
| HIV.D.DE792 | Trichomonas vaginalis | Client tested for Trichomonas vaginalis |
| HIV.D.DE793 | Syphilis (Treponema pallidum) | Client tested for Syphilis (treponema pallidum) |
| HIV.D.DE794 | Herpes simplex virus (HSV1, HSV2) | Client tested for herpes simplex virus (HSV1, HSV2) |
| HIV.D.DE795 | Mycoplasma genitalium | Client tested for Mycoplasma genitalium |
| HIV.D.DE796 | Mpox | Client tested for Mpox |
| HIV.D.DE797 | Hepatitis B | Client tested for Hepatitis B |
| HIV.D.DE798 | Hepatitis C | Client tested for Hepatitis C |
| HIV.D.DE799 | Other | Client tested for other STI |
Generated Narrative: ValueSet HIV.D.DE79
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE80
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE802
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE803 | Positive | Test result is positive for syphilis |
| HIV.D.DE804 | Negative | Test result is negative for syphilis |
| HIV.D.DE805 | Inconclusive | Test result is inconclusive |
Generated Narrative: ValueSet HIV.D.DE808
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE809 | Positive | Test result is positive for Neisseria gonorrhoeae |
| HIV.D.DE810 | Negative | Test result is negative for Neisseria gonorrhoeae |
| HIV.D.DE811 | Inconclusive | Test result is inconclusive |
Generated Narrative: ValueSet HIV.D.DE81
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE813
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE814 | Blood | Blood specimen to be collected |
| HIV.D.DE815 | Urine | Urine specimen to be collected |
| HIV.D.DE816 | Cervical or vaginal swab | Cervical or vaginal swab to be collected |
| HIV.D.DE817 | Urethral or penile swab | Urethral or penile swab to be collected |
| HIV.D.DE818 | Rectal swab | Rectal swab to be collected |
| HIV.D.DE819 | Other | Other specimen type to be collected |
Generated Narrative: ValueSet HIV.D.DE82
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.D.DE821
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE822 | Treponemal | Treponemal test used |
| HIV.D.DE823 | Non-treponemal | Non-treponemal test used |
| HIV.D.DE824 | POC Test | Point-of-care (POC) test used |
| HIV.D.DE825 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.D.DE826 | Other | Other test used |
Generated Narrative: ValueSet HIV.D.DE828
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE829 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.D.DE830 | POC Test | Point-of-care (POC) test used |
| HIV.D.DE831 | Culture | Culture test used |
| HIV.D.DE832 | Microscopy | Microscopy test used |
| HIV.D.DE833 | Other | Other type of test used |
Generated Narrative: ValueSet HIV.D.DE83
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE84 | First-line ART regimen for adults and adolescents | First-line ART regimen for adults and adolescents living with HIV |
| HIV.D.DE85 | First-line ART regimen for children | First-line ART regimen for children living with HIV |
| HIV.D.DE86 | First-line ART regimen for neonates | First-line ART regimen for neonates living with HIV |
| HIV.D.DE87 | Second-line ART regimen for adults and adolescents | Second-line ART regimen for adults and adolescents living with HIV |
| HIV.D.DE88 | Second-line ART regimen for children | Second-line ART regimen for children living with HIV |
| HIV.D.DE89 | Third-line ART regimen | Third-line ART regimen for people living with HIV (Not defined by WHO. National programmes should develop policies for third-line ART) |
Generated Narrative: ValueSet HIV.D.DE836
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE837 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.D.DE838 | POC Test | Point-of-care (POC) test used |
| HIV.D.DE839 | Culture | Culture test used |
| HIV.D.DE840 | ELISA | ELISA test used |
| HIV.D.DE841 | Microscopy | Microscopy test used |
| HIV.D.DE842 | Other | Other type of test used |
Generated Narrative: ValueSet HIV.D.DE845
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE846 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.D.DE847 | POC Test | Point-of-care (POC) test used |
| HIV.D.DE848 | Culture | Culture test used |
| HIV.D.DE849 | Microscopy | Microscopy test used |
| HIV.D.DE850 | Other | Other type of test used |
Generated Narrative: ValueSet HIV.D.DE853
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE854 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.D.DE855 | Antibody test | Antibody test used |
| HIV.D.DE856 | Other | Other type of test used |
Generated Narrative: ValueSet HIV.D.DE858
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE859 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.D.DE860 | Microscopy | Microscopy test used |
| HIV.D.DE861 | Other | Other type of test used |
Generated Narrative: ValueSet HIV.D.DE864
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE865 | Positive | Test result is positive |
| HIV.D.DE866 | Negative | Test result is negative |
| HIV.D.DE867 | Inconclusive | Test result is inconclusive |
Generated Narrative: ValueSet HIV.D.DE869
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE870 | Treponemal | Treponemal test used |
| HIV.D.DE871 | Non-treponemal | Non-treponemal test used |
| HIV.D.DE872 | POC Test | Point-of-care (POC) test used |
| HIV.D.DE873 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.D.DE874 | Other | Other test used |
Generated Narrative: ValueSet HIV.D.DE877
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE878 | Positive | Test result is positive |
| HIV.D.DE879 | Negative | Test result is negative |
| HIV.D.DE880 | Inconclusive | Test result is inconclusive |
Generated Narrative: ValueSet HIV.D.DE893
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE894 | F0-4, fibrosis staging | Fibrosis staging of liver disease |
| HIV.D.DE895 | F4 or cirrhosis, presence of cirrhosis | Presence of cirrhosis |
Generated Narrative: ValueSet HIV.D.DE897
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE898 | Working, able to perform usual work inside and outside the home | Client is able to perform usual work inside and outside the home (working) |
| HIV.D.DE899 | Ambulatory, able to perform activity of daily living (ADL), not able to work | Client is able to perform activity of daily living (ADL), not able to work (ambulatory) |
| HIV.D.DE900 | Bedridden not able to perform ADL | Client is dedridden not able to perform ADL |
Generated Narrative: ValueSet HIV.D.DE90
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE91 | ABC + 3TC + ATV/r | Regimen containing abacavir, lamivudine, and atazanavir/ritonavir |
| HIV.D.DE92 | ABC + 3TC + DTG | Regimen containing abacavir, lamivudine, and dolutegravir |
| HIV.D.DE93 | ABC + 3TC + EFV | Regimen containing abacavir, lamivudine, and efavarinez |
| HIV.D.DE94 | ABC + 3TC + LPV/r | Regimen containing abacavir, lamivudine, and lopinavir/ritonavir |
| HIV.D.DE95 | ABC + 3TC + NVP | Regimen containing abacavir, lamivudine, and nevirapine |
| HIV.D.DE96 | ABC + 3TC + RAL | Regimen containing abacavir, lamivudine, and raltegravir |
| HIV.D.DE97 | AZT + 3TC + ATV/r | Regimen containing zidovudine, lamivudine, and atazanavir/ritonavir |
| HIV.D.DE98 | AZT + 3TC + DRV/r | Regimen containing zidovudine, lamivudine, and darunavir/ritonavir |
| HIV.D.DE99 | AZT + 3TC + DTG | Regimen containing zidovudine, lamivudine, and dolutegravir |
| HIV.D.DE100 | AZT + 3TC + EFV | Regimen containing zidovudine, lamivudine, and efavirenz |
| HIV.D.DE101 | AZT + 3TC + EFV 600 mg | Regimen containing zidovudine, lamivudine, and efavirenz 600 mg |
| HIV.D.DE102 | AZT + 3TC + LPV/r | Regimen containing zidovudine, lamivudine, and lopinavir/ritonavir |
| HIV.D.DE103 | AZT + 3TC + NVP | Regimen containing zidovudine, lamivudine, and nevirapine |
| HIV.D.DE104 | AZT + 3TC + RAL | Regimen containing zidovudine, lamivudine, and raltegravir |
| HIV.D.DE105 | TAF + 3TC + DTG | Regimen containing tenofovir alafenamide, lamivudine, and dolutegravir |
| HIV.D.DE106 | TAF + FTC + DTG | Regimen containing tenofovir alafenamide, emtricitabine, and dolutegravir |
| HIV.D.DE107 | TDF + 3TC + ATV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and atazanavir/ritonavir |
| HIV.D.DE108 | TDF + 3TC + DRV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and darunavir/ritonavir |
| HIV.D.DE109 | TDF + 3TC + DTG | Regimen containing tenofovir disoproxil fumarate, lamivudine, and dolutegravir |
| HIV.D.DE110 | TDF + 3TC + EFV | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz |
| HIV.D.DE111 | TDF + 3TC + EFV 400 mg | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (400 mg) |
| HIV.D.DE112 | TDF + 3TC + EFV 600 mg | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (600 mg) |
| HIV.D.DE113 | TDF + 3TC + LPV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and lopinavir/ritonavir |
| HIV.D.DE114 | TDF + 3TC + NVP | Regimen containing tenofovir disoproxil fumarate, lamivudine, and nevirapine |
| HIV.D.DE115 | TDF + 3TC + PI/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and a boosted protease inhibitor |
| HIV.D.DE116 | TDF + 3TC + RAL | Regimen containing tenofovir disoproxil fumarate, lamivudine, and raltegravir |
| HIV.D.DE117 | TDF + FTC + ATV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and atazanavir/ritonavir |
| HIV.D.DE118 | TDF + FTC + DRV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and darunavir/ritonavir |
| HIV.D.DE119 | TDF + FTC + DTG | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and dolutegravir |
| HIV.D.DE120 | TDF + FTC + EFV | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz |
| HIV.D.DE121 | TDF + FTC + EFV 600 mg | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz (600 mg) |
| HIV.D.DE122 | TDF + FTC + LPV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and lopinavir/ritonavir |
| HIV.D.DE123 | TDF + FTC + NVP | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and nevirapine |
| HIV.D.DE124 | TDF + FTC + PI/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and a boosted protease inhibitor |
| HIV.D.DE125 | TDF + FTC + RAL | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and raltegravir |
| HIV.D.DE126 | Other | Other regimen based upon WHO recommendations |
Generated Narrative: ValueSet HIV.D.DE903
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE904 | Rifampicin | Rifampicin currently being taken by, or considered for, client |
| HIV.D.DE905 | Halofantrine | Halofantrine currently being taken by, or considered for, client |
| HIV.D.DE906 | Lovastatin | Lovastatin currently being taken by, or considered for, client |
| HIV.D.DE907 | Simvastatin | Simvastatin currently being taken by, or considered for, client |
| HIV.D.DE908 | Hormonal contraception | Hormonal contraception currently being taken by, or considered for, client |
| HIV.D.DE909 | Metformin | Metformin currently being taken by, or considered for, client |
| HIV.D.DE910 | Astemizole | Astemizole currently being taken by, or considered for, client |
| HIV.D.DE911 | Terfenadine | Terfenadine currently being taken by, or considered for, client |
| HIV.D.DE912 | TDF | TDF currently being taken by, or considered for, client |
| HIV.D.DE913 | Simeprevir | Simeprevir currently being taken by, or considered for, client |
| HIV.D.DE914 | Ombitasvir + paritaprevir/ritonavir + dasabuvir | Ombitasvir + paritaprevir/ritonavir + dasabuvir currently being taken by, or considered for, client |
| HIV.D.DE915 | Methadone | Methadone currently being taken by, or considered for, client |
| HIV.D.DE916 | Buprenorphine | Buprenorphine currently being taken by, or considered for, client |
| HIV.D.DE917 | Dofetilide | Dofetilide currently being taken by, or considered for, client |
| HIV.D.DE918 | Carbamazepine | Carbamazepine currently being taken by, or considered for, client |
| HIV.D.DE919 | Phenobarbital | Phenobarbital currently being taken by, or considered for, client |
| HIV.D.DE920 | Phenytoin | Phenytoin currently being taken by, or considered for, client |
| HIV.D.DE921 | Polyvalent cation products containing Mg, Al, Fe, Ca and Zn | Polyvalent cation products containing Mg, Al, Fe, Ca and Zn currently being taken by, or considered for, client |
| HIV.D.DE922 | Amodiaquine | Amodiaquine currently being taken by, or considered for, client |
| HIV.D.DE923 | Cisapride | Cisapride currently being taken by, or considered for, client |
| HIV.D.DE924 | Ergotamine | Ergotamine currently being taken by, or considered for, client |
| HIV.D.DE925 | Dihydroergotamine | Dihydroergotamine currently being taken by, or considered for, client |
| HIV.D.DE926 | Midazolam | Midazolam currently being taken by, or considered for, client |
| HIV.D.DE927 | Triazolam | Triazolam currently being taken by, or considered for, client |
| HIV.D.DE928 | Estrogen-based hormonal contraception | Estrogen-based hormonal contraception currently being taken by, or considered for, client |
| HIV.D.DE929 | Ribavirin | Ribavirin currently being taken by, or considered for, client |
| HIV.D.DE930 | Peginterferon alfa-2a | Peginterferon alfa-2a currently being taken by, or considered for, client |
| HIV.D.DE931 | Other | Other medication currently being taken by, or considered for, client |
Generated Narrative: ValueSet HIV.D.DE934
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE935 | Pulmonary TB | Client's symptoms include pulmonary TB |
| HIV.D.DE936 | Lymph node TB | Client's symptoms include lymph node TB |
| HIV.D.DE937 | Extrapulmonary TB | Client's symptoms include extrapulmonary tuberculosis (TB) |
Generated Narrative: ValueSet HIV.D.DE939
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE940 | Diagnosed TB | Client is diagnosed with TB disease |
| HIV.D.DE941 | TB excluded | Client is not diagnosed with TB |
Generated Narrative: ValueSet HIV.D.DE942
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE943 | Bacteriologically confirmed | A person from whom a biological specimen is positive by smear microscopy, culture or a WHO-recommended rapid diagnostic |
| HIV.D.DE944 | Clinically diagnosed | A person who does not fulfil the criteria for bacteriological confirmation but has been diagnosed with TB disease by a medical practitioner who has decided to give the person a full course of TB treatment |
Generated Narrative: ValueSet HIV.D.DE947
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE948 | New | A person with TB disease who has never been treated for TB before or has only previously ever taken TB drugs for less than 1 month |
| HIV.D.DE949 | Recurrent | A person with TB disease who was previously treated for TB, was declared cured or treatment completed at the end of their most recent course of TB treatment and is now diagnosed with a new episode of TB. |
| HIV.D.DE950 | Re-registered | A person with TB disease who had been notified previously as a TB case, but was not declared cured or treatment completed, and is now being registered for a new course of TB treatment. |
| HIV.D.DE951 | Unknown | A person with TB disease who has undocumented history of TB treatment |
Generated Narrative: ValueSet HIV.D.DE956
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE957 | Screening with cough | Client screened for TB based on cough symptom |
| HIV.D.DE958 | Screening with any TB symptom | Client screened for TB based on any TB symptom |
| HIV.D.DE959 | W4SS single screening algorithm | Client screened for TB based on the WHO-recommended four-symptom screen |
| HIV.D.DE960 | CRP single screening algorithm | Client screened for TB based on C-reactive protein (CRP) testing |
| HIV.D.DE961 | CXR single screening algorithm | Client screened for TB with a chest radiography (CXR) |
| HIV.D.DE962 | Parallel screening algorithm with W4SS and CRP | Client screened for TB using parallel screening with WHO-recommended four-symptom screen and C-reactive protein (CRP) testing |
| HIV.D.DE963 | Sequential positive screening algorithm with W4SS and CRP | Client screened for TB using sequential positive screening with WHO-recommended four-symptom screen and C-reactive protein (CRP) testing. |
| HIV.D.DE964 | Sequential negative screening algorithm with W4SS and CRP | Client screened for TB using sequential negative screening with WHO-recommended four-symptom screen and C-reactive protein (CRP) testing |
| HIV.D.DE965 | Parallel screening algorithm with W4SS and CXR | Client screened for TB using the parallel screening algorithm with W4SS and CXR |
| HIV.D.DE966 | Sequential positive screening algorithm with W4SS and CXR | Client screened for TB using sequential positive screening with WHO-recommended four-symptom screen and chest radiography |
| HIV.D.DE967 | Sequential negative screening algorithm with W4SS and CXR | Client screened for TB using sequential negative screening with WHO-recommended four-symptom screen and chest radiography |
| HIV.D.DE968 | Screening with mWRD | Client screened for TB with a molecular WHO-recommended rapid diagnostic test (mWRD), such as an Xpert MTB/RIF test to detect Mycobacterium tuberculosis (MTB) |
| HIV.D.DE969 | Clinical assessment | Client screened for with a clinical evaluation for tuberculosis (TB) based on national guidelines. Clinical assessment may be used as an eligibility evaluation for testing with LF-LAM or for empiric TB treatment. |
| HIV.D.DE970 | Other TB screening algorithm | Client screened for tuberculosis (TB) with a different screening method not listed |
Generated Narrative: ValueSet HIV.D.DE973
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE974 | Current cough | Client has a cough regardless of duration |
| HIV.D.DE975 | Prolonged cough (>=2w) | Client has a prolonged cough of 2 weeks or more |
| HIV.D.DE976 | Fever of 39 °C or greater | Client has a fever with a measured temperature of 102.2 °F/39 °C or greater |
| HIV.D.DE977 | Weight loss (reported) | Unexplained weight loss |
| HIV.D.DE978 | Night sweats | Client reports experiencing night sweats |
| HIV.D.DE979 | Poor weight gain | Client reports poor weight gain of child or infant or growth curve flattening or weight for age <-2 Z-scores. |
| HIV.D.DE980 | Reduced playfulness | Client reports reduced playfulness of child |
| HIV.D.DE981 | Chest pain | Client reports chest pain |
| HIV.D.DE982 | Haemoptysis | Client reports experiencing haemoptysis |
| HIV.D.DE983 | Lethargy | Client reports lethargy |
| HIV.D.DE984 | No symptoms of TB identified |
Generated Narrative: ValueSet HIV.D.DE986
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE987 | Screen positive for TB | Screening result was positive for tuberculosis (TB) |
| HIV.D.DE988 | Screen negative for TB | Screening result was negative for tuberculosis (TB) |
| HIV.D.DE989 | Inconclusive | Screening result was inconclusive for tuberculosis (TB) |
Generated Narrative: ValueSet HIV.D.DE992
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE993 | LF-LAM | Client tested for tuberculosis with a lateral flow urine lipoarabinomannan assay |
| HIV.D.DE994 | mWRD test for TB | Client tested with a WHO-recommended molecular diagnostic test to detect Mycobacterium tuberculosis (MTB) |
| HIV.D.DE995 | Microscopy - Sputum acid-fast bacilli (AFB) | Client tested for tuberculosis with a sputum acid-fast bacilli (AFB) |
| HIV.D.DE996 | TB Culture | Client tested for tuberculosis (TB) with a culture |
Generated Narrative: ValueSet HIV.E.DE104
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE105 | HIV-positive | Test result is HIV-positive |
| HIV.E.DE106 | HIV-negative | Test result is HIV-negative |
| HIV.E.DE107 | HIV-inconclusive | Test result is HIV-inconclusive |
Generated Narrative: ValueSet HIV.E.DE108
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE109 | Not exposed | Infant or child is not known to have been exposed to HIV |
| HIV.E.DE110 | HIV-exposed | Infant had known exposure to HIV |
| HIV.E.DE111 | Unknown HIV exposure | Don't know whether infant or child was exposed to HIV, such as if mother's HIV status is unknown |
Generated Narrative: ValueSet HIV.E.DE114
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE115 | Sex worker | Infant's mother is a sex worker |
| HIV.E.DE116 | People who inject drugs | Infant's mother is a person who injects drugs |
| HIV.E.DE117 | Trans and gender-diverse people | Infant's mother identifies as trans and gender-diverse |
| HIV.E.DE118 | People living in prisons and other closed setting | Infant's mother is in a prison or closed setting |
Generated Narrative: ValueSet HIV.E.DE127
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE128 | Exclusively breastfeeding | Specifies whether the infant is exclusively being breastfed by the mother |
| HIV.E.DE129 | Replacement feeding | Infant is not receiving any breast milk with a diet that provides all the nutrients needed until they can be fully fed on family foods |
| HIV.E.DE130 | Mixed feeding | Infant younger than 6 months of age is given other liquids and/or foods together with breast milk. This could be water, other types of milk or any type of solid food. |
Generated Narrative: ValueSet HIV.E.DE136
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE137 | Daily | Iron supplements prescribed for daily intake |
| HIV.E.DE138 | Weekly | Iron supplements prescribed for daily intake |
Generated Narrative: ValueSet HIV.E.DE141
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE142 | HIV-positive | Infant's mother is HIV-positive |
| HIV.E.DE143 | HIV-negative | Infant's mother is HIV-negative |
| HIV.E.DE144 | Unknown | Don't know HIV status - client does not know partner's HIV status |
Generated Narrative: ValueSet HIV.E.DE145
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE146 | HIV-positive | Infant's mother is HIV-positive |
| HIV.E.DE147 | HIV-negative | Infant's mother is HIV-negative |
| HIV.E.DE148 | Unknown | Don't know HIV status - client does not know partner's HIV status |
Generated Narrative: ValueSet HIV.E.DE149
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE150 | Positive | Test result is positive for syphilis |
| HIV.E.DE151 | Negative | Test result is negative for syphilis |
| HIV.E.DE152 | Inconclusive | Test result is inconclusive |
Generated Narrative: ValueSet HIV.E.DE155
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE156 | No condom use during sex with more than one partner in the past 6 months | Recent vaginal or anal sexual intercourse without a condom with more than one partner |
| HIV.E.DE157 | STI in the past 6 months | A recent history (in the last 6 months) of a sexually transmitted infection (STI) by laboratory testing or self-report of syndromic STI treatment |
| HIV.E.DE158 | A sexual partner in the past 6 months had one or more HIV risk factors | A recent sex partner of the client had HIV risk factors |
| HIV.E.DE159 | PrEP requested by client | Client is requesting PrEP, reflecting a decision-making process has already taken place and suggesting of substantial risk of HIV |
Generated Narrative: ValueSet HIV.E.DE168
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE169 | Rapid diagnostic test for HIV | Antibody test for HIV performed with a rapid diagnostic (RDT) |
| HIV.E.DE170 | Enzyme immunoassay for HIV | Antibody test for HIV performed with an enzyme immunoassay (EIA) |
| HIV.E.DE171 | Nucleic acid test for HIV | Virological test, which includes testing for early infant diagnosis |
| HIV.E.DE172 | Dual HIV/syphilis rapid diagnostic test | Antibody test for HIV and syphilis performed with a rapid diagnostic |
Generated Narrative: ValueSet HIV.E.DE17
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE18 | No past pregnancy complications | No known past pregnancy problems |
| HIV.E.DE19 | Does not know of any past pregnancy complications | Don't know if there were any problems during past pregnancies |
| HIV.E.DE20 | Pre-eclampsia | A condition specific to pregnancy, arising after the 20th week of gestation, characterized by hypertension and proteinuria. Oedema may also be present, but is no longer considered a cardinal sign because it is present to some extent in most pregnancies. If not controlled, pre-eclampsia will lead to eclampsia which is characterized by fits, followed by coma, and has a high mortality rate. |
| HIV.E.DE21 | Eclampsia | A condition peculiar to pregnancy or a newly delivered woman, characterized by fits followed coma. The woman usually has hypertension and proteinuria. The fits may occur in the antepartum, intrapartum or early postpartum periods. |
| HIV.E.DE22 | Alcohol use | Alcohol intake |
| HIV.E.DE23 | Baby died within 24 hours of birth | The woman's baby died within 24 hours of childbirth |
| HIV.E.DE24 | Prolonged labour | The woman's experienced prolonged labour |
| HIV.E.DE25 | Convulsions | Woman had convulsions during her past pregnancy |
| HIV.E.DE26 | Forceps | Woman required forceps delivery |
| HIV.E.DE27 | Gestational diabetes mellitus | Hyperglycaemia first detected at any time during pregnancy |
| HIV.E.DE28 | Heavy bleeding (during or after delivery) | Woman was bleeding heavily during or after giving birth during previous pregnancy/pregnancies |
| HIV.E.DE29 | Macrosomia | Fetus large for gestational age |
| HIV.E.DE30 | Perineal tear (3rd or 4th degree) | Woman experienced 3rd or 4th degree perineal tear |
| HIV.E.DE31 | Substance use | Illicit drug use (e.g. cannabis, amphetamines, prescription stimulants, opioids, opiates, ecstasy, cocaine) |
| HIV.E.DE32 | Tobacco use | Use of tobacco products, in any form |
| HIV.E.DE33 | Vacuum delivery | Woman required vacuum delivery |
| HIV.E.DE34 | Other past pregnancy problems | Woman experienced other past pregnancy problems not described above |
Generated Narrative: ValueSet HIV.E.DE173
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE174 | 12-month visit | HIV-exposed infant attending MCH services for a 12-month visit |
| HIV.E.DE175 | 24-month visit | HIV-exposed infants attending MCH services for a 24-month visit |
| HIV.E.DE176 | First visit after the end of breastfeeding | HIV-exposed infant attending MCH services for a first visit after the end of breastfeeding |
Generated Narrative: ValueSet HIV.E.DE180
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.E.DE183
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.E.DE186
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE187 | Positive | Positive HIV test result from the nucleic acid test |
| HIV.E.DE188 | Negative | Negative HIV test result from the nucleic acid test |
| HIV.E.DE189 | Indeterminate | Indeterminate HIV test result from the nucleic acid test |
Generated Narrative: ValueSet HIV.E.DE190
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE191 | Positive | Positive HIV test result from the nucleic acid test |
| HIV.E.DE192 | Negative | Negative HIV test result from the nucleic acid test |
| HIV.E.DE193 | Indeterminate | Indeterminate HIV test result from the nucleic acid test |
Generated Narrative: ValueSet HIV.E.DE194
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.E.DE200
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE201 | Reactive | The result of the HIV assay in the testing strategy was reactive |
| HIV.E.DE202 | Non-reactive | The result of the HIV assay in the testing strategy was non-reactive |
| HIV.E.DE203 | Invalid | The result of the HIV assay in the testing strategy was invalid |
Generated Narrative: ValueSet HIV.E.DE204
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE205 | Reactive | The result of the HIV assay in the testing strategy was reactive |
| HIV.E.DE206 | Non-reactive | The result of the HIV assay in the testing strategy was non-reactive |
| HIV.E.DE207 | Invalid | The result of the HIV assay in the testing strategy was invalid |
Generated Narrative: ValueSet HIV.E.DE208
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE209 | Reactive | The result of the HIV assay in the testing strategy was reactive |
| HIV.E.DE210 | Non-reactive | The result of the HIV assay in the testing strategy was non-reactive |
| HIV.E.DE211 | Invalid | The result of the HIV assay in the testing strategy was invalid |
Generated Narrative: ValueSet HIV.E.DE212
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE213 | Reactive | The result of the HIV assay in the testing strategy was reactive |
| HIV.E.DE214 | Non-reactive | The result of the HIV assay in the testing strategy was non-reactive |
| HIV.E.DE215 | Invalid | The result of the HIV assay in the testing strategy was invalid |
Generated Narrative: ValueSet HIV.E.DE216
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE217 | Reactive | The result of the first syphilis assay in the testing strategy was reactive |
| HIV.E.DE218 | Non-reactive | The result of the first syphilis assay in the testing strategy was non-reactive |
| HIV.E.DE219 | Invalid | The result of the HIV assay in the testing strategy was invalid |
Generated Narrative: ValueSet HIV.E.DE220
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE221 | Reactive | The result of the first syphilis assay repeated in the testing strategy was reactive |
| HIV.E.DE222 | Non-reactive | The result of the first syphilis assay repeated in the testing strategy was non-reactive |
| HIV.E.DE223 | Invalid | The result of the first syphilis assay repeated in the testing strategy was invalid |
Generated Narrative: ValueSet HIV.E.DE225
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE226 | HIV-positive | Infant is HIV-positive |
| HIV.E.DE227 | HIV-negative | Infant is HIV-negative |
| HIV.E.DE228 | Unknown | Infant has unknown HIV status |
Generated Narrative: ValueSet HIV.E.DE230
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE231 | HIV-positive | The infant is HIV-positive |
| HIV.E.DE232 | HIV-negative and no longer breastfeeding | The infant is HIV-negative and the mother has quit breastfeeding |
| HIV.E.DE233 | HIV status unknown | The final HIV status of the child is unknown because the infant died, was lost to follow-up or transferred out without ever having an HIV-positive diagnosis or is active in care but was not tested at 18 months |
Generated Narrative: ValueSet HIV.E.DE234
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE235 | Lost to follow-up | Twenty-eight days or more since last missed appointment |
| HIV.E.DE236 | Transferred out | The client transferred to another facility |
| HIV.E.DE237 | Death (documented) | People living with HIV previously on ART who are confirmed to have died from any cause |
| HIV.E.DE238 | Refused (stopped) treatment | Client was contacted and confirmed to have stopped ART |
Generated Narrative: ValueSet HIV.E.DE240
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.E.DE246
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE247 | A+ | Mother's blood type and blood Rh factor is A+ |
| HIV.E.DE248 | A- | Mother's blood type and blood Rh factor is A- |
| HIV.E.DE249 | B+ | Mother's blood type and blood Rh factor is B+ |
| HIV.E.DE250 | B- | Mother's blood type and blood Rh factor is B- |
| HIV.E.DE251 | O+ | Mother's blood type and blood Rh factor is O+ |
| HIV.E.DE252 | O- | Mother's blood type and blood Rh factor is O- |
| HIV.E.DE253 | AB+ | Mother's blood type and blood Rh factor is AB+ |
| HIV.E.DE254 | AB- | Mother's blood type and blood Rh factor is AB- |
Generated Narrative: ValueSet HIV.E.DE255
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE256 | Positive | Result of test for asymptomatic bacteriuria is positive |
| HIV.E.DE257 | Negative | Result of test for asymptomatic bacteriuria is negative |
| HIV.E.DE258 | Unknown | Result of test for asymptomatic bacteriuria is unknown |
Generated Narrative: ValueSet HIV.E.DE259
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE260 | 0 | Result of urine protein test of mother during ANC visit is '0' |
| HIV.E.DE261 | + | Result of urine protein test of mother during ANC visit is '+' |
| HIV.E.DE262 | ++ | Result of urine protein test of mother during ANC visit is '++' |
| HIV.E.DE263 | +++ | Result of urine protein test of mother during ANC visit is '+++' |
Generated Narrative: ValueSet HIV.E.DE264
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE265 | Chronic hypertension | Hypertension detected pre-pregnancy or before 20 weeks' gestation |
| HIV.E.DE266 | Essential | Hypertension without a known secondary cause (pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE267 | Secondary | Hypertension with a known secondary cause (e.g. renal disease; detected pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE268 | White-coat hypertension | sBP greater than or equal to 140 and/or dBP greater than or equal to 90 mmHg when measured in the office or clinic, and BP less than 135/85 mmHg using HBPM or ABPM readings (pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE269 | Masked hypertension | BP that is less than 140/90 mmHg at a clinic/office visit, but greater then or equal to 135/85 mmHg at other times outside the clinic/ office (pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE270 | Gestational hypertension | Hypertension arising de novo at greater than or equal to 20 weeks' gestation in the absence of proteinuria or other findings suggestive of pre-eclampsia |
| HIV.E.DE271 | Transient gestational hypertension | Hypertension arising at greater than or equal to 20 weeks' gestation in the clinic, which resolves with repeated BP readings |
| HIV.E.DE272 | Pre-eclampsia | Pre-eclampsia |
| HIV.E.DE273 | Superimposed on chronic hypertension | Among women with chronic hypertension, development of new proteinuria, another maternal organ dysfunction(s), or evidence of uteroplacental dysfunction. |
Generated Narrative: ValueSet HIV.E.DE41
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE42 | Already on ART at first antenatal care visit | The pregnant woman was already on antiretroviral therapy (ART) at first antenatal care visit |
| HIV.E.DE43 | Newly on ART during pregnancy | The pregnant woman started ART during her pregnancy |
| HIV.E.DE44 | Newly on ART during labour and delivery | The woman started ART during labour and delivery |
Generated Narrative: ValueSet HIV.E.DE47
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE48 | Live birth | Outcome of pregnancy was a live birth |
| HIV.E.DE49 | Early fetal loss/miscarriage | Outcome of pregnancy was early fetal loss/miscarriage |
| HIV.E.DE50 | Induced abortion | Outcome of pregnancy was induced abortion |
| HIV.E.DE51 | Stillbirth | Outcome of pregnancy was stillbirth |
Generated Narrative: ValueSet HIV.E.DE52
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE53 | Spontaneous vaginal delivery | Mode of delivery for current pregnancy spontaneous vaginal delivery (SVD) |
| HIV.E.DE54 | Assisted vaginal delivery | Mode of delivery for current pregnancy was assisted vaginal delivery |
| HIV.E.DE55 | Caesarian section (C/S, operative delivery) | Mode of delivery for current pregnancy was caesarian section (C/S; operative delivery) |
Generated Narrative: ValueSet HIV.E.DE6
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE7 | Last menstrual period (LMP) | Gestational age (GA) calculated from LMP |
| HIV.E.DE8 | Ultrasound | Woman's gestational age today calculated field using ultrasound GA and ultrasound date |
| HIV.E.DE9 | Symphysis fundal height (SFH) or abdominal palpation | If LMP is unknown and either ultrasound wasn't done or it wasn't done early enough, then show the option for health worker to enter GA in weeks based on Symphysis Fundal Height (SFH) or abdominal palpation. |
Generated Narrative: ValueSet HIV.E.DE62
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE63 | Not preterm | The birth was not preterm |
| HIV.E.DE64 | Preterm (<37 weeks gestation) | Gestational age at birth was <37 weeks |
| HIV.E.DE65 | Very preterm (<32 weeks gestation) | Gestational age at birth was <32 weeks |
Generated Narrative: ValueSet HIV.E.DE67
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE68 | Health facility | The woman delivered at a health facility |
| HIV.E.DE69 | Home | The woman delivered at home |
| HIV.E.DE70 | Other | The woman delivered at another location that is not at home or at a health facility |
Generated Narrative: ValueSet HIV.E.DE75
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.E.DE91
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE92 | Female | Client identifies as female |
| HIV.E.DE93 | Male | Client identifies as male |
| HIV.E.DE94 | Other | Client identifies in a non-binary way |
Generated Narrative: ValueSet HIV.G.DE13
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE14 | Liquid plasma specimen for viral load testing | Liquid plasma and using ethylenediaminetetraacetic acid (EDTA) or plasma preparation tubes for viral load test |
| HIV.G.DE15 | Dried blood spot specimen | Dried blood spot specimen (DBS) for viral load test |
| HIV.G.DE16 | Dried plasma spot from a plasma separation card | Dried plasma spot from a plasma separation card for viral load test |
Generated Narrative: ValueSet HIV.G.DE18
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE19 | Positive | HBsAg test result was positive |
| HIV.G.DE20 | Negative | HBsAg test result was negative |
| HIV.G.DE21 | Indeterminate | HBsAg test result was indeterminate |
Generated Narrative: ValueSet HIV.G.DE22
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE23 | Test delayed to next contact or referred | Test has been delayed to the next contact or client was referred to another provider/facility |
| HIV.G.DE24 | Stock-out or expired | Test out of stock or stock present but expired |
| HIV.G.DE25 | Machine or technician not available or machine not functioning | Test machine or technician is unavailable, or machine is not functioning |
| HIV.G.DE26 | Client declined / refused test | Client declined or refused test being undertaken |
| HIV.G.DE27 | Other | Other reason test not performed |
Generated Narrative: ValueSet HIV.G.DE29
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE30 | Hepatitis B positive | Client is positive for Hepatitis B |
| HIV.G.DE31 | Hepatitis B negative | Client is negative for Hepatitis B |
Generated Narrative: ValueSet HIV.G.DE35
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE36 | Test delayed to next contact or referred | Test has been delayed to the next contact or client was referred to another provider/facility |
| HIV.G.DE37 | Stock-out or expired | Test out of stock or stock present but expired |
| HIV.G.DE38 | Machine or technician not available or machine not functioning | Test machine or technician is unavailable, or machine is not functioning |
| HIV.G.DE39 | Client declined / refused test | Client declined or refused test being undertaken |
| HIV.G.DE40 | Other | Other reason test not performed |
Generated Narrative: ValueSet HIV.G.DE43
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE44 | Positive | HCV test result was positive |
| HIV.G.DE45 | Negative | HCV test result was negative |
| HIV.G.DE46 | Indeterminate | HCV test result was indeterminate |
Generated Narrative: ValueSet HIV.G.DE48
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE49 | Detected | HCV was detected |
| HIV.G.DE50 | Not detected | HCV was not detected |
Generated Narrative: ValueSet HIV.G.DE51
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE52 | Hepatitis C positive | Client is positive for hepatitis C |
| HIV.G.DE53 | Hepatitis C negative | Client is negative for hepatitis C |
Generated Narrative: ValueSet HIV.G.DE55
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE56 | Treponemal | Treponemal test used |
| HIV.G.DE57 | Non-treponemal | Non-treponemal test used |
| HIV.G.DE58 | POC Test | Point-of-care (POC) test used |
| HIV.G.DE59 | NAAT | Nucleic Acid Amplification Test (NAAT) used |
| HIV.G.DE60 | Other | Other test used |
Generated Narrative: ValueSet HIV.G.DE62
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE63 | Test delayed to next contact or referred | Test has been delayed to the next contact or client was referred to another provider/facility |
| HIV.G.DE64 | Stock-out or expired | Test out of stock or stock present but expired |
| HIV.G.DE65 | Machine or technician not available or machine not functioning | Test machine or technician is unavailable, or machine is not functioning |
| HIV.G.DE66 | Client declined / refused test | Client declined or refused test being undertaken |
| HIV.G.DE67 | Other | Other reason test not performed |
Generated Narrative: ValueSet HIV.G.DE70
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE71 | Positive | Test result is positive for syphilis |
| HIV.G.DE72 | Negative | Test result is negative for syphilis |
| HIV.G.DE73 | Inconclusive | Test result is inconclusive |
Generated Narrative: ValueSet HIV.G.DE74
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.G.DE75 | Syphilis positive | Client is positive for syphilis |
| HIV.G.DE76 | Syphilis negative | Client is negative for syphilis |
Generated Narrative: ValueSet HIV.H.DE1
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.H.DE2 | Missed care visit | Client did not present for a care appointment as scheduled / as expected |
| HIV.H.DE3 | Missed medication pickup | Client did not pick up medication as scheduled from pharmacy or other drug distribution point |
| HIV.H.DE4 | Did not initiate ART | Client did not initiate ART at the same time as diagnosis (e.g., because they required additional counselling) and required follow-up for ART initiation |
| HIV.H.DE5 | Incomplete visit | Client presented for care, but left before services were completed, e.g., due to long wait times or not staying to have labs taken |
| HIV.H.DE6 | Inconclusive HIV status | Client has not returned for a follow-up test after an inconclusive test result |
| HIV.H.DE7 | Test results received | Client needs to be informed of test results (e.g., viral load) |
| HIV.H.DE8 | Other follow-up reason | Client was followed up for another reason |
Generated Narrative: ValueSet HIV.H.DE13
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.H.DE14 | Home visit | Contacted client at home |
| HIV.H.DE15 | Text message | Contacted client by short message service (SMS) text |
| HIV.H.DE16 | Phone | Contacted client by phone call |
Generated Narrative: ValueSet HIV.H.DE17
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.H.DE18 | Client | The client was the source of information |
| HIV.H.DE19 | Informed by treatment provider | Source of information was a treatment provider of the client |
| HIV.H.DE20 | Informed by family or partner | Source of information was a family member of partner |
| HIV.H.DE21 | Other source of information | Information about the client's status was provided by someone else |
Generated Narrative: ValueSet HIV.H.DE23
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.H.DE24 | Returning to clinic | Client was located and agreed to return to clinic |
| HIV.H.DE25 | Self-transferred out | Client transferred to another facility for care (client-initiated transfer, not provider-initiated transfer) |
| HIV.H.DE26 | Hospitalized | Client was hospitalized |
| HIV.H.DE27 | Refused to return | Client was found but declined to return to treatment |
| HIV.H.DE28 | Not located | Attempt was made to locate client, but client was not found |
| HIV.H.DE29 | Died (reported) | The client was reported as having died |
Generated Narrative: ValueSet HIV.H.DE34
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.H.DE35 | Already knew positive | The partner or contact of the index case already knew they are HIV-positive |
| HIV.H.DE36 | Newly diagnosed | The partner or contact of the index case is newly diagnosed as HIV-positive |
| HIV.H.DE37 | Negative | The partner or contact of the index case is newly diagnosed is HIV-negative |
Generated Narrative: ValueSet HIV.H.DE41
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.H.DE42 | Lost to follow-up | Twenty-eight days or more since last missed appointment |
| HIV.H.DE43 | Transferred out | The client transferred to another facility |
| HIV.H.DE44 | Death (documented) | People living with HIV previously on ART who are confirmed to have died from any cause |
| HIV.H.DE45 | Refused (stopped) treatment | Client was contacted and confirmed to have stopped ART (reasons may include stigma and discrimination, faith healing, etc.) |
Generated Narrative: ValueSet HIV.H.DE50
This value set includes codes based on the following rules:
Generated Narrative: ValueSet HIV.H.DE53
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.H.DE54 | Forgot | Client reported not being adherent because they forgot |
| HIV.H.DE55 | Toxicity/side effects | Client reported not being adherent because of toxicity/side effects |
| HIV.H.DE56 | Busy | Client reported not being adherent because they were busy |
| HIV.H.DE57 | Change of routine | Client reported not being adherent because of a change of routine |
| HIV.H.DE58 | Travel cost | Client reported not being adherent because of travel cost |
| HIV.H.DE59 | Distance to clinic | Client reported not being adherent because of distance to clinic |
| HIV.H.DE60 | Client lost/ran out of pills | Client reported not being adherent because of client lost/ran out of pills |
| HIV.H.DE61 | Stock-out | Client reported not being adherent because of a stock-out |
| HIV.H.DE62 | Too ill | Client reported not being adherent because of being too ill |
| HIV.H.DE63 | Pill burden | Client reported not being adherent because of the pill burden |
| HIV.H.DE64 | Felt well | Client reported not being adherent because they felt well |
| HIV.H.DE65 | Depression | Client reported not being adherent because of depression |
| HIV.H.DE66 | Alcohol use | Client reported not being adherent because of alcohol use |
| HIV.H.DE67 | Substance use | Client reported not being adherent because of substance use (i.e., drugs) |
| HIV.H.DE68 | Stigma/disclosure concerns | Client reported not being adherent because of stigma/disclosure concerns |
| HIV.H.DE69 | Lack of food | Client reported not being adherent because of a lack of food |
| HIV.H.DE70 | Poor palatability | Client reported not being adherent because of poor palatability |
| HIV.H.DE71 | Other | Client reported not being adherent because of other reason |
Generated Narrative: ValueSet HIV.H.DE74
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.H.DE75 | Toxicity/side effects | Client stopped ART because of toxicity/side effects |
| HIV.H.DE76 | Severe illness, hospitalization | Client stopped ART because of severe illness, hospitalization |
| HIV.H.DE77 | Drugs out of stock | Client stopped ART because of drugs being out of stock |
| HIV.H.DE78 | Client lacks finances | Client stopped ART because client lacked finances |
| HIV.H.DE79 | Excluded HIV infection in infant | Client stopped ART because the infant was determined to not have HIV |
| HIV.H.DE80 | Other reason for stopping ART | Client stopped ART for other reason |
Generated Narrative: ValueSet HIV.I.DE2
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.I.DE3 | Hospital | Client's clinical status warrants hospitalization |
| HIV.I.DE4 | Referral for screening including diagnostics and lab testing | The client is referred because they need a lab test done and/or diagnostics done, but those services are unavailable at the current health facility or providers. This includes referral for TB screening (is symptomatic of TB, has had close contact with confirmed TB case, etc.) and other comorbidities or coinfections. |
| HIV.I.DE5 | TB referral | Referral for TB care |
| HIV.I.DE6 | Antenatal care referral | Client was referred because the client is pregnant |
| HIV.I.DE7 | Referral for other general services | If none of the reasons above apply, this should be selected |
Generated Narrative: ValueSet HIV.PRV.DE11
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.PRV.DE12 | HIV-positive | Client's contact is HIV-positive |
| HIV.PRV.DE13 | HIV-negative | Client's contact is HIV-negative |
| HIV.PRV.DE14 | Unknown | Client does not know contact's HIV status |
Generated Narrative: ValueSet HIV.PRV.DE2
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.PRV.DE3 | PrEP service | Client accessed PrEP services |
| HIV.PRV.DE4 | OAMT | Client accessed opioid agonist maintenance treatment (OAMT) services |
| HIV.PRV.DE5 | NSP | Client accessed needle-syringe programme (NSP) services |
| HIV.PRV.DE6 | STI services | Client accessed sexually transmitted infection (STI) services |
| HIV.PRV.DE7 | VMMC | Client accessed voluntary medical male circumcision (VMMC) services |
| HIV.PRV.DE8 | Other | Client accessed other HIV prevention services |